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ABSTRACT: NEURON GLIAL INTERACTIONS IN CORTICAL NEURON 
DENDRITE GROWTH. 
Interactions between neurons and glia occupy a central role in many aspects of 
development, maintenance, and function of the central nervous system (CNS). A 
fundamental event in CNS development is the elaboration of two distinct neuronal 
processes, axons and dendrites. The overall aim of this research was to characterize 
the interactions between central nervous system neurons and astroglial cells that 
regulate dendrite growth from cerebral cortical neurons. 
Embryonic (El8) mouse cerebral cortical neurons were cocultured with early 
postnatal (P4) rat astroglia derived from cerebral cortex, retina, olfactory bulb, 
mesencephalon, striatum and spinal cord. Axon and dendrite outgrowth from 
isolated neurons was quantified using morphological and double-labeling 
immunohistochemical techniques at 18 hours and 1, 3 and 5 days in vitro. Neurons 
initially extended the same number of neurites, regardless of the source of glial 
monolayer; however, astroglial cells differed in their ability to maintain primary 
dendrites. Homotypic cortical astroglia maintained the greatest number of primary 
dendrites. Astroglia derived from the olfactory bulb and retina maintained 
intermediate numbers of dendrites, whereas only a small number of primary 
dendrites were maintained by astroglia derived from striatum, spinal cord or 
mesencephalon. Initially longer axons were observed from neurons grown on 
astroglia that did not maintain dendrite number. After 5 days in vitro, axon growth 
was similar on the various monolayers, total primary dendrite outgrowth, however, 
was nearly threefold greater on astroglia derived from the cortex, retina and 
olfactory bulb than on astroglia derived from mesencephalon, striatum or spinal 
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cord. This effect was principally on the number of primary dendrites rather than the 
elongation of individual dendrites and was independent of neuron survival. 
Similar morphological differences were observed after 5 days in vitro when cortical 
neurons were grown on polylysine in either a noncontact coculture system where 
astroglia continuously conditioned the culture medium or in astroglial conditioned 
medium. Preliminary biochemical analysis of the medium conditioned by cortical 
astroglia using heat and trypsin degradation, ultracentrifugation, dialysis, and 
heparin affinity chromatography suggested that a heparin binding protein with a 
molecular weight between 10 and lOOkDa may be responsible for astroglial mediated 
dendrite growth. Neurons that were grown in medium conditioned by either 
mesencephalic or cortical astroglia for the first 24 hours followed by culture medium 
from astroglia of the alternate source for 4 days in vitro, confirmed that astroglia 
maintained, rather than initiated, the outgrowth of the primary dendritic arbor. 
In the next series of experiments, E18 mouse cortical neurons were cocultured with 
neonatal (P4) or mature (P12) rat astroglia derived from cortex and mesencephalon 
or astroglia derived from P4 and P12 lesioned cortex. After 5 days in vitro the 
maturational age of astroglia did not appear to alter the extent of primary dendrite 
growth; instead dendrite growth reflected the region of the CNS from which the 
astroglia were derived. By contrast, a reduced ability to support axon growth from 
mouse cortical neurons in culture was observed on astroglia derived from mature 
rat cortex or mesencephalon. Reactive astroglia demonstrated similar neurite 
supporting characteristics to mature astroglia and were able to maintain dendrite 
growth, principally primary dendrite number. Axon elongation, however, was 
reduced on both neonatal and mature reactive astroglia. Neuron survival did not 
correlate with the ability of the various astroglia to support process outgrowth. 
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Collectively these results indicate: 1) neuron-glial interactions are critical for the 
regulation of process outgrowth from embryonic cortical neurons in vitro, 2) axon 
and dendrite growth appear to be differently controlled by astroglia, 3) CNS astroglia 
demonstrate regional differences in maintaining, but not initiating growth of the 
primary dendritic arbor, 4) this effect may be due, in part, to release of a diffusible 
heparin binding protein factor, and 5) mature and reactive astroglia support primary 
dendrite, but limited axon growth. 
We propose therefore that the local astroglial environment maintains primary 
dendrite growth from neurons until synaptic contacts can be established. A 
mechanism that maintains the primary dendritic arbor and allows separate 
regulation of axon and dendrite growth, prior to the arrival of afferents, may be 
critical for establishing appropriate and specific synaptic connections. These findings 
have important implications in understanding development and function of the 
mammalian central nervous system and may lead to novel strategies for 
intervention in acute and chronic neurological disorders. 
Key words: Astrocyte, astroglia, axon, cortex, dendrite, development, glia, gliosis, 
injury, neuron, neurite. 
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INTRODUCTION AND SPECIFIC AIMS 
The elaboration of two distinct neuronal processes, axons and dendrites is a 
fundamental event in neuron differentiation and of critical significance as it 
establishes the neuron's functional polarity in the nervous system (Kuffler et 
al 1984, Steward 1989a, Kandel et al 1991, Peters et al 1991, Spruston et al 1994). 
Despite the enormous diversity of dendritic form in the mammalian central 
nervous system (CNS; Ramon y Cajal 1954, Peters et al 1991), little is known 
about the precise mechanisms that regulate establishment and maintenance 
of dendrite morphology. 
An understanding of the factors involved in the growth and maintenance of 
the dendritic arbor of CNS neurons will substantially impact both the basic 
and clinical neurosciences. First, dendritic remodeling and growth occurs 
throughout life (Greenough et al 1985, Levine and Truman 1985, Coleman 
and Flood 1986, Purves et al 1986, Petit et al 1988, Purves et al 1988, Black et al 
1990, Kolb and Gibb 1991, Popov et al 1992, Jones and Schallert 1994) and is 
thought to underlie memory (Lynch et al 1986, Schacher et al 1993), learning 
(Greenough et al 1985, Black et al 1990) and adaptation to the environment 
(Feldman and Dowd 1975, Coleman and Flood 1976, Greenough et al 1979, 
Purves et al 1986, 1988, Jones and Schallert 1994). Second, abnormalities in 
dendrite structure are frequently observed in acute neurologic insults such as 
trauma or stroke (Mattson et al 1988a, Kitigawa et al 1989, Taft et al 1992) and 
in neurodegenerative conditions such as Alzheimer's disease (Buell and 
Coleman 1979, McKee et al 1989). Finally, following injury dendrite growth is 
thought to play a role in recovery of neuron function (Coleman and Flood 
1986, Jones and Schallert 1994). 
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Over the past 15 years it has become increasingly apparent that glial cells are 
important to many aspects of neuron growth and differentiation during 
development of the CNS. Following neuron generation in the ventricular 
and subventricular zone of the embryonic brain, radial glia guide neuroblasts 
to their appropriate location (Levitt and Rakic 1980, Rakic 1988, Snow et al 
1990a and 1990b, Steindler 1993). The pioneering axons in the long fiber tracts 
of the CNS typically grow in association with the end feet of radial glia (Silver 
et al 1982, Silver and Ogawa 1983, Norris and Kalil 1991) while in vitro studies 
have consistently found that astroglia will support neuron survival (Banker 
1980) and neurite outgrowth (Noble et al 1984, Fallon et al 1985, Tomaselli et 
al 1988). More recently tissue culture experiments have demonstrated that 
astroglia can influence neuron polarity and dendrite morpholgy in 
sympathetic (Bruckenstein and Higgins 1988, Tropea et al 1988, Johnson et al 
1989), sensory (De Konnick et al 1993), and mesencephalic neurons (Denis-
Donini et al 1984, Chamak et al 1987, Autillo-Touati et al 1988, Rousselet et al 
1988 and 1990). 
Whether astroglia can influence the growth of dendrites from cerebral cortical 
neurons is not known. Furthermore, the characteristics of astroglial mediated 
dendrite growth are largely unknown. Therefore, the overall aim of this 
research was to characterize the interactions between CNS neurons and glial 
cells that regulate cerebral cortical neuron dendrite growth. The specific aims 
addressed by the experiments described in this report were as follows: 
1. Do astroglia influence dendrite growth from cerebral cortical neurons? 
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2. Do astroglia derived from various CNS reg10ns demonstrate regional 
differences in supporting dendrite growth from cortical neurons? 
3. Do astroglia mediate dendrite growth by cell-specific interactions or by the 
release of diffusable factors? 
4. Do astroglia initiate or maintain growth of the dendritic arbor from cortical 
neurons? 
5. Do mature astroglia support dendrite growth? 
6. Do reactive astroglia support dendritic growth? 
7. Do astroglia release an identifiable factor or factors that support dendrite 
growth? 
DEVELOPMENTAL NEUROBIOLOGY: THE LINK BETWEEN SCIENTIST 
AND CLINICIAN 
4 
Neurologic injuries and disease that lead to neuron loss or degeneration 
represent a significant health problem. For example, in the United States 
spinal cord injuries leading to paralysis affect 10, 000 people a year, head 
injuries about 500, 000, stroke about 1.5 million, and neurodegenerative 
conditions such as Alzheimer's disease, Parkinson's disease, and 
Huntington's disease affect millions more (Kurtzke 1975, Caveness 1979, 
Kalsbeek et al 1980, Kurtzke 1983, Terry and Katzman 1983, Dyken et al 1984, 
AHA, Stroke Facts 1986). Many patients afflicted by these conditions now 
survive as a result of improved health care and advances in diagnosis. 
Prognosis for full neurologic recovery has generally been poor; however, 
knowledge recently gained from basic science research suggests that a real 
hope of recovery may soon be possible. 
Experimental evidence accumulated in the last 20 years demonstrating 
reorganization and growth of the CNS following injury in both animals and 
humans (Raisman 1969, Grady et al 1989), has challenged the prevailing 
notion that the mammalian CNS does not regenerate. Furthermore, it is now 
apparent that reorganization of the CNS occurs in a wide variety of settings, 
appears to be functionally significant, and may contribute to behavioral 
recovery (Steward 1989b). This discovery of CNS plasticity has opened the 
door for therapies that potentially can modify outcome after CNS injury. 
Until recently there have been few direct treatments for CNS-injured 
patients; most efforts have been directed toward stabilizing the physiologic 
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condition, preventing secondary complications, or rehabilitation. During the 
last ten years, however, treatments aimed at preventing or reversing the 
damage of CNS injury and promoting repair of the tissue have emerged. The 
majority of these emerging treatments including: 1) administration of 
exogenous substances that prevent the cascade of deterioration resulting from 
loss of neuronal trophic support or that stimulate and promote naturally 
occurring growth responses (Kromer 1986, Walicke et al 1986, Morrison et al 
1987, Uniscker et al 1987, Yamada et al 1991, Gluckman et al 1992, Mattson et 
al 1993, Thanos et al 1993, Svedsen et al 1994), 2) replacement of lost tissue by 
grafts (Villegas-Perez et al 1988), 3) insertion of implantable drug infusion 
pumps, polymer drug delivery systems, biocompatible mechanical nerve 
guides, or sensory prostheses (Harbaugh 1989, Lipton 1989), and 4) neural 
transplantation using fetal, adrenal, neural, glial, genetically engineered, or 
immortalized cells (Bjorklund and Stenevei 1984, Sladek and Gage 1988, Kliot 
et al 1990, Blakemore and Franklin 1991, Kawaja and Gage 1991, Prim et al 
1993), have been observed to stimulate neuron survival, growth and 
differentiation in vitro or promote functional recovery in experimental 
animals. In humans, however, use of these various therapeutic strategies are 
still in their infancy (Lindvall 1991, Madrazo et al 1991). 
Potential therapeutic approaches have evolved because of improved 
experimental techniques by which complex structures can be analyzed and 
reduced to their constituent parts; such a reductionist approach has resulted 
in advances in understanding basic cellular and molecular properties of the 
CNS (Jacobsen 1991). Of importance to neurosurgeons and neurologists is the 
close relationship between development, degeneration and regeneration 
(Holder and Clark 1988, Bastmeyer et al 1993). Numerous factors that promote 
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survival or differentiation of developing CNS neurons can also prevent cell 
death in a variety of conditions and so provide a promise of effectively 
treating acute injuries, stroke or neurodegenerative conditions (Sugiyama et 
al 1989, Mattson and Rychlik 1990, Cheng and Mattson 1991, Rosenberg 1991, 
Yamada et al 1991, Mattson et al 1993, Svendsen et al 1994). Factors involved 
in development may or may not mediate regeneration, however, the study of 
neurodevelopment is critical if we are ultimately to devise rational 
therapeutic strategies to reverse the clinical and behavioral manifestations of 
brain injury, cerebral ischemia, or neurodegenerative conditions. 




The adult mammalian brain is made of individual units: neurons and glia. 
The complex and diverse functions of the mammalian CNS including 
perception, memory, coordination, and motor movement depend on specific 
connections and interactions between neurons, neurons and glia, and 
between neurons and end organs. In large part, the particular pattern of 
connections is determined by the morphology and structure of the 
component parts (Lasek 1988, Kandel et al 1991, Schacher et al 1993). 
Neuron structure was not appreciated until the late 19th century when 
Camillo Golgi (1873) introduced a histological technique, silver impregnation, 
that allowed individual neurons to be seen. Using this technique, Ramon y 
Cajal (1894 and 1954) was able to describe the fine structure of the nervous 
system, including neuron structure, differences between neurons, and the 
precise connections between neurons. What Cajal and neuroanatomists since 
then have observed is that the feature that most dramatically distinguishes 
neurons is their shape, specifically the number and form of processes 
elaborated by the cell (Nauta and Freitag 1984, Steward 1989a, Kandel et al 
1991, Peters et al 1991). 
Neurons elaborate two different type of processes: axons and dendrites. 
Multipolar neurons predominate in the mammalian central nervous system. 
Each neuron varies in size and shape, but each exhibits a complex form, 
8 
highly characteristic of that neuron type, that is largely determined by the 
morpholgy of its processes. Well differentiated, mature neurons elaborate two 
types of processes in vitro and in vivo. The two types of processes, axons and 
dendrites differ from each other in: 1) morphology (Peters et al 1991, Steward 
1989a, Deitch and Banker 1993), 2) organelles and biochemistry (Torres and 
Steward 1992, Deitch and Banker 1993), 3) surface structure (Craig et al 1992, 
Ferreira et al 1993), 4) cytoskeletal composition (Caceres et al 1986, Kosik and 
Finch 1987, Pennypacker et al 1991), 5) microtubule polarity (Baas et al 1988, 
Craig et al 1992), 6) synaptic structure (Bartlett and Banker 1984b, Fletcher et al 
1991), 7) ion channels, electrophysiology and function (Steward 1989a, Kandel 
et al 1991, Craig et al 1993, Spruston et al 1994), and 8) growth characteristics 
(Dotti et al 1988, Sargent 1989). 
Morphology. 
Neurons typically elaborate one axon that arises from a specialized region of 
the neuron cell body, the axon hillock. By contrast, a neuron typically has 
several dendrites, that branch out from the cell body in a tree like manner 
(Barlett and Banker 1984a and 1984b, Peters et al 1991, Deitch and Banker 
1993). Axons are long, thin and of relatively uniform diameter until their 
terminal arborization, whereas dendrites are relatively short, tapering 
processes, whose length is proportional to the diameter of their stem (Dotti et 
al 1988). In addition, axons may be myelinated and can cross the interface 
between the peripheral and central nervous systems; dendrites, however, are 
very rarely myelinated and generally do not cross the peripheral and central 
nervous system interface. Finally, the branching pattern differs: axons tend to 
elaborate branches at right angles depending on their interaction with their 
surroundings, whereas dendrite branching can occur at a variety of angles. 
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Organelles and biochemistry. 
Dendrites are in many ways extensions of the cell body. Ultrastructural and in 
situ hybridization studies reveal that dendrites contain polyribosomes and 
other organelles including rough endoplasmic reticulum and golgi bodies, 
whereas axons have a greater density of smooth endoplasmic reticulum, 
particularly within the axonal growth cone (Bartlett and Banker 1984a and 
1984b, Steward 1989a, Peters et al 1991, Torres and Steward 1992, Deitch and 
Banker 1993). The paucity of ribosomes in axons is one of most reliable means 
of differentiating axon and dendrite. 
The fundamental biochemical difference between axons and dendrites is the 
capability for protein synthesis (Torres and Steward 1992). In mature neurons 
protein synthetic machinery is restricted to the cell body and dendrites, 
whereas the axon hillock and axon cannot synthesize proteins. Proteins 
required for maintenance of axonal integrity and synaptic transmission must 
be carried distally by axonal transport. 
Several lines of evidence indicate that local protein synthesis occurs in 
dendrites. First, dendritic polyribosomes are often found under sites of 
synaptic specialization and become prominent during synapse growth 
(Bartlett and Banker 1984b, Steward 1989a, Peters et al 1991, Torres and 
Steward 1992, Deitch and Banker 1993). Second, a culture technique that 
allows axons and dendrites to be cultured separately, demonstrates that 
labeled amino acids are incorporated into dendrites, but not axons (Torres and 
Steward 1992). Finally, following 3H-uridine pulse labeling, recently 
synthesized RNA is selectively transported into dendrites of hippocampal 
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neurons in culture (Davis et al 1987). Most of the mRNA is for MAP2 and 
calcium/ calmodulin dependent protein kinase, two proteins integral to 
cytoskeletal stability (Kleinman et al 1990). Taken together, these 
observations suggest that local protein synthesis may induce modifications of 
synaptic structure, which is consistent with observations demonstrating that 
dendrites are sites of the highest oxidative energy metabolism in the nerve 
cell, particularly during periods of synaptogenesis (Wong-Riley 1989). 
Surface structure. 
Axons and dendrites differ in their complement of proteins, receptors, and 
adhesion molecules located on their surface membranes (Craig et al 1992). For 
example, in hippocampal neurons in culture the receptors for d-bungarotoxin 
(Banker and Waxman 1988), or transferrin (Cameron et al 1991) are restricted 
to the somatodendritic domain. 
The selective distribution of membrane proteins correlates with the 
development of neuronal polarity. For example, immunoreactivity for the 
membrane associated protein, GAP-43, is initially uniformly distributed in 
developing hippocampal neurons in culture. At the earliest stage an axon can 
be identified, GAP-43 is preferentially localized to the axon growth cone, 
whereas other processes that develop into dendrites loose GAP-43 
immunoreactivity (Goslin and Banker 1990, Goslin et al 1990). 
Membrane spanning glycoproteins present on axons and dendrites differ. For 
example, amyloid precursor protein (APP) immunoreactivity is highly 
enriched in the axonal compartment of hippocampal neurons in culture 
(Ferreira et al 1993). The axonal localization of APP is consistent with its 
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recently identified role in axon elongation (Sola et al 1993, Moya et al 1994). 
Dendrites do not demonstrate immunoreactivity for APP, however, the 
mRNA for APP has been reported in dendrites of neurons in culture (Strong 
et al 1990). By contrast, tissue section studies do not suggest a dendritic 
localization for APP mRNA (Lewis et al 1988). 
Membrane anchored proteins may be selectively distributed to axons or 
dendrites. For example, in hippocampal neurons in vitro, neuronal 
glycosylphosphatidylinositol (GPI) anchored Thy-1 is localized to the axon 
surface (Dotti et al 1991). Another GPI anchored protein, TAG-1, a cell 
adhesion molecule, is also localized to axons (Furley et al 1990). Not all GPI 
anchored proteins, however, are located exclusively in axons. For example, 
F3/Fll is found in both axons and dendrites (Craig et al 1992). 
Cytoskeletal composition. 
The neuronal cytoskeleton is composed of several classes of molecules, such 
as microfilaments, intermediate filaments, microtubules and microtubule 
associated proteins (Cleveland and Hoffman 1991, Solomon 1992). 
Immunohistochemical studies both in vitro and in vivo demonstrate that 
molecular differences between axons and dendrites extend to the cytoskeleton 
(Shaw et al 1985, Dotti et al 1987, Kosik and Finch 1987, Pennypacker et al 
1991). For example, neurofilament, an intermediate filament, exists in several 
isoforms of different molecular weights in axons and proximal dendrites; the 
phosphorylated, high molecular weight isoform (NF-H), however, is only 
found in fully differentiated axons (Sternberger and Sternberger 1983, Shaw et 
al 1985, Dahl et al 1986, Pennypacker et al 1991). 
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The structural architecture of the cytoskeleton differs in axons and dendrites. 
For example, in mature axons, microtubules, composed of tubulin, are 
arranged in tightly packed bundles, whereas they are more widely spaced in 
dendrites (Bartlett and Banker 1984a and 1984b). In part, microtubule spacing 
is determined by the presence of a particular microtubule associated protein 
(Chen et al 1992). 
Microtubule associated proteins (MAP's) are a class of umque accessory 
proteins that bind and promote the assembly of neuronal microtubules 
(Cleveland and Hoffman 1991, Lee 1993); they are selectively localized in 
differentiated neurons. For example, MAP2, a high molecular weight, heat 
stable protein is found in dendrites (Caceres et al 1984a, 1984b and 1986, Matus 
et al 1986, Dotti et al 1987). By contrast, axons express a low molecular weight 
MAP, tau (Kosik and Finch 1987, Lee 1993). Other microtubule associated 
proteins, such as MAPlb, are selectively phosphorylated in axons. 
Microtubule polarity. 
Microtubules in the axon are all oriented in the same direction; the plus end 
is oriented toward the direction of the growth cone, whereas the minus end is 
anchored in the microtubule organizing center located in the cell body. By 
contrast, microtubules in dendrites extend their plus ends toward or away 
from the cell body (Baas et al 1988, Craig et al 1992). 
Synaptic structure. 
Synapses are a unique characteristic of neurons; axons and dendrites, 
however, differ in their contribution to synaptic structure and polarity. Axons 
terminate in presynaptic terminals, whereas dendrites are generally 
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postsynaptic (Bloom 1972, Bartlett and Banker 1984a and 1984b, Peters et al 
1991). Exceptions, such as axo-axonic or dendro-dendritic synapses are found 
in the olfactory bulb and retina. 
Axons and dendrites demonstrate several distinctive structural differences at 
the synapse. For example, dendritic microspecializations known as dendritic 
spines are found at sites of synaptic contact. The size and length of dendritic 
spines varies with the activity of the presynaptic terminal (Schade et al 1972, 
Globus et al 1973, Feldman and Dowd 1975, Purpura 1975, Harris and Stevens 
1988). Dendritic spines, however, are difficult to evaluate as they are near the 
limit of light microscopic resolution; the exact function, therefore, is not 
known. Experimental and theoretical evidence is now accumulating that 
dendritic spines create an isolated biochemical environment around synapses 
and influence the dynamics of intracellular second messengers such as 
calcium (Koch and Zador 1993). 
Synaptic vesicle antigens are selectively distributed to axons (Fletcher et al 
1991), consistent with axon storage and release of neurotransmitters (Young 
and Poo 1983). By contrast, use of in situ hybridization and 
immunohistochemical techniques suggests that some growth factors, such as 
brain derived neurotrophic factor (BDNF), may be selectively released from 
the dendritic compartment of rat hippocampal and cortical neurons in 
culture (Wetmore et al 1991 and 1994). This selective release of growth factors 
may play a potential autocrine or paracrine role and provide local trophic 
support for the maintenance of plasticity and reorganization in the CNS 
(Mattson et al 1989 and 1993). 
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Ion channels, electrophysiology and function. 
The dendritic compartment contains various neurotransmitter gated ion 
channels that determine whether a synapse is excitatory or inhibitory. For 
example, glycine, gamma aminobutyric acid (GABA, Killisch et al 1991), and 
selective glutamate (alpha-amino 3-hydroxy-5-methyl-4-isoxaozole proprionic 
acid, AMPA, Craig et al 1993) gated ion channels are found on dendrites. By 
contrast, axons express sodium channels (Kandel et al 1991). 
The axon is the main conducting unit of the neuron, whereas dendrites are 
the principle receptive surface of the neuron (Kuffler et al 1984, Peters et al 
1991). Axons propagate an all or none transient electrical signal, the action 
potential, over great distances. The action potential is based on transient 
opening of voltage dependent sodium channels that generate membrane 
depolarization followed by repolarization that is mediated by increased 
potassium conductance. Once an action potential is initiated in any part of the 
axon, it is conducted on unless there is a physical interruption in the axon, or 
appropriate ion channels are inactivated. Most dendrites conduct passively as 
cable conductors; dendrite shape, in large part, determines the conducting 
properties (Steward 1989a, Kandel et al 1991). The discovery of voltage-gated 
ion channels on dendrites, however, is now challenging this view (Spruston 
et al 1994). 
Growth characteristics. 
Axons and dendrites demonstrate different growth characteristics (Dotti et al 
1988, Sargent 1989). The neuron first supports growth of a single axon, then 
growth of multiple dendrites. In general, axons elongate faster, grow long 
distances, fasciculate, and arborize when they reach their target. Dendrites 
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grow shorter distances, do not fasciculate and arborize locally. The differences 
in growth characteristics implies that the development of axons and dendrites 
may be differently regulated; the growth and elaboration of dendrites is 
reviewed more fully in chapter 5. 
Sorting of axonal and dendritic constituents. 
How axonal and dendritic constituents are segregated into polarized domains 
is not clear (Craig et al 1992). Recent experimental observations, however, 
suggest the interaction of both intrinsic and extrinsic signaling mechanisms. 
For example, synaptic vesicle proteins are selectively distributed in isolated 
hippocampal neurons in vitro; the formation of large clusters typical of 
presynaptic specializations, however, requires contact with the appropriate 
target (Fletcher et al 1991). 
Sorting of neuronal surface components may also involve an interaction of 
mechanisms intrinsic to individual neurons and mechanisms mediated by 
cell-cell interactions. For example, the viral glycoproteins, vesicular stomatitis 
virus G protein and fowl plague virus hemagglutinin are sorted to the axonal 
and somatodendritic domains respectively, in cultured hippocampal neurons 
(Dotti and Simons 1990). In epithelial cells these same viral glycoproteins are 
sorted to the apical and basolateral domains. The onset of polarity in 
epithelial cells requires an internal mechanism of vesicular sorting, but is 
only initiated in response to external signals such as cell-substrate and cell-cell 
adhesion (Simons et al 1992). 
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DENDRITES: PHYSIOLOGIC AND PATHOLOGIC SIGNIFICANCE 
Introduction. 
The dendritic arbor of CNS neurons can influence the overall function of the 
CNS in several ways. First, dendritic variation is one of the most striking 
features of CNS nerve cells (Ramon y Cajal 1954, Peters et al 1991) and of 
critical significance as it establishes polarity and allows each neuron to 
function in a network to receive, process, store, and transmit information. 
Second, dendrites appear to be among the most plastic morphologic elements 
in the nervous system (Purves et al 1988), and may compensate for neuronal 
loss in the CNS that accompanies normal aging (Coleman and Flood 1986, 
Jones and Schallert 1994). Finally, although the nature of the dendritic 
response to injury has not been clearly established, data is accumulating from 
many laboratories that implicates dendrites in several pathologic states 
ranging from Alzheimer's disease (Buell and Coleman 1979, McKee et al 1989) 
to stroke (Mattson et al 1988a, Kitigawa et al 1989, Shigeno et al 1993) and 
trauma (Taft et al 1992). This chapter will briefly review the physiological and 
pathological significance of the dendritic arbor. 
Dendrites influence synaptic function. 
The intimate pattern of synaptic connections in the CNS underlies all aspects 
of neuronal function (Kuffler et al 1984, Spruston et al 1994); these 
interactions are, in part, regulated by dendritic structure (Midtgaard 1994). 
Input from different presynaptic neurons is often distributed to several 
dendritic compartments at the synapse. The spatial and temporal integration 
of signals from various presynaptic neurons depends on the electrical 
properties of the dendrites forming the synapse and the distance between 
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dendrites; these properties are related to dendrite morphology (Midtgaard 
1994). For example, most dendrites act as cable conductors (Steward 1989a); 
cable conducting properties depend upon the relationship between internal 
resistance and membrane resistance. Internal resistance is determined by the 
internal diameter of individual dendrites (Kandel et al 1991). 
Dendrites and neural plasticity. 
At the end of the 19th century it was postulated that dendrites change shape, 
retract, or extend in response to functional demands of the environment 
(Rable-Ri.ickard 1890, Ramon y Cajal 1894 and 1954). Subsequent experimental 
data from several systems indicates that the mammalian brain can modify its 
neuronal circuitry through changes in the number, type and efficiency of 
synapses primarily by alterations in dendrite number and morpholgy 
(Greenough et al 1985, Levine and Truman 1985, Coleman and Flood 1986, 
Purves et al 1986, Petit et al 1988, Purves et al 1988, Black et al 1990, Kolb and 
Gibb 1991, Popov et al 1992, Jones and Schallert 1994). For example, 
quantitative Golgi analysis of hippocampal pyramidal neurons in the 
hibernating ground squirrel, demonstrates morphologic correlates in dendrite 
length, branching, and spine morphology with topor and arousal (Popov et al 
1992). 
Modification of the dendritic architecture provides a means by which the 
nervous system can adjust aspects of its functions to age, development and 
the environment (Feldman and Dowd 1975, Coleman and Flood 1976, 
Greenough et al 1979, Purves et al 1986 and 1988, Jones and Schallert 1994). 
Furthermore, it is postulated that these structural changes underlie memory 
and learning (Lynch 1986, Schacher et al 1993). For example, extensive 
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exposure to motor learning tasks enhances dendritic arborization and 
increases synapse number in the cortex and cerebellum (Greenough et al 1985, 
Black et al 1990). Adults and embryos may use common mechanisms and 
molecules to modify synapses and dendritic architecture, thereby linking the 
once separate fields of developmental neurobiology and learning and 
memory (Cline and Constatine-Paton 1989). 
Dendrites, plasticity and neuronal cell loss. 
Dendritic proliferation is seen in regions of the brain that demonstrate age 
related neuron loss (Coleman and Flood 1986). Neuron cell loss is a 
characteristic feature of many pathologic conditions in the CNS including 
hypoxia, ischemia, seizures, trauma, and neurodegenerative conditions such 
as Alzheimer's disease. Generally, neuron cell loss must be substantial before 
functional deficits are observed suggesting a considerable capacity for neural 
plasticity. This process of reorganization is poorly understood; one possible 
mechanism may be dendrite growth (Coleman and Flood 1986, Isacson and 
Sofroniew 1992, Jones and Schallert 1994). For example, following unilateral 
lesions to the sensorimotor cortex in experimental animals, significant 
dendrite growth is observed in the non-lesioned homotopic cortex (Isacson 
and Sofroniew 1992, Jones and Schallert 1994). The extent of compensatory 
dendrite growth correlates with the degree of functional recovery (Jones and 
Schallert 1994). 
Dendrites and acute neurologic insults. 
Excitatory amino acids (EAA) normally function as neurotransmitters; 
glutamate, an EAA, excites virtually all CNS neurons. There is substantial 
evidence, however, that in high concentrations excitatory amino acids, 
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particularly glutamate, may be integral to the pathophysiology of neuron 
injury and death in acute events such as epilepsy, stroke or trauma (Tecoma 
et al 1989, Katayama et al 1990, Beal 1992, Bullock et al 1992, Hayes et al 1992, 
Baker et al 1993, Lipton and Rosenberg 1994). The cytotoxic effects of 
glutamate are primarily mediated through agonist action at the N-methyl D 
aspartate (NMDA) subclass of glutamate receptors and result from excess 
influx of calcium into cells (Choi et al 1987, Choi et al 1988, Mattson et al 1989, 
Hartley et al 1993). 
Several lines of evidence suggest that dendrites may be particularly 
vulnerable to excitatory amino acid neurotoxicity. 1) Excitatory synapses are 
found primarily on dendrites (Peters et al 1991), hence dendrites would be 
most vulnerable and sensitive to stimulation by excitatory agonists. 2) In situ 
hybridization and immunocytochemistry of mature rat hippocampal neurons 
in culture demonstrate subcellular localization of glutamate receptors; the 
NMDA ionotropic receptors Glu Rl-3 are localized on dendritic spines (Craig 
et al 1993). By contrast, axon staining of the glutamate receptor subunit Glu Rl 
is not observed. 3) Following exposure to toxic amounts of glutamate, or 
related EAA in vivo and in vitro, the first neuronal changes observed are 
acute swelling of dendrites and cell bodies. This is followed by slowly 
evolving neuronal degeneration. By contrast, axons and glia are relatively 
refractory to EAA induced lesions (Coyle et al 1981, Schwartz et al 1983, Choi 
et al 1987, Choi 1988, Rosenberg et al 199, Shigeno et al 1993). 
The dendritic cytoskeleton and acute neurologic insults. 
A feature of both ischemia and traumatic brain injury 1s an increase in 
extracellular potassium and intracellular calcium (Katayama et al 1990, Siesjo 
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1992); both can alter the phosphorylation state of MAP2, a component of the 
cytoskeleton unique to dendrites (Halpain and Greengard 1990, Diaz-Nido et 
al 1993, Montoro et al 1993). In addition, increased intracellular calcium 
activates proteases; calcium activated proteases and the phosphorylation state 
of MAP2 play critical roles in the normal processing of cytoskeletal proteins 
(Tsuyama et al 1987, Yamauchi and Fujisawa 1988, Johnson et al 1991). For 
example, highly phosphorylated MAP2 is unable to bind to tubulin (Tsuyama 
et al 1987) or promote actin bundling (Yamauchi and Fujisawa 1988). 
Therefore, trauma or ischemia induced alterations in ion concentration may 
regulate the functional state of a major dendritic cytoskeletal protein and in 
turn modulate neuron morphology and function. 
Experimental observations suggest that the dendritic cytoskeleton may be 
altered in traumatic brain injury and ischemia. For example, 3 hours after 
moderate fluid percussion injury, quantitative Western blot evaluation of 
MAP2 levels in rat hippocampal tissue, demonstrates a significant decrease in 
MAP2 levels (Taft et al 1992). By contrast, histological studies evaluating the 
pathophysiology of traumatic brain injury, demonstrate that the function and 
viability of axons and the axonal cytoskeleton is often damaged before neuron 
somal or dendritic change is observed (Povlishock et al 1992). These 
conflicting reports, however, suggest that axons and dendrites may be 
differently damaged or vulnerable following injury or ischemia. 
Degradation of the dendritic cytoskeleton, in experimental models of 
ischemia, can be an early indicator of neuron damage and correlates 
immunohistochemically with neurons destined to die. For example, 3 
minutes after right common carotid artery occlusion in the gerbil, ischemic 
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changes can be detected in dendrites of the subiculum CA1 region of the 
ipsilateral hippocampus using immunohistochemical labels for MAP2. 
Detection of ischemic changes using hematoxylin and eosin stains occurs in a 
more delayed fashion (Kitigawa et al 1989). 
Dendrites and neurodegenerative conditions. 
Alzheimer's disease is the most prevalent cause of dementia in industrialized 
countries and a leading cause of premature death or institutionalization in 
people greater than 65 years old (Evans et al 1989, Perry 1992). Symptomatic 
Alzheimer's disease is characterized histopathologically by neuron loss, 
aberrant somatodendritic sprouting (Ihara 1988), neurofibrillary tangles (NFT) 
and extracellular deposits of B-amyloid protein (fs-AP). Quantitative studies 
suggest that these lesions correlate with the degree of dementia (Blessed et al 
1968). 
Substantial evidence suggests that dendritic pathology may be implicated in 
Alzheimer's disease. 1) In the aging brain an increase in dendrite growth is 
observed in areas of neuron loss; this age related increase, however, is not 
observed in Alzheimer's disease (Buell and Coleman 1976, Coleman and 
Flood 1986, Hanks and Flood 1991). 2) In neuritic plaques a cytoskeletal 
protein, tau, that is normally found in axons, is dislocated into the 
somatodendritic compartment where it colocalizes with MAP2 (McKee et al 
1989). 3) Senile plaques from patients with Alzheimer's disease demonstrate 
immunohistochemical labeling for heparan sulfate and chondroitin sulfate 
proteoglycans (Snow and Wright 1989, DeWitt et al 1993); these proteoglycans 
do not support dendrite growth in vitro (Lafont et al 1992). 4) The addition of 
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fs-amyloid protein to rat hippocampal neurons m culture results m 
dystrophic dendrite formation (Pike et al 1992). 
Deposits of fs-amyloid protein present in senile plaques of patients with 
Alzheimer's disease (Spillanti et al 1990, Quon et al 1991, Perry 1992) may 
contribute to dendrite injury. For example, fs-AP has been demonstrated to 
enhance glutamate and calcium ionophore induced toxicity of cortical and 
hippocampal neurons in culture, apparently by potentiating the influx of 
calcium and destabilizing intracellular calcium metabolism (Mattson et al 
1992). Neurons in the mammalian CNS use calcium as a second messenger 
that mediates a variety of adaptive responses and morphologic plasticity, 
including dendrite growth. Inability to maintain intracellular calcium within 
critically normal levels results in dendrite retraction (Mattson et al 1989, 
Mattson 1992). 
Alterations in dendrite structure are associated with many other 
neurodegenerative conditions such as malnutrition (Jacobsen 1991), 
intrauterine growth retardation (Rees and Harding 1988), developmental 
deprivation and lead exposure (Petit et al 1983), and human mental 
retardation (Purpura 1975). Furthermore, excitatory amino acids, which as 
discussed above may render dendrites particularly vulnerable to pathologic 
insult, have been suspected as mediators of neuronal injury in many chronic 
neurodegenerative conditions including Huntington's disease, AIDS 
dementia complex, and amyotrophic lateral sclerosis (Lipton and Rosenberg 
1994). Thus, it is of critical significance to understand dendrite development, 
not only to answer fundamental questions in developmental neurobiology, 
neurophysiology, memory and learning, but also to devise novel strategies 
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for intervention and rational treatment for acute neurologic disorders and 




The process by which a morphologically simple neuroblast develops into a 
morphologically complex, mature neuron involves several stages. First, 
neuroectoderm containing a uniform population of neuroepithelial 
precursors is formed by induction of undifferentiated ectoderm by mesoderm. 
The neuroepithelial precursor cells then diversify into immature neurons 
and glial cells, and following mitosis, immature neurons migrate away from 
the ventricular germinal zone. After reaching their final position, neurons 
extend axons and a primitive dendritic arbor. When the axon encounters an 
appropriate target, further dendrite outgrowth occurs and complex but precise 
synaptic contacts are formed. Finally, interaction with the environment 
results in functional refinement and modification of neuron morphology. 
The sequence of events is well described; however, the signals that initiate 
and control the events are not well understood (Purves and Lichtman 1985, 
Jacobsen 1991, McConnell 1991 and 1992). 
Decisions that control neuron phenotype may occur at any of the 
developmental stages described above (Levitt et al 1981, McConnell 1991, 
Schlagger and O'Leary 1991, McConnell 1992, Goodman and Shatz 1993). The 
final outcome of a cell's phenotype, however, appears to be determined by a 
complex interplay between cell lineage, including the inherited pattern of 
gene regulation and cytoplasmic factors that control gene regulation, and 
environmental factors including, positional information, cell-cell 
interactions, cell-cell signaling and diffusible factors (Raff 1989, McConnell 
1991). 
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The cerebral cortex is that part of the brain that has expanded most during 
primate evolution; when do cortical neurons elaborate their dendritic arbor? 
Golgi, 3tt thymidine autoradiographic, and ultrastructural studies 
demonstrate that cortical neurons first elaborate dendrites following 
completion of migration. The leading process of a bipolar migrating neuron 
becomes the apical dendrite, other dendrites develop de nova. Primary 
dendrites arise directly from the cell body late in embryogenesis. 
Subsequently, during the early postnatal period, secondary and tertiary 
branches appear, and finally dendritic spines develop (Ramon Cajal 1954, 
Shoumakis and Hinds 1978, Miller 1988). These morphologic observations are 
consistent with immunohistochemical and protein biochemical analysis that 
demonstrate that MAP2, a dendrite specific cytoskeletal protein, is first 
detected once neurons have reached their final position in the developing 
mouse cortex (Crandall et al 1986). 
While much is known about axon development, relatively little is known 
about the factors that regulate dendrite growth. Growth of dendrites could 
come about in one of several ways. First, the emergence of dendrites from the 
cell body and the pattern of branching may occur as a matter of chance. 
Second, the specificity of dendrite growth may be determined by factors 
intrinsic to the cell including its genetic endowment or cytoskeleton. Third, 
dendrite growth may be regulated by interactions between the neuron and its 
environment including the local cellular environment, extracellular matrix, 
cell adhesion molecules, neurotrophic factors, and neuronal activity. Finally, 
dendrite growth may represent an interplay between factors intrinsic and 
26 
factors extrinsic to the cell. This chapter will review potential mechanisms of 
dendrite growth. 
Dendritic ontogeny recapitulates phylogeny. 
The form of the dendritic tree becomes more elaborate during evolution. 
Ramon y Cajal (1894) first suggested this concept at the end of the last century; 
recent morphologic observations of neurons in the superior cervical ganglion 
(Purves et al 1986, Voyvodic 1987, Purves et al 1988) support his hypothesis. 
First, in the rat, the size and complexity of the dendritic arbor is directly 
proportional to the animal's body size. Second, comparative studies of the 
mammalian superior cervical ganglion in several species demonstrate that 
there are differences in species related to differences in body size. Dendritic 
arborizations increase in length and complexity as the animal grows; an 
increase in body size, however, does not correlate with an increase in the 
number of autonomic neurons (Purves et al 1988). 
Genes and dendrite growth. 
Direct control of dendrite development by specific genes has not been 
demonstrated, however, evidence is accumulating that suggests genes or gene 
products may directly or indirectly influence dendrite growth. For example, 
when pAntp, a 60 amino acid long polypeptide that corresponds to the 
homeodomain of Antennapedia, a Drosophilia homeotic gene, is added to 
embryonic rat mesencephalic neurons (Joliot et al 1991) or chick spinal cord 
motorneurons (Bloch-Gallego et al 1993) in culture, enhanced neuron 
differentiation is observed. The neuronotrophic activity of pAntp is linked to 
the propensity of the polypeptide to bind to cognate sequences in 
homeoprotein regulated genes (Le Roux et al 1993). Indirectly this may 
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influence dendrite growth as northern blot analysis and transfection 
experiments demonstrate that the expression of amyloid precursor protein, 
which can regulate axon growth (Sola et al 1993, Moya et al 1994), can be 
downregulated in cultured cells expressing the mouse homeoprotein Hox 3.1 
(Violette et al 1992). 
Intrinsic control of dendrite growth: arguments for and against. 
Several observations, including fractal analysis have been taken to imply that 
the point of origin of axons and dendrites and their initial outgrowth are 
determined by factors intrinsic to the neuron (Schade et al 1962, Van der Loos 
1965, Wise et al 1979, Bartlett and Banker 1984a, Banker and Waxman 1988, 
Steward 1989a, Jacobsen 1991, Neale et al 1993): 1) dendritic maturation occurs 
in a predictable temporal and spatial pattern, 2) improperly aligned neurons 
conserve their dendritic morphology, and 3) neurons deprived of their 
normal axonal input form morphologically distinct axons and dendrites. 
Morphologic observations suggest that dendritic maturation proceeds in a 
ventrodorsal or inside out sequence: 1) dendrites of neurons in the ventral 
lateral geniculate nucleus mature before those of the dorsal lateral geniculate 
nucleus, 2) cortical neuron dendrites mature later than the dendrites of 
neurons located in central nuclei that project to the cortex, and 3) dendrites of 
neurons located in deeper cortical layers mature before those located in 
superficial layers (Schade et al 1962, Wise et al 1979, Jacobsen 1991). While 
these observations may imply that factors intrinsic to the cell determine the 
pattern of dendrite growth, transplant studies using neurons that are not fully 
differentiated, indicate that the position of the neuron can define its 
phenotype (Renfranz et al 1991, Schlagger and O'Leary 1991, McConnel 1992). 
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For example, when an immortalized cell line from the hippocampus that 
expresses the intermediate filament nestin, typically found in proliferating 
cells, is transplanted into neonatal hippocampus or cerebellum, the 
morphologic characteristics acquired by the transplanted cells are 
characteristic of neurons and glia found at the implantation site (Renfranz et 
al 1991). 
Neurons typically give rise to one axon and a predictable number of dendrites 
that appear to originate at predictable locations. For example, the main 
dendritic trunk of cortical pyramidal neurons, originates from the apex of the 
pyramidal shaped cell body. By contrast, the axon and basal dendrites emerge 
from the basal pole. Most pyramidal cells are oriented so that apical dendrite 
points to the cortical surface and the axon toward the white matter. 
Sometimes pyramidal cells are misaligned and rotated 180 degrees; however, 
the cell still extends identifiable apical and basal dendrites (Van der Loos 
1965). This observation implies intrinsic control of dendrite elaboration, 
however, it is not clear to what extent the local cellular environment 
influences process outgrowth. 
Neurons deprived of their normal targets, afferent input, or contact with 
other neurons and glia continue to elaborate dendrites. For example, 
dissociated hippocampal neurons in culture develop in defined stages 
characterized by the formation of neurites and differentiation into 
morphologically distinct axons and dendrites (Bartlett and Banker 1984a, Dotti 
et al 1988). Considerable dendrite growth is observed and quantitative 
assessment of the dendritic branching observed in vitro, indicates that it does 
not differ significantly from either predicted branching or dendritic branching 
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observed in vivo (Banker and Waxman 1988). These experiments implied 
that the establishment of neuronal polarity was intrinsic to the neuron and 
corresponded to the expression of a neuronal maturation program. The 
neurons, however, were grown in the presence of medium conditioned by 
astrocytes which subsequent experiments have found can influence neuron 
polarity (Denis-Donini et al 1984, Chamak et al 1987, Autillo-Touati et al 1988, 
Rousselet et al 1988, Rousselet et al 1990, De Konnick et al 1993). 
Further observations of developing neurons in culture suggest that dendrite 
growth is not determined by intrinsic factors alone. First, morphologic and 
ultrastructural analysis of developing hippocampal neurons indicate that the 
axonal or dendritic nature of a newly growing process is not determined at its 
initiation but only occurs after 3 or 4 days in vitro (Cacerces et al 1986, Dotti et 
al 1988, Deitch and Banker 1993). Second, when a growing axon is transected 
shortly after differentiation, other processes, including the developing 
dendrites can develop axonal characteristics (Goslin and Banker 1990, Goslin 
et al 1990). Finally, a prominent differentiating feature of axons and dendrites 
is compartmentation of mRNA into dendrites only (Deitch and Banker 1993, 
Kleinman et al 1994). In situ hybribization studies of developing hippocampal 
neurons, however, demonstrates that newly synthesized mRNA is 
translocated into both axons and dendrites early in development, but only 
into dendrites after polarity emerges (Kleinman et al 1994). 
Dendrite growth and the cytoskeleton. 
In fully differentiated neurons, immunohistochemical studies demonstrate 
that cytoskeletal constituents are located in either a dendritic or an axonal 
domain (Binder et al 1984, Cacerces et al 1984b, DeCamilli et al 1984, Huber 
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and Matus 1984, Shaw et al 1985, Foster et al 1987). For example, MAP2 is 
highly enriched in dendrites, whereas neurofilament and tau are 
concentrated in axons; it was therefore hypothesized that the synthesis and 
expression of specific cytoskeletal elements is a crucial regulatory factor in 
process elaboration and differentiation (Cacerces et al 1984a, Matus et al 1986, 
Matus 1988). 
Expression of specific cytoskeletal proteins, however, may not determine 
process differentiation since the strict compartmentalization of cytoskeletal 
proteins is observed after the initial elaboration of neurites. For example, 
quantitative, double-labeled immunohistochemical analysis of developing 
embryonic hippocampal or cortical neurons in vitro, indicates that MAP2 is 
found in all processes at initiation of outgrowth; is then coexpressed with 
neurofilament or tau, and is only selectively expressed in dendrites after 
about 4 days in vitro (Cacerces et al 1986, Kosik and Finch 1987, Pennypacker 
et al 1991). Furthermore, the expression of MAP2 is not sufficient to induce 
the formation of dendrites. For example, in culture medium containing 
serum, sympathetic neurons develop a dendritic arbor that expresses MAP2. 
In serum free medium the neurons are usually unipolar and elaborate an 
axon; MAP2 expression, however, is still observed (Higgins et al 1988). 
Neurons may become polarized following selective stabilization of 
microtubules (Kirschner and Mitchison 1986, Rousselet et al 1990). According 
to this hypothesis, microtubules of unpolarized cells are unstable; an external 
signal impinging on one region of the cell causes a local biochemical change 
that alters microtubule stability or density in that region and subsequently 
results in elongation. Whether microtubules determine, or are only features 
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of dendrite differentiation is not clear. For example, ultrastructural analysis of 
developing hippocampal neurons indicates that differences in microtubule 
polarity orientation and density first appear after axons and dendrites have 
developed other differentiating features such as sorting of ribosomes (Deitch 
and Banker 1993). 
A role for the cytoskeleton in process differentiation and subsequent dendrite 
growth suggests that the somatic cytoskeleton carries a template for neuron 
polarity. Since axonal microtubules are all oriented in the same direction, the 
position of the microtubule organizing center (MOTC), might determine 
polarity. In cultured hippocampal cells the position of the MOTC correlates 
with an indentation in the nuclear membrane; during morphologic 
differentiation, however, the position of the MOTC does not correlate with 
the position of the axonal growth cone (Dotti and Banker 1992). 
Dendrite growth: the role of afferents, synapses and neurotransmitters. 
Dendrites often develop in parallel with the ingrowth of afferents and 
formation of synaptic contacts. For example, in the developing dentate gyrus 
of the rat, differentiation of granule cell dendrites occurs during the same 
period as ingrowth of afferents and synaptogenesis (Bloom 1972, Cowan et al 
1980). Furthermore, the number of afferents may be an important factor that 
determines the size and complexity of the dendritic tree (Perry and Linden 
1982, Leventhal et al 1989, Sanes et al 1992a). For example, if a region of retinal 
ganglion cells in the primate retina is surgically depleted, enlargement of the 
remaining ganglion cells and dendrites is observed in the cell poor region 
suggesting that the dendrites are competing for the available afferents 
(Leventhal et al 1989). 
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The role of afferents on dendrite growth and maintenance is well 
documented. For example, partial removal of excitatory afferents to the 
nucleus laminaris of the chick brainstem auditory nucleus results in rapid 
and selective atrophy of deafferented dendrites with little or no effect on 
other dendrites (Rubel et al 1981, Deitch and Rubel 1984). In the autonomic 
nervous system, dendritic retraction is observed after axotomy, however, 
following renervation the dendritic arbor re-expands (Yawo 1987). 
Synapses are regarded as the unique characteristic of neurons for information 
storage and transfer; they may also provide developmental signals. The 
synaptotropic theory posits that dendritic growth and branching are initiated 
and maintained by the synapses formed on growth cones of dendrites 
(Vaughan 1989). Synapse formation may primarily modulate dendrite 
branching. For example, in the absence of synaptic activity, dendrites of 
cultured cerebellar Purkinje cells continue to elongate. Once synaptic contact, 
identified by electrical activity, is made, dendrite elongation ceases and 
branching begins. When endogenous electrical activity is blocked by the 
administration of tetrodotoxin dendrites continue to elongate (Schilling et al 
1991). These tissue culture observations are consistent with in situ 
ultrastructural observations that suggest that synaptic contact is particularly 
important for the growth of tertiary dendrites and dendritic spines (Harris 
and Stevens 1988). 
How do afferents or synapses modulate dendrite growth? The axon terminal, 
once it reaches its target may provide a retrograde signal that initiates or 
maintains dendrite growth (Yawo 1987). For example, retrograde transport of 
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nerve growth factor (NGF) is observed in the autonomic nervous system 
(Levi-Montaclini 1987). When NGF is administered to sympathetic neurons 
in vivo, or vertebrate sensory neurons in vitro, an increase in dendritic 
arborization is observed (Snider 1988, De Konnick et al 1993). Alternatively, 
neurotransmitters may provide cell extrinsic signals to neurite outgrowth in 
the vertebrate CNS (Mattson et al 1988a, 1988b, and 1989). For example, in 
isolated hippocampal neurons in vitro, glutamate can cause selective 
regression of dendrites through a calcium dependent mechanism without 
significantly affecting either axon growth or neuron survival (Mattson et al 
1988a, 1989b, and 1989). Calcium may be an important second messenger in 
neuron modulation of dendrite growth. In addition to mediating the effect of 
glutamate on dendrite elongation, intracellular calcium homeostasis is 
altered at the time of synapse formation in cultured Purkinje cells, when, as 
noted above, dendrite elongation ceases and branching begins (Schilling et al 
1991). 
Can dendrite growth occur without afferent or synaptic influence? 
Several observations suggest that the parallel development of dendrites and 
afferents is not invariable. First, neuronal form can develop in the absence of 
neuronal activity. Tetrodotoxin which blocks neuron activity is released by 
the Taricha newt; when pieces of the Taricha embryo are grafted to embryos 
of Ambystomid urodeles, the host embryos are paralyzed until the toxin 
wears off. Despite the absence of neural activity, morphologically normal 
spinal cord motorneurons are formed (Twitty and Johnson 1934). Second, in 
situ observations using intracellular injections of horseradish peroxidase, 
lipid soluble tracers, or quantitative Golgi analysis demonstrate that dendritic 
projections, although immature are established before the arrival of afferents 
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in a variety of developing systems including the sympathetic ganglia 
(Voyvodic 1987), spinal cord (Snider et al 1992), dorsal lateral geniculate 
nucleus (Sutton and Brunso-Bechtold 1993), brainstem (Hammer et al 1981), 
and cortex (Wise et al 1979, Petit et al 1988). 
Tissue culture studies provide further evidence that some aspects of dendrite 
growth can occur without afferents. For example, isolated hippocampal 
neurons that develop in vitro without afferents can form dendritic arbors 
similar to that seen in vivo. (Barlett and Banker 1984a, Banker and Waxman 
1988). In addition, dendrite elongation may be diminished by afferents in 
vitro. For example, decreased dendrite growth is observed from hippocampal 
neurons when they are grown on a bed of their afferents, axons from the 
enterorhinal cortex (Mattson et al 1988). Dendritic branching, however, may 
require afferent or synaptic activity. For example, when the density of 
cultured hippocampal neurons is increased, or cultured cerebellar neurons 
establish synaptic contacts (Schilling et al 1991), dendritic branching, but not 
length, is enhanced. 
Neuron activity determines the final form of the dendritic arbor. 
The observations described above suggest that afferent or synaptic activity is 
not always required for the initial development of dendrites, but may be 
necessary for the full development of a mature dendritic arbor. There is 
substantial evidence that the final form of the dendritic arbor depends on the 
presence and function of afferents (Smith 1981, Greenough et al 1985, Black et 
al 1990, Kolb and Gibb 1991, Sanes et al 1990 and 1992a, Jones and Schallert 
1994). For example, in the weaver mouse, a mutation that affects 
differentiation of cerebellar granule cells, Purkinje cells fail to receive their 
35 
normal innervation; dendrites are much shorter and less branched than 
those observed extending from normal Purkinje cells (Rakic and Sidman 
1973). 
Afferent function depends, in large part, on the environment; the 
environment an animal encounters, such as sensorimotor deprivation or 
increased functional activity, can lead to alterations in size, structure, or 
orientation of dendrites (Globus et al 1973, Greenough et al 1985, Purves et al 
1986, Black et al 1990, Jacobsen 1991). For example, when rats are raised in an 
enriched environment, a greater density of dendritic spines is observed on 
pyramidal neurons in the visual cortex than when the rats are raised in a 
deprived environment (Globus et al 1973). Visual deprivation results in the 
redistribution of visual cortex stellate cell dendrites. Normally these dendrites 
arborize extensively in the fourth cortical layer where the majority of lateral 
geniculate body afferents terminate. By contrast, after unilateral enucleation, 
stellate cell dendrites avoid the fourth layer and arborize in other layers of the 
visual cortex (Valverde 1968). 
How does neuron function influence dendritic architecture? Observations in 
several systems demonstrate that during the course of development and 
maturation, refinement, rather than development, of the dendritic arbor 
relies on the presence of afferents (Smith 1981, Greenough et al 1985, Black et 
al 1990, Kolb and Gibb 1991, Sanes et al 1990, 1992a and 1992b, Jones and 
Schallert 1994). Hypertrophic responses, such as increased dendritic 
arborization and complexity, primarily at higher order branches (Greenough 
et al 1985, Coleman and Flood 1986, Leventhal et al 1989, Black et al 1990, 
Sanes et al 1992a, Jones and Schallert 1994) and increased spine density 
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(Globus et al 1973, Harris and Stevens 1988) or regressive events, such as a 
decrease in the number of primary dendrites, (Smith 1981), total process 
length (Weiss and Pysh 1978), branch points, (Rogowoski and Feng 1982, 
Sanes and Siverls 1991), or number of dendritic spines (Ramoa et al 1988) 
have been described in a wide variety of systems and may account for 
functional refinement of the dendritic arbor. For example, the dendritic 
arborization of the lateral superior olive (central auditory nucleus) in the 
gerbil varies along its tonotopic axis, being more constrained at higher sound 
frequency projection regions (Sanes et al 1990). Electrophysiologic and Golgi 
impregnated quantitative morphologic observations demonstrate that these 
differences occur after the response to airborne sound, and are primarily 
manifest by a reduction in total dendritic length and number of branch points 
(Sanes et al 1992b). The number of primary dendrites, however, does not 
change significantly, consistent with the concept that at least a primitive 
dendritic arbor, possibly subject to intrinsic or other environmental signals, 
can develop before neuronal activity. 
Glial cells influence dendrite growth. 
The local cellular environment can mediate neuron form (Renfranz et al 
1991, Schlagger and O'Leary 1991, Grove et al 1992, McConnel 1992, Reh 1992, 
Marvin and McKay 1993). For example, in the retina, progenitor cells 
differentiate according to the cells that surround them rather than an 
intrinsic mechanism (Reh 1992). 
Neurons are surrounded by glial cells; in the vertebrate CNS glial cells are 
between 10 and 50 times more numerous than neurons (Pope 1978, Nauta 
and Freitag 1986). Interactions between neurons and glia occupy a central role 
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in the function of the nervous system (Barres 1991, Martin 1992, Finkbeiner 
1993) and are of great importance in determining the structural organization 
and development of the brain. For example, during development glial cells, 
particularly astrocytes, have been demonstrated to be important for: neuron 
survival (Banker 1980), neuron migration (Levitt and Rakic 1980, Rakic 1988, 
Gasser and Hatten 1990), establishment of brain cytoarchitecture (Snow et al 
1990a and 1990b, Steindler 1993), neurite outgrowth (Noble et al 1984, Fallon 
1985, Tomaselli et al 1988), axon guidance (Silver et al 1982, Silver and Ogawa 
1983, Norris and Kalil 1991), establishment of neuron polarity (Denis-Donini 
et al 1984), and synaptogenesis (Rouget et al 1993). 
Do glial cells have a role in dendrite growth? Experimental observations in 
the peripheral and autonomic nervous systems suggest that both the presence 
or absence of glia can influence dendrite morphology. For example, when 
cultured in the absence of glia, rat sympathetic neurons do not develop 
dendrites, although they extend axons. When glial cells are added the 
sympathetic neurons promptly elongate their dendritic arbor (Bruckenstein 
and Higgins 1988, Tropea et al 1988, Johnson et al 1989). By contrast, the 
presence of glial cells inhibits the extension of dendrites from neonatal rat 
sensory neurons in culture. Dendrite growth is observed when the glial cells 
are removed (De Konnick et al 1993). 
In the CNS, tissue culture experiments suggest that dendrite morpholgy can 
be modified by the glial environment. For example, embryonic mouse 
mesencephalic neurons when cocultured with astroglia develop different 
morphologic, immunohistochemical, and ultrastructural dendritic 
characteristics depending on the anatomic origin of the astroglia. When 
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grown on, or in medium conditioned by homotypic mesencephalic astroglia, 
mesencephalic neurons grow both an axon and an extensive dendritic arbor. 
By contrast, when mesencephalic neurons are grown on, or in medium 
conditioned by heterotypic striatal astroglia, axon growth occurs but poor 
dendritic arborization is observed (Denis-Donini et al 1984, Chamak et al 1987, 
Autillo-Touati et al 1988, Rousselet et al 1988 and 1990). 
Apart from the experiments described above, the role of glial modulation of 
dendrite growth from neurons has not been extensively investigated. 
Although ample evidence exists that astroglia can influence dendrite 
morphogenesis, the mechanism of this influence remains unclear. Do 
astroglia support cortical neuron dendrogenesis? Do astroglia derived from 
various regions of the CNS support dendrite growth or are there regional 
differences in astroglial support of dendrite growth? Do astroglia initiate, 
maintain or refine the dendritic arbor? Does astroglial age influence dendrite 
growth? Do reactive astroglia, that are characteristic of the injured brain, 
influence dendrite growth? Do astroglia mediate dendrite growth by cell-
specific interactions or by the release of diffusable factors? The experiments 
described in this study will attempt to answer some of these questions using 
tissue culture, quantitative immunohistochemical techniques, and protein 
biochemistry. 
The role of nutrition, hormones and opioids on dendrite growth. 
Whereas the predominant influence on dendrite growth is derived from the 
surrounding cellular environment, neuronal activity and factors intrinsic to 
the neuron, several other factors have been observed to influence the shape 
of the dendritic arbor. Among others, these factors include nutrition, 
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glucocorticoid, thyroid, and sex hormone levels, endogenous opiods and 
retinoic acid (Lauder 1983, Fischer et al 1986, Hauser et al 1989, Goldstein et al 
1990, McEwan 1991, Jacobsen 1991). For example, the most striking feature of 
malnutrition on the cerebral or cerebellar cortex of rats is a reduction of 
dendritic spine density (Jacobsen 1991). Along similar lines, the total number 
of dendritic spines present on cerebellar neurons is decreased in fetal sheep 
suffering intrauterine growth retardation, in part, because the length, but not 
the number of granule cell dendrites and the branching density and branch 
length of Purkinje cell dendrites is reduced (Rees and Harding 1988). 
The nervous system regulates and responds to the endocrine system; in turn 
hormones can influence dendrite growth (Goldstein et al 1990, McEwan 1991). 
For example, dendrite morphology is influenced by levels of sex hormones in 
both the male and the female. In the male, dendrites of the spinal 
bulbocavernous nucleus motorneurons extend and retract in response to 
testosterone levels throughout the rats life (Goldstein et al 1990). In the 
female rat, dendritic spines present on neurons in the ventromedial 
hypothalamus and the hippocampus appear and disappear during the course 
of the ovarian estrous cycle in response to levels of estradiol. By contrast, 
estradiol does not induce significant changes in dendritic spine density in the 
male (McEwan 1991). 
Factors such as nutrition, hormones and opiods appear to refine the dendritic 
arbor rather than primarily promote dendrite growth (Rees and Harding 1988, 
Hauser et al 1989, Jacobsen 1991 McEwan 1991). For example, in neonatal rats, 
continuous blockade of endogenous opioid receptors by the exogenous 
antagonist, naltrexone, significantly increases dendritic spine density, but not 
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primary dendrite number elaborated by cerebral cortical neurons (Hauser et al 
1989). Other factors, such as retinoic acid, may play an important role in the 
induction of dendrite growth. For example, retinoic acid induces the 
extension of branched and unbranched neurites in neuroblastoma cells 
(Fischer et al 1986). Furthermore, retinoic acid is among the few factors 
known to modulate homeogene expression (Boncinelle et al 1991). Since 
homeogenes specify positional information in the developing and adult 
mammalian spinal cord and brain (Awgulewitsch and Jacobs 1990, Simeone 
et al 1992 Prochiantz et al 1993), it is conceivable that an interrelationship 
between genetic factors such as homeogenes and extrinsic factors such as 
retinoic acid may account for the anatomical specificity observed in 
mesencephalic or striatal glial promotion of mesencephalic neuron dendrite 
growth. 
Towards a theory of dendrite development. 
The variety of factors, described in the preceding sections, that can influence 
dendrite development emphasize that there is probably no general theory of 
dendrite morphogenesis, except at the most abstract level. Dendrite 
development may occur in three stages: 1) initiation of dendrite outgrowth, 2) 
establishment and maintenance of basic structure, the primary dendritic 
arbor, and 3) establishment of the final dendritic arbor, including secondary 
and tertiary branches and its subsequent refinement and remodeling. Each 
stage in dendrite development may be influenced by different factors: 1) 
intrinsic factors may initiate growth, 2) the local cellular environment may 
influence the primary structure, and 3) neuron activity and the environment, 
including such diverse factors as nutrition and the level of stimulation, may 
determine the final dendritic structure. The principle hypothesis of the 
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experiments reported in this study is that the local astroglial environment 
influences the primary dendritic arbor extended by a neuron. Ultimately, 
however, the cumulative effect of different factors, that work in concert on 




The abundance of cellular phenotypes, and the anatomical, physiologic, and 
biochemical complexity of the mammalian CNS presents a barrier to 
elucidating the function of individual cells, the interactions that occur 
between cells, and the development of cellular morphology. Glial cells in 
vivo are particularly difficult to identify and study since many of the 
approaches used to study neurons such as electrophysiology, selective 
lesioning, or retrograde labeling can not be readily applied (Levison and 
McCarthy 1991). 
Many methods exist to isolate individual cells; primary tissue culture 
provides a means of studying large volumes of pure cells in which variables 
affecting the cell can be simplified, controlled and manipulated and a means 
by which growth and inhibitory factors of interest can be isolated (Levison 
and McCarthy 1991). The technique of cell culture was developed at the 
beginning of this century (Harrison 1910). During the last 15 years, cell culture 
has been used extensively to study glial function, particularly function of the 
most numerous type of glial cell, astrocytes (McCarthy and DeVellis 1980, 
Levison and McCarthy 1991). The ability to study glia in culture has resulted, 
in part, from refinements of in vitro techniques and the development of 
immunological markers that unambiguously identify glial cells and subtypes 
(Raff et al 1978, Eng 1985). Much of our knowledge of the functional 
properties of various glial cells are derived from tissue culture studies 
(Hansson 1988, Lilien and Raff 1990, Barres 1991, Hatten et al 1991, 
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Kapfhammer and Schwab 1992, Kimelberg 1992, Martin 1992, Eddlestone and 
Mucke 1993, Finkbeiner 1993, Murphy et al 1993, McMillan et al 1994). 
Several lines of evidence suggest that glia in vitro and in vivo may be 
similar: 1) glia in culture express many of the same ultrastructural properties 
observed in vivo (Kimelberg 1983, Bovolenta et al 1987, Peters et al 1991), 2) 
the most numerous type of glial cell, astrocytes, express similar quantities of 
the astrocyte enriched protein, glial fibrillary acidic protein (GFAP, Eng 1985), 
and the astrocyte specific enzyme, glutamine synthetase (Schousbee 1981),in 
vitro and in vivo, 3) electrophysiologic properties are similar in vitro and in 
vivo (Kimelberg 1983, Hansson 1988), 4) the timing of glial differentiation 
(Lillien and Raff 1990) and maturation appears similar in vivo and in vitro, 
provided serum is present in the culture media (Hatten 1984, Williams et al 
1985, Smith et al 1986, Smith et al 1990), and 5) astrocytes in culture release a 
large variety of neuropeptides, neurotransmitters, cytokines and growth 
factors; although this in vitro observation may represent an artifact, injured 
or reactive astrocytes in vivo have also been observed to release many of 
these same factors (McMillian et al 1994). 
Glial cells are divided into two major classes by size and embryology: 
microglia and macroglia. Microglia are small cells that originate from the 
mesoderm and generally are mobilized after injury to the nervous system. 
Macroglia are larger cells derived from the neural plate and consist of three 
principle types: 1) astrocytes, that can be specifically identified by labeling with 
antibodies against GFAP (Dahl and Bignami 1976, Eng 1985), 2) the myelin 
producing cells of the CNS, oligodendrocytes, that can be identified by 
antibodies against galactocerebroside (Raff et al 1978), and 3) Schwann cells, 
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the principle glial cell of the peripheral nervous system. Astrocytes are the 
most numerous glial cell and occupy 50% of the brain's volume (Pope 1978, 
Nauta and Freitag 1986, Schwarz and Marini 1992). The culture techniques 
used in the experiments described in this study are designed to obtain purified 
type 1 astrocyte cultures (McCarthy and de Vellis 1980, Raff et al 1983, Levison 
and McCarthy 1991), or in the case of the retina, a specialized form of 
astrocyte, the Muller glial cell (Sarthy 1985, Cameron and Rakic 1991). 
Astrocytes can be readily identified at the light microscopic level. In addition 
astrocytes contain an unique intermediate filament, GFAP, that permits 
unambiguous immunohistochemical identification of astrocytes (Dahl and 
Bignami 1976, Eng 1985, Cleveland and Hoffman 1991). Several classes of 
astrocytes, that differ in appearance and location can be found in the mature 
brain. Broadly, astrocytes can be divided into protoplasmic astrocytes, found 
in the gray matter, or fibrous astrocytes that are more abundant in white 
matter (Peters et al 1991). 
Tissue culture studies suggest an alternate view of broad astrocyte (or 
astroglial) subtypes based on cell lineage (Raff et al 1983, Miller et al 1989, Raff 
1989). In the lineage model astrocytes are designated as type 1 or type 2 based 
on immunologic and morphologic criteria. These subtypes were first 
described in the optic nerve (Raff et al 1983) and subsequently have been 
observed in other regions of the nervous system, including the cerebral 
cortex, cerebellum and spinal cord (Miller and Raff 1984, Williams et al 1985, 
Behar et al 1988, Ingraham and McCarthy 1989, Schwarz and Wilson 1992). 
Type 1 astrocytes are found in gray matter and are proposed to be the cell 
culture equivalent of protoplasmic astrocytes, whereas type 2 astrocytes are 
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regarded as the cell culture equivalent of fibrous or perinodal astrocytes 
(Miller and Raff 1984, ffrench-Constant et al 1986). Whether the type 1 or type 
2 astrocyte lineage applies to all CNS regions (Hirano and Goldman 1988, 
Goldman and Vaysee 1991, Fok-Seang and Miller 1992, Black et al 1993), or is 
relevant in situ (Skoff and Knapp 1991) is not clear, therefore the terms are 
best reserved for astroglia in tissue culture only. 
In general, the properties displayed by astroglia in culture have been verified 
in vivo (Schwarz and Marini 1992); there are, however, several important 
caveats to consider when interpreting results obtained from tissue culture 
experiments. First, astroglia in culture are generally prepared from immature 
brain. Although the origin and properties of cultured astroglia obtained from 
adult and neonatal rat brain appear similar, it is unclear whether cultured 
astroglia should be considered mature or immature cells (Norton et al 1988, 
Norton and Farooq 1989). Second, astroglia in culture are removed from their 
normal environment and so can not interact with other neural cells. 
Depending on whether they are cultured alone, or with other neural cells, in 
particular neurons, astroglia exhibit different physiologic properties 
(Corvalan et al 1990, Barres et al 1990a and 1990b) and morphologies (Hatten 
1985, Mason et al 1988, Ingraham and McCarthy 1989, Gasser and Hatten 1990). 
The relevance of neuron induced astroglial morphologic changes is not 
known (Hatten et al 1991). Third, astroglia in culture are exposed to serum, 
whereas in vivo, the blood brain barrier shields astroglia from blood derived 
factors; the presence of serum can influence astroglial differentiation 
(Morrison and de Vellis 1981, Raff et al 1983, Ingraham and McCarthy 1989, 
Raff 1989, Landis et al 1990). Fourth, astroglia in culture are in an artificial 
environment; astroglial proliferation, differentiation, morphology and 
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antigenicity may all be affected by the composition of the culture media and 
substrate (Dahl 1981, Hatten et al 1991). 
Astrocytes occupy a central role in the formation, maintenance and function 
of the nervous system (summarized in Table 1). To examine the influence of 
astroglia on dendrite growth from CNS neurons several experimental 
techniques, including: 1) primary tissue culture and chimeric coculture in 
which purified mouse cortical neurons were cultured with rat astroglial 
monolayers or medium conditioned by rat astroglia, 2) image intensification 
and quantitative computer assisted immunohistochemical and morphologic 
analysis, and 3) protein biochemistry were used. The experimental techniques 
are described in detail in Materials and Methods. 
Neurons. 
Mouse neurons can be specifically identified by the immunolabel M6. The M6 
antigen is a 35kDa glycoprotein that can be isolated from deoxycholate 
solubilized membrane fractions of mouse brain (Lagenaur et al 1992). The 
antibody to M6 is species specific and labels only mouse neurons and their 
processes. M6 has been extensively studied in interspecies transplants (Lund 
et al 1985) and to determine cell fate and commitment of retinal progenitor 
cells (Reh 1992). Chimeric coculture was therefore used to: 1) minimize 
neuron influence on dendrite growth, as a small number of readily 
identifiable neurons could be plated in a high density glial environment, and 
2) prevent inadvertent analysis of neurons that may have contaminated the 
glial cultures. M6 was used in combination with immunolabels specific for 
proteins found in axons or dendrites. Prior to using the various antibodies, 
their presence in mouse cortex was confirmed by Western blot analysis and 
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the sequence of their developmental expression was examined by 
quantitative immunohistochemical techniques (chapter 8). 
TABLE 1: SUMMARY OF KNOWN OR POTENTIAL FUNCTIONS OF 




Regulate development of 
multipotent progenitor cells 
Neuron migration 




Establishment of neuron polarity 
Modulate neuron morphology 
Syna ptogenesis 
Formation of Nodes of Ranvier 
Regulate myelination 
MAINTENANCE AND FUNCTION 
Form glial limitans 
REFERENCE 
Banker 1980, O'Malley et al 1992 
Raff 1989 
Levitt and Rakic 1980, Rakic 1988, 
Gasser and Hatten 1990 
Snow et al 1990, Steindler 1993 
Noble et al 1984, Fallon 1985 
Silver et al 1982, Norris and Kalil 
1991 
Denis-Donini et al 1984 
Prochiantz et al 1990, Qian et al 1992 
Rouget et al 1993 
ffrench-Constant et al 1986 
Boyles et al 1985, Raff 1989, 
Blakemore and Franklin 1991, Dutly 
and Schwab 1991 
Peters et al 1991 
Induce blood brain barrier formation Janzer and Raff 1987, Joo 1987 
Regulate cerebral blood supply 
Regulate vessel caliber 
Paulson and Newman 1987, Aoki et 
al 1991 
Murphy et al 1990 
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Regulate extracellular and interstitial Kimelberg 1983, Barres 1991, 
sodium, calcium and chloride Sontheimer et al 1991, Finkheimer 
concentration 1993 
Extracellular potassium buffer 
Modulate neuronal ion channels or 
currents 
Acid base balance 
Nutrient or metabolite supply for 
neurons 
Source of neurotrophic factors 
- Ciliary neurotrophic factor 
- Epidermal growth factor 
- Fibroblast growth factor 
- Glial maturation factor 
- Insulin like growth factor 
- Interleukins 
- Nerve growth factor 
- Platelet derived growth factor 
- Transforming growth factor 
Source of plasma proteins 
Source of proteases and protease 
inhibitors 
Source of neuropeptides 
Kuffler et al 1966, Orkand 1977, 
Barres et al 1990a, Barres 1991 
Black et al 1989, Sontheimer et al 
1991, Black et al 1993, Wu and Barish 
1994 
Kimelberg 1983, Chesler 1990 
Lowry et al 1964, Tsacopoulos et al 
1988 and 1994 
Lillien et 1988 
Gomez-Pinilla et al 1988 
Ferrara et al 1988 Gonzalez et al 1990, 
Woodward et al 1992 
Lim 1985 
Rotwein et al 1988 
Beneviste et al 1990, Wesselingh et 
al 1990 
Furukawa et al 1986, Lu et al 1991, 
Saad et al 1991, Yoshida and Gage 
1991, Zafra et al 1992 
Mapstone 1991, Yeh et al 1991 
Fallon et al 1990, Wesselingh et al 
1990, Saad et al 1991 
Kalderon et al 1990, Zahs et al 1993 
Kalderon et al 1990, Deschepper et al 
1991, Zahs et al 1993 
Shinoda et al 1989, Intebi et al 1990, 
Zahs et al 1993 
Enkephalin metabolism 
Nitric oxide/ endothelium derived 
relaxing factor metabolism 
Prostanoid metabolism 
Iron metabolism 
Glutamate and ammonia 
metabolism 
Modify synaptic transmission and 
plasticity 
Release neurotransmitters, 
neuromodulators and neuroactive 
substances 
Uptake of excitatory amino acids 
Uptake of neurotransmitters and 
neuromodulators including GABA, 
taurine, norepinephrine, dopamine, 
serotonin, acetyl-choline, histamine, 
adenosine, prostoglandins, 
benzodiazepines, vasoactive 
intestinal peptide, glucagon, and 
somatostatin 
Neuron-glial and glial-neuron 
signaling 
INJURY AND REPAIR 
Wall off necrotic tissue 
Phagocytosis 
Control deposition of scar tissue 
Shinoda et al 1989 
Murphy et al 1990, 1993 
Pearce et al 1989 
Orita et al 1990, Zahs et al 1993 
Norenberg 1979, Schousbee 1981, 
Kaneko et al 1988 
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Pomeroy and Purves 1988, Theodosis 
and Poulain 1989, Smithson et al 
1990 
Barres 1991, Flott and Seifert 1991, 
Gallo et al 1981, Martin 1992 
Murphy and Pearce 1987, Ahmed et 
al 1990, Ortega et al 1991, Clark and 
Mobbs 1992, Schwarz 1993, 
Holzwarth et al 1994 
Hansson 1988, Lerea and McCarthy 
1989, Bevan 1990 
Cornell-Bell et al 1990, Barres 1991, 
Ortega et al 1991, Dani et al 1992, Van 
den Pol et al 1992 
Berry et al 1983, Mathewson and 
Berry 1985, Reier et al 1992 
Noske et al 1982 
Logan et al 1992 
N europrotection 
Provide lipids for membrane 
biosynthesis 
Immune response 
Diminish excess iron loads 
Neurite growth 
Inhibit axon growth 
Growth factor production 
- Epidermal growth factor 
- Fibroblast growth factor 
- Insulin like growth factor 1 
- Nerve growth factor 
51 
Vilbulsreth et al 1987, Sugiyama et al 
1989, Mattson and Rychlik 1990, 
Rosenberg 1991, Rosenberg et al 1992, 
Giulian et al 1993 
Diedrich et al 1991 
Hertz et al 1990 
Orita et al 1990, Zahs et al 1993 
David et al 1990, Kawaja and Gage 
1991 
Berry et al 1983, Reier et al 1983, 
Liuzzi and Lasek 1987 
Nieto-Sampedro et al 1982, 
Manthorpe et al 1983 
Nieto-Sampedro et al 1988 
Finklestein et al 1988, Gomez-Pinilla 
et al 1992, Logan et al 1992 
Garcia Estrada et al 1992 
Bakhit et al 1991 
Table 1: The table lists published data or reviews describing known or 
potential functions, or evidence for a function for astrocytes in the CNS. 
Astrocytes were thought to be important in brain function at the beginning of 
the 20th century (Lugaro et al 1907), but, until recently, were relegated to a 
static, passive support function. Today, there is substantial experimental 
evidence that astrocytes are dynamic partners in CNS function and actively 
participate in the formation, maintenance, and repair of the central nervous 
system. The following broad categories of astrocyte function are recognized: 1) 
development of neuron and CNS architecture, 2) exchange mechanism 
between capillaries and neurons, 3) extracellular ionic micro-environment 
regulation, 4) provision of neuronal nutrition or trophic support and 
regulation of neuronal metabolism, 5) synaptic activity regulation, 6) 
intercellular signaling, and 7) repair and protection of the injured CNS. 
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MATERIALS AND METHODS 
TISSUE CULTURE 
Dissociated cerebral cortex neuron cultures. 
Highly enriched populations of dissociated cerebral cortical neurons were 
prepared from the brains of mouse embryos. Pregnant Balb / c mice (E18) were 
killed by decapitation following CO2 anesthesia and the embryos removed 
under sterile conditions. Frontal cerebral cortex was dissected in sterile 
Hank's balanced salt solution (HBSS). After carefully removing the 
meninges, the cortex was minced into 1mm pieces and dissociated into a 
single cell suspension using the following protocol: 1) pieces of frontal cortex 
were placed in 5 ml of Ca2+, Mg2+ free HBSS; 2) the pieces of cortex were 
incubated at room temperature in this solution for 10 minutes and then 0.5 
ml of a 2.5% trypsin solution was added; 3) the incubation was continued for 
another 10 minutes on a shaking device at 37°C. At the end of incubation, the 
trypsin was inactivated by adding 0.5 ml of fetal bovine serum; 4) the cells 
were then concentrated by centrifugation (1500rpm, 5 minutes) and the 
supernatant was removed; 5) fresh medium (2 ml) was added and the pellet 
was triturated to a single cell suspension; 6) the cells were plated in 
DMEM:F12 (without glutamate or aspartate, GIBCO, Grand Island, NY) 
supplemented with insulin, (25µg/ml); transferrin, (lOOµg/ml); putrescine, 
( 60uM); selenium, (30nM); progesterone (20nM) and penicillin/ streptomycin. 
For all experiments, the cortical neurons were plated at low density 
(lxl04cells/ml) and maintained for 5 days either on astroglial substrates (see 
glial cell cultures) in serum free medium (above), or poly-D-lysine (50-100 
µg/ml) coated coverslips in the presence of continuously conditioned 
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astroglial medium (see noncontact transfilter experiments) or astroglial 
conditioned medium (see conditioned medium). Cells were grown at 37°C in 
an atmosphere of 5% CO2 
Glial cell cultures. 
Astroglial cultures from different CNS regions, were obtained from postnatal 
day 4 Sprague Dawley rat pups. This particular age was chosen to facilitate 
dissection of discrete anatomical regions and maximize astroglial purity 
(McCarthy and De Vellis 1980, Kimelberg 1983, Hatten 1985, Giulian et al 1988, 
Misson et al 1991, Schwartz and Wilson 1992). After careful removal of the 
meninges and as much white matter as possible, pieces of frontal cerebral 
cortex, mesencephalon, olfactory bulb, striatum, spinal cord or the entire 
retina were dissociated on a shaking device in Ca2+ Mg2+ free HBSS 
containing 0.25% trypsin at 370c for 20 minutes. At the end of the incubation 
the trypsin was inactivated with 0.5 ml of fetal bovine serum. The cells were 
collected by centrifugation (1500rpm, 5 minutes) and the supernatant 
removed. Fresh medium (2 ml) was added and the cells triturated to a single 
cell suspension. The cells were then plated (approximately lx1Q5cells/ml) in 
25 ml plastic tissue culture flasks and maintained in 10% serum containing 
medium (DMEM & Hams F-12, GIBCO) until they reached confluence (10-14 
days). Glial cultures were purified for astroglia or Muller glia using a 
modification of published methods (Levinson & McCarthy 1991). Briefly, 
confluent monolayers were shaken overnight (250rpm for 18 hours at 370C) 
to remove loosely adherent phase bright cells. The remaining attached cells 
were first washed in HBSS and then exposed to 0.25% trypsin in Ca2+ Mg2+ 
free HBSS for 30 seconds. The cells were then incubated in Ca2+ Mg2+ free 
HBSS at 37°C for 5 minutes and further detached cells discarded. The 
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remaining adherent cells were removed from the flasks following incubation 
in Ca2+ Mg2+ free HBSS containing 0.1 % trypsin at 370c for 5 minutes. After 
this incubation, the trypsin was inactivated with fetal bovine serum and the 
remaining cells were rinsed in serum containing medium and dispersed. The 
cells were then plated (approximately lxl05cells/ml) onto glass coverslips, 
coated with either poly-D-Lysine/laminin (20µg/ml) for Muller glia or poly-
D-Lysine for other glial subpopulations, placed in individual wells of a 24 
well plate, and allowed to form a confluent monolayer (2-5 days). Once a 
confluent monolayer was formed mouse cortical neurons were introduced. 
Meningeal fibroblast monolayers were derived from the meninges of P4 rat 
pup meninges and prepared as described above. For all the co-culture 
experiments, the cells were maintained in chemically defined medium as 
described above for dissociated neuronal cultures. 
Mature and reactive glial cell cultures. 
Mature astroglia, derived from cortex and mesencephalon, were obtained 
from P12 rat pups (Smith et al 1986 and 1990) as described in glial cell cultures 
above and allowed to mature in culture for 2 weeks before use. Reactive 
astroglia were obtained from P4 or P12 rat pups that had received a 
penetrating cortical lesion, under anesthesia on Pl or P9 respectively. Rats 
were anesthetized by hypothermia and CO2 narcosis. After removing the 
meninges, a series of stab wounds to a depth of 3-5mm were made with a 
flame heated 27 gauge needle in the left frontal cortex. Wounds were 
approximately 5mm long by 3mm wide. Bleeding was stopped with gelfoam 
(Upjohn) and the incision was closed. After rewarming, animals were 
returned to nursing mothers. Non lesioned animals were used as controls as 
several studies have demonstrated reactive glial changes, of varying severity, 
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m regions of the brain distal to a lesion, including in the contralateral 
hemisphere (Steward et al 1990, Moumdjian et al 1991, Garcia Estrada et al 
1992, Anezaki et al 1992). Cells obtained from lesioned animals were purified 
as described in glial cell cultures above. 
Non contact transfilter experiments. 
To test for the effect of secreted factors from astroglia, purified astroglial cells 
were obtained as described for glial cultures above. Cells were then plated at 
high density (approximately lxl05cells/ml) on Millicell culture inserts 
(0.4µm) in 24 well plates and allowed to grow to confluence. For non contact 
coculture experiments, cortical neurons were plated at low density 
(lxl04cells/ml) onto poly-D-lysine (50-100 µg/ml) coated coverslips located 
beneath the millipore filter. Small legs elevate the filter over each coverslip 
thus neurons are continuously exposed to astroglial conditioned medium. 
Cells were grown at 370c in an atmosphere of 5% CO2. 
Conditioned medium. 
Astroglial conditioned medium was obtained from purified, confluent 
mesencephalic or cortical glial monolayers. The monolayers were first 
washed extensively with HBSS and serum free medium and then incubated 
for 48 hours in serum free, chemically defined medium (see neuron cultures). 
The collected conditioned medium was concentrated 5-fold by Speedvac 
ultracentrifugation (Savant Instruments, Hicksville, NY), pooled and after 
being sterile filtered (0.2µm, Millipore, Bedford MA), was reconstituted in the 
same volume of chemically defined medium prepared for neuronal cultures. 
Conditioned medium was stored at -700C and thawed before use. 
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PROTEIN BIOCHEMISTRY 
SDS-PAGE and immunoblotting of mouse cortex. 
Brain homogenates were prepared from E18 cortex in 50mM Tris, pH 8.0, 
50mM NaCl, 1 % NP-40, lOOµg/µl phenylmethylsulfonyl fluoride (PMSF, 
Sigma, St. Louis, MO) and lµg/µl aprotinin. Samples were solubilized in 3% 
SDS, 10% 2-mercaptoethanol, 65mM Tris-HCl, (pH 6.8) and boiled for 2 
minutes. After boiling, 15µ1 of sample was loaded onto a 8% SDS-
polyacrylamide gel and electrophoresed according to the Laemmli procedure 
using a minigel system (Biorad, Richmond CA). The gel was then 
electroblotted onto nitrocellulose using a sandwich transfer apparatus 
(Biorad) in 25mM Tris and 0.25% SDS. Blots were processed to block 
nonspecific protein binding in 5% dry milk, PBS (pH 7.5) and 0.1 % Tween 
followed by incubation overnight with the primary antibody in 5% dry milk, 
PBS (pH 7.5) and 0.1 % Tween at 40c (anti-MAP2 1:100, anti-NF-H 1:200, anti-
M6 1:10) Blots were washed three times and incubated in secondary antibodies 
at room temperature. After subsequent washing the blot was developed using 
the ECL system (Amersham Life Sciences, Little Chalfont, England). 
Denaturation of conditioned medium. 
Medium conditioned by cortical astroglia was heat inactivated at 900C for 15 
minutes. Heated medium was centrifuged at 3000g for 10 minutes and 
supplemented with a mixture of hormones and proteins (see neuron 
medium). Conditioned medium was also treated with trypsin (0.1 %; GIBCO) 
at 37°C for 30 minutes. The reaction was stopped by adding 0.1 % fetal calf 




Medium conditioned by cortical astroglia was concentrated by spinning in 
Centricon-100 tubes (molecular weight cut off lOOkDa; Amicon, Danvers MA) 
in a refrigerated centrifuge (1000 rpm, 60 minutes; Sorvall, DuPont 
Instruments, Wilmington DE). Low molecular components of the 
conditioned medium were removed by dialysis in tubing with a molecular 
cutoff of lOkDa (Spectrasphore, Spectrum, Los Angeles CA) for 24 hours 
against sterile 0.5M NaCl at 40c and then against sterile 0.15M NaCl for 36 
hours at 40c. The dialysate was partially concentrated on polyethylene glycol, 
desalted on a Sephadex gel filtration column (Pierce, Rockford IL), further 
concentrated in a refrigerated Speedvac apparatus (Savant Instruments), 
sterile filtered, and reconstituted in chemically defined medium (see neuron 
cultures). Protein concentration was estimated by uv spectrophotometry 
(Beckman Instruments, Fullerton CA.). 
Heparin affinity chromatography. 
Medium conditioned by cortical astroglia was diluted with PBS (O.OlM 
KH2P04, 0.15 M NaCl, pH7.4) and applied at a linear flow rate of 15cm/hr 
onto small heparin-agarose columns (5ml; Biorad). The columns were then 
washed with application buffer (O.OlM KH2P04, 0.15M NaCl, pH7.4) and 
coupling determined by measuring the absorbance of the elute and 
application buffer at 280nm. The bound protein was eluted with l.5MNaCl in 
application buffer. The column elutes were desalted on a Sephadex gel 
filtration column (Desalting Column HR-10/10; Pierce), concentrated in a 
refrigerated Speedvac apparatus (Savant Instruments), sterile filtered and 
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reconstituted in chemically defined medium. Total protein was determined 
by the Pierce Commassie Protein Assay (Pierce). 
Protein radiolabeling. 
Purified, confluent monolayers were incubated for 48 hours in chemically 
defined medium. The medium was removed and the monolayer washed 
with methionine depleted medium. After adding methionine depleted 
chemically defined medium (MEM, Select-Amine, GIBCO) and 355 
methionine (50µCi/ml; 1600Ci/mmol, Amersham), the monolayers were 
incubated at 370c for a further 3 hours. 
Protein extraction from astroglial monolayers and conditioned medium. 
Astroglial cultures grown to confluence and labeled with 355 methionine 
were removed from the culture flasks by aspirating off the medium, rinsing 
the cells with ice cold HBSS and scrapping the flask with a rubber policeman. 
After centrifugation (1500rpm, 10 minutes) the tissue was placed in single 
detergent lysis buffer (50mM Tris Cl, pH 8.0; 150mM NaCl; 0.02% Sodium 
Azide; lOOµg/ml PMSF; lµg/ml aprotinin; 1 % NP-40) added for 15 minutes at 
4°C. Following centrifugation (1500rpm, 10 minutes, 4°C), the supernatant 
was dissolved in SDS sample buffer and boiled for 5 minutes. Conditioned 
medium was dissolved in SDS sample buffer and boiled for 5 minutes. 
Samples were subjected to sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (8 and 12% SDS-PAGE; Biorad). Equal amounts of protein 
(25µg) were loaded for each cell extract. Protein concentrations were 
determined using the Bicinchoninic acid (BCA) protein assay system using 
bovine serum albumin as a standard (BCA, Pierce). Gels were fixed in 10% 
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glacial acetic acid, 20% methanol, dried and exposed to xray film (Kodak XAR-
2) for 48 hours. 
Peptide growth factors. 
The following growth factors were tested: Transforming growth factor (TGF , 
lOng/ml; Collaborative Research, Bedford MA), Epidermal growth factor 
(EGF, lOng/ml; Collaborative Research), Nerve growth factor (NGF, 2.SS and 
7S isoform, 200ng/ml; Collaborative Research), Platelet derived growth factor 
(PDGF, lOng/ml; Collaborative Research), acidic Fibroblast growth factor 
(aFGF, lng/ml), and basic Fibroblast growth factor (bFGF, lng/ml; R&D 
Systems, Minneapolis, MN). 
IMMUNOHISTOCHEMISTRY AND ANALYSIS 
lmmunohistochemical identification of cells in culture. 
Different glial cell types were distinguished using the following monoclonal 
or polyclonal antibodies: anti-GFAP (glial fibrillary acidic protein, Boeringer-
Mannheim, Indianapolis, IN, 1:100), anti-Vimentin (Baeringer-Mannheim, 
1:100), OX-42 (Harlan Bioproducts for Science, Indianapolis IN, 1:100), A2B5 
(hybridoma supernatant, American Tissue Type Collection, Rockville, MD, 
1:10), Thy 1.1 (OX7 clone ascites, Cedar Lane, Hornby, Ontario), Nerve growth 
factor receptor (NGFR) specific rat monoclonal antibody (RAT 192 lg, 
generously donated by Dr. Mark Bothwell, University of Washington, 
Seattle), Nestin (RAT 401, generously provided by Dr. Susan Hockfield, Yale 
University, New Haven), galactocerebroside antiserum (Gal-C, Chemicon, 
Temecula, CA, 1:50), and a polyclonal antiserum raised in rabbits against 
cellular retinaldehyde binding protein (CRALBP from Dr. J. Sarri, University 
60 
of Washington, Seattle). Supernatant from hybridoma cells was used without 
dilution, while ascites from these cells was typically diluted 1:10. A minimum 
of 5 coverslips were labeled with each antibody and labeled cells were counted 
from a minimum of 5 arbitrarily selected fields to determine the cellular 
phenotypic composition of the glial monolayers. 
Mouse neuronal cell bodies and neurites were immunostained with a mouse 
neuron specific monoclonal antibody, M6 (hybridoma cell line raised in rat 
and generously donated by Dr. C. Lagenaur, University of Pittsburgh, 
Pittsburgh, 1:10). Axons were identified with a rabbit polyclonal antiserum to 
the 200 kDa neurofilament protein (NF-H, Sigma, 1:200). A mouse 
monoclonal antibody to microtubule associated protein 2, (MAP2, Boeringer-
Mannheim, 1:100) was used as a specific marker of dendrites. 
Prior to immunostaining, coverslips were fixed in 4% paraformaldehyde 
(O.lm phosphate buffer, 4% sucrose, pH 7.4, 60 minutes, 200C) and then 
washed 3 times in O.lm phosphate buffer (PBS). In order to visualize cell 
surface antigens such as those recognized by A2B5, Thy 1.1, M6 or Gal-C, cells 
were first incubated in O.lm PBS containing 1 % bovine serum albumin 
(Sigma, 30 minutes, 200C); to visualize intracellular antigens such as NF-H or 
MAP2, cells were permeabilized with 0.05% Triton X-100 (O.lm PBS, 1 % 
bovine serum albumin, 30 minutes, 200C). Primary antibodies were diluted 
in PBS with or without 0.3% Triton X and incubated for 1 hour at 200C). After 
the primary incubation, the cells were washed 3 times in PBS containing 4% 
goat serum (Sigma). Labeling was detected with fluorescein or rhodamine 
conjugated antibodies (1:200 in PBS, 1 hour, 200C). Mouse antibodies were 
visualized with fluorescien coupled goat anti-mouse lg (Cappel, Organon 
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Technika, Durham NC). Rabbit or rat antibodies were visualized using direct 
or indirect immunofluorescence with rhodamine conjugated goat anti- rat or 
-rabbit lg. In some cases indirect immunofluorescent labeling was carried out 
using biotinylated secondary antibodies (anti-mouse or rabbit IgG, Sigma, 10 
µg/ml) followed by avidin-TRITC (Sigma) or streptavidin-FITC (Molecular 
Probes, Eugene, OR). Omission of the primary antibody eliminated the 
observed immunoreactivity on the various cultures. lmmunostained 
cultures were washed in PBS and mounted onto glass slides in aqueous 
mounting solution (Fluromount). 
Primary antibodies raised in different hosts were used to perform double-
labeling experiments, according to standard published techniques (Beltz and 
Burd 1989), to quantify neurite growth. Working dilutions of the respective 
primary antibodies were applied in sequential incubations. Secondary 
antibodies were not mixed but were presented sequentially to the appropriate 
primary antibody. Each secondary antibody was labeled with a different 
fluorochrome: FITC (green), RITC (red) or Texas Red (orange red). Double-
labeling was prepared according to the following protocol: 1) first primary 
antibody, 2) secondary antibody or secondary biotinylated antibody if 
appropriate, 3) avidin or strepavidin fluorochrome, 4) second primary 
antibody, and then repeat steps 2 and 3. 
Analysis of cortical neuron survival and process outgrowth. 
Neuron survival was assessed by estimating the number of viable purified 
neurons present at 1, 3 and 5 days in vitro using both morphologic and 
immunocytochemical techniques. Six random microscopic fields on five 
coverslips were examined in three separate cultures of each cellular subtype. 
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At each time point the number of viable neurons was counted 
microscopically and expressed as a percentage of the number of viable cells 
that were initially plated. The initial number of surviving cells was calculated 
at 3 hours by counting the number of attached cells after the plating medium 
had been replaced with fresh medium to remove any unattached cells. The 
number of attached cells 3 hours after plating was taken to be 100%. The 
results of preliminary experiments demonstrated that viability counts 
according to these criteria agreed within 5% with counts of cell viability 
determined with Trypan Blue exclusion. 
The growth of neurites from cortical neurons identified by M6, NF-H and 
MAP2 immunoreactivity was analyzed after 5 days in vitro, and in some 
experiments, where indicated, at 18 hours, 1, 2 and 3 days in vitro. Double-
labeling immunohistochemical techniques using a combination of: 1) MAP2 
and M6, 2) MAP2 and NF-H, or 3) M6 and NF-H were used in all experiments 
to quantify neurite growth and cytoskeletal protein expression. Filters specific 
for each emission wavelength were used to block out emission form one 
fluorochrome while examining the other. A computer generated density 
profile of each immunolabel was created to determine its presence objectively 
(Image Analyst; Automax, Billerica, MA). Briefly, in preliminary experiments 
we calculated the average width of neurites to specify a plot profile (N). Plot 
profiles were calculated at right angles to each neurite and only pixels within 
the profile were included in the computation of density. Density readings 
were converted into calibrated units using standard curves that had been 
predetermined against a standard, calibrated optical density tablet. 
Measurements of density were treated as relative values and units were 
arbitrary. Density was derived from the formula: N x mean density - N x 
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background density (N = number of pixels in selection). Immunoreactive cells 
were examined in six different microscopic fields selected at random on a 
minimum of 5 coverslips for each experimental condition. To avoid 
ambiguity only isolated neurons whose cell bodies were immunoreactive for 
MAP2, and whose cell bodies and processes were not in contact with other 
neurons were quantified. At least three experiments for each test condition or 
cell monolayer were carried out; approximately 100 neurons were examined 
in each experimental condition. 
For measurements of neurite length, neurons were examined at a final 
image magnification of 400X. Fluorescent images of the neurons were 
recorded with an image intensifier coupled to a CCD video camera (Motion 
Analysis, Eugene, OR) and analyzed with a Macintosh II image processing 
program (Image Analyst). Neurite lengths were measured by tracing the total 
length of any neurite extending from a neuron cell body. Recorded lengths 
were calibrated at the same magnification using a microscope slide 
micrometer. The number of minor neurites or primary dendrites per cell, the 
length of major neurites or axons, the length of minor neurites or primary 
dendrites, the total length of minor neurites or primary dendrites, and, in 
some experiments, the total neurite length per cell were calculated. Analysis 
of statistical significance of any observed differences between substrates was 
done using ANOVA, Student's unpaired T-test, or the Mann-Whitney U 
procedure. 
THE DEVELOPMENTAL TIME COURSE OF PROCESS SPECIFIC 
CYTOSKELETAL PROTEIN EXPRESSION IN EMBRYONIC MOUSE 
CORTICAL NEURONS IN VITRO 
INTRODUCTION 
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Most neurons in the vertebrate CNS are polarized and elaborate two distinct 
types of processes, dendrites and axons which exhibit distinct morphologic, 
electrophysiologic, cytoskeletal, and biochemical differences (Sargent 1989, 
Craig et al 1992). One of the most striking differences between axons and 
dendrites is cytoskeletal composition. In the mature CNS, biochemical and 
immunohistochemical studies indicate that cytoskeletal proteins are 
compartmentalized into either an axons or a dendrites (de Camilli et al 1984, 
Huber and Matus 1984, Carden et al 1985, Crandall et al 1986, Matus et al 1986. 
It is postulated that the regionalization of cytoskeletal constituents is largely 
responsible for the complex and diverse shapes of neurons and thus is of 
critical significance for neuron function. 
The precise mechanism that contributes to the segregation of cytoskeletal 
proteins is largely unresolved (Craig et al 1992). Primary culture systems, in 
which individual neurites are visible, have been used principally to examine 
how the neuron cytoskeleton is sorted into either an axon or a dendrite since 
individual cells can be labeled with immunohistochemical markers against 
dendrite or axon specific proteins. For example, neurofilament, particularly 
the highly phosphorylated 200 kDa isoform (NF-H; Carden et al 1985, Shaw et 
al 1985, Foster et al 1987, Pennypacker et al 1991) or tau (Kosik and Finch 1987) 
are the major cytoskeletal components found in axons, whereas microtubule 
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associated protein type 2 (MAP2) is localized to the cell body and dendrites 
(Caceres et al 1986, Kosik and Finch 1987, Higgins et al 1988, Pennypacker et al 
1991). The identification of axons or dendrites based on the distribution of 
cytoskeletal immunolabels in vitro corresponds to process identification in 
situ and at the ultrastructural level (Banker and Waxman 1988). 
When developing neuronal processes are examined in vitro, however, strict 
compartmentation of cytoskeletal constituents is not observed during the 
initial elaboration of neurites (Caceres et al 1986, Kosik and Finch 1987, 
Higgins et al 1988, Pennypacker et al 1991). For example, in rat hippocampal 
neurons, MAP2 is initially present in both axons and dendrites (Caceres et al 
1986, Pennypacker et al 1991) and can be coexpressed with either NF-H 
(Pennypacker et al 1991) or tubulin (Caceres et al 1986) before process 
differentiation is complete. During the course of neuron differentiation and 
process development, immunolabel separation is observed; MAP2 staining 
becomes more intense in dendrites and is progressively lost from the axon. 
By contrast, immunolabels for tubulin or NF-Hare expressed in the axon and 
are not observed in dendrites. Identification of an axon or a dendrite based 
solely on immunohistochemical criteria can only be made after about 3 or 4 
days in vitro. Similar immunohistochemical observations, using antibodies 
to MAP2 and tau, have been reported for developing rat embryonic cerebral 
cortical neurons (Kosik and Finch 1987). These immunohistochemical 
observations in culture are consistent with morphologic observations, using 
time lapse microscopy, of developing mouse hippocampal neurons in vitro 
(Dotti et al 1988). 
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The time course of axon and dendrite development and sorting of process 
specific cytoskeletal proteins in the developing mouse cortex is not known. 
Therefore we utilized quantitative morphologic and immunohistochemical 
analysis to examine neurite formation in primary cultures of embryonic 
mouse cortical neurons to determine the time course of: 1) morphologic 
differentiation of axons and dendrites, and 2) MAP2 and NF-H segregation 
into dendrites and axons respectively. The results are consistent with 
prev10us observations, and demonstrate that for embryonic mouse cortical 
neurons in vitro MAP2 and NF-H segregate into dendrites or axons 
respectively, but not at the initiation of process outgrowth. 
MATERIALS AND METHODS 
Cortical neurons were prepared form the brains of E18 Balb / c mouse embryos, 
plated at low density and maintained in serum free medium on rat cortical 
astroglial monolayers as described in chapter 7. The growth of neurites from 
cortical neurons identified by M6, NF-H or MAP2 immunoreactivity was 
analyzed after 18 hours, 1, 3 and 5 days in vitro. Three experiments for each 
time point were carried out. A total of 100 immunoreactive neurons, double-
labeled with MAP2, NF-H, and M6, were examined at each time point as 
described in chapter 7 
RESULTS 
Cytoskeletal and surface antigen recognition in El8 mouse cortical neurons. 
Antibody recognition of neural cytoskeletal constituents and surface markers 
depends on several factors including: 1) the species from which the tissue was 
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obtained, 2) the animal's developmental age, 3) the region of the brain 
examined, and 4) the particular antibody used in the analysis (Shaw and 
Weber 1982, Sternberger and Sternberger 1983, Pachter and Liem 1984, Dahl 
and Bignami 1985, Crandall et al 1986, Carden et al 1987, Crandall and Fischer 
1989, Pennypacker et al 1991). We therefore examined the presence of MAP2, 
NF-H and M6 in E18 mouse brain. Cortical extracts were separated on SDS 
polyacrylamide gels and immunoblotted with the monoclonal antibodies to 
MAP2, NF-H and M6 intended for immunohistochemical analysis. Figure 1 
illustrates the results of this analysis; antibodies against MAP2, NF-H and M6 
identified the corresponding protein in brain homogenates derived from E18 
mouse cortex. 
N eurite identification. 
In order to characterize the identity of a neurite as either a dendrite or an 
axon, light microscopic morphological and immunohistochemical criteria 
were used. Dendrites elaborated by mature neurons followed a relatively 
straight course from the cell body and demonstrated immunoreactivity for 
MAP2 (Caceres et al 1986, Matus et al 1986, Pennypacker et al 1991). Along its 
projection, the dendrite tapered; its length being proportional to the diameter 
of the stem. Branches from dendrites occurred at acute angles. By contrast, 
mature axons were immunoreactive for the 200 kDa neurofilament protein, 
NF-H, (Shaw et al 1985, Pennypacker et al 1991) and were more uniform in 
diameter, longer and less branched and followed a wandering course. 
Branches when they did occur, were at an obtuse angle. 
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FIGURE 1: Brain homogenates from El8 mouse cortex were separated on 8% 
SOS-PAGE gels and electroblotted onto nitrocellulose. The blot was incubated 
with primary antibodies to a) MAP2, b) NF-Hor c) M6 followed by a secondary 
antibody and demonstrates the expression of each protein marker in E18 
mouse cortex. 





Morphology of developing axons and dendrites. 
A strict division between the immature axon and dendrite, based solely on 
light microscopic morphology, is not always possible in developing rat 
cortical or hippocampal neurons in vitro (Caceres et al 1986, Kosik and Finch 
1987, Dotti et al 1988, Pennypacker et 1991). The presumptive axon, however, 
can be differentiated from other processes by its growth characteristics (Dotti et 
al 1988). Experiments evaluating the response of hippocampal neurons to 
neurite transection in vitro indicate that once the length of one process 
exceeds the length of others by lOµm or more it is specified as the axon and 
rapidly acquires axon properties (Goslin and Banker 1990, Goslin et al 1990). 
Sequential observation and time lapse video microscopy of developing 
hippocampal neurons demonstrates that this transformation occurs after 18 
to 24 hours in culture (Dotti 1988) and is closely correlated with the selective 
segregation of cellular constituents (Goslin and Banker 1990, Goslin et al 1990, 
Deitch and Banker 1993, Kleinman et al 1994). Ultrastructural morphologic 
differences are first visible between 1 and 3 hours after the establishment of 
polarity (Deitch and Banker 1993). With continued growth the longer process 
acquires all the morphological, biochemical and immunohistochemical 
features characteristic of axons and the remaining processes acquire features 
of dendrites (Dotti et al 1988, Goslin and Banker 1990, Goslin et al 1990, Deitch 
and Banker 1993, Kleinman et al 1994). Therefore, in early cultures, before 
immunostaining was segregated, the presumptive axon was defined as that 
process with the greatest length after the computerized measurement of all 
neurites of a cell. 
To characterize the sequence of morphologic development demonstrated by 
axons and dendrites elaborated by mouse cortical neurons in culture, we 
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examined developing E18 neurons and their processes at 18 hours, 1, 2, 3 and 
5 days in vitro using phase contrast microscopy. Within 18 hours of plating 
most neurons had extended multiple processes of similar lengths and 
morpholgy. By 1 DIV (day in vitro) neurons typically extended a single long 
process and several shorter ones. Subtle morphological differences between 
axons and dendrites were first observed when the length of the longest 
neurite exceeded the length of other processes by at least 15 µm. This was first 
observed at 24 hours in vitro on all the various monolayers. Distinct 
morphologic differentiation of processes was observed in most neurons after 
3 DIV and, by 5 DIV, all neurites examined demonstrated either axon or 
dendrite morphology. 
Distribution of cytoskeletal proteins in developing mouse cortical neurons. 
Previous studies that have examined the time course of process outgrowth 
from hippocampal (Caceres et al 1986, Dotti et al 1986, Pennypacker et 1991) or 
rat cortical neurons (Kosik and Finch 1987) in vitro, indicate that segregation 
of cytoskeletal elements is not coincident with the elaboration of processes; 
instead it is achieved after about 3 days in vitro. Therefore, to characterize the 
time course of cytoskeletal protein segregation in mouse cortical neurons and 
determine the earliest time point at which axons and dendrites from mouse 
cortical neurons could be distinguished by immunohistochemical criteria, we 
examined the morphology and segregation of cytoskeletal elements in E-18 
mouse cortical neurons, using double-labeling immunohistochemical 
techniques, at 18 hours and 1, 2, 3 and 5 days in vitro . Primary neurites were 
characterized according to their expression of cytoskeletal proteins, MAP2, 
NF-H, or both and expressed as a percentage of the total number of neurites 
examined at each time point. A computer quantified density profile of each 
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immunolabel was created to determine its presence objectively (Figure 2). To 
prevent ambiguity on cell phenotype, only cell bodies that expressed MAP2 
were included in this quantitative analysis. A total of 100 neurons were 
examined at each time point. The results are summarized in Table 2. 
As described in previous studies (Caceres et al 1986, Kosik and Finch 1987, 
Higgins et al 1988, Pennypacker et al 1991), the immunoreactivity for 
cytoskeletal components is initially not confined to particular neurites. 
Instead, the immunoreactivity for cytoskeletal components begins to be 
differentially localized as mouse cortical neurons developed features of axons 
or dendrites in culture (Table 1 and Figure 3). NF-H expression became more 
intense in axons and MAP2 labeling more intense in dendrites. The 
segregation of MAP2 and NF-H to dendrites and axons, respectively, takes 
place over several days. Although initial signs of segregation are present at 2 
DIV, even by 3 DIV, the segregation in detectable immunoreactivity is not 
complete. For example, 60% of presumptive axons are immunoreactive for 
both MAP2 and NF-H; MAP2 is present in only the proximal portion of 
nearly two thirds of these neurites, whereas NF-H labeling is present along 
the entire length of the presumptive axon, including the growth cone. Thirty 
seven percent and 3% of presumptive axons are exclusively immunoreactive 
for NF-Hand MAP2 respectively. 
By 5 DIV immunohistochemical segregation of these cytoskeletal antigens is 
complete (Figures 4 and 5). Coexpression of MAP2 and NF-H 
immunoreactivity, however, still occurs in nearly half the axons. In axons that 
demonstrate coexpression of immunolabels, MAP2 immunoreactivity is 
found only in the proximal portion of virtually all processes examined. 
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FIGURE 2: Fluorescent images of neurons, double-labeled with MAP2 and 
NF-H, were recorded with an image intensifier coupled to a CCD video camera 
(Motion Analysis) and analyzed with a Macintosh II image processing 
program (Image Analyst; Automax). A computer quantified density profile 
was used to determine objectively the presence of MAP2 or NF-H 
immunolabeling of neurites elaborated by mouse cortical neurons in vitro. 
The values illustrated are those obtained from a single neuron at 5 DIV. a) - d) 
demonstrates density of MAP2 immunoreactivity in: a) proximal dendrite, b) 
distal dendrite, c) distal axon and d) proximal axon. The density of NF-H 
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TABLE 2: NEURITE IMMUNOHISTOCHEMICAL CHARACTERISTICS 
18 HRS/1 DIV 2DIV 3DIV 5DIV 
ALL NEURITES 
MAP2only 100 58.8 54.3 65 
NF-Honly 0 0 14.3 14.2 
BOTH 0 41.2 31.4 13.3 
AXON 
MAP2only 100 26.6 3 0 
NF-Honly 0 0 36.6 53.1 
BOTH 0 73.3 60 46.9 
MAP2 proximal* 0 22.7 61 80 
DENDRITE 
MAP2only 100 69.7 76 98.9 
NF-Honly 0 0 4 0 
BOTH 0 30.3 20 1.1 
Table 2: Segregation of process specific cytoskeletal immunolabels is not 
coincident with neurite elaboration from mouse cortical neurons in culture, 
but occurs after at least 3 DIV with progressive loss of MAP2 expression from 
axons. Primary neurites that extended from MAP2 positive neurons were 
characterized according to their expression of cytoskeletal proteins: MAP2, 
NF-H or both and expressed as a percentage of the total number of neurites 
examined. Presumptive axons and dendrites were characterized according to 
morphologic criteria or relative length as described in Materials and Methods 
(n=lOO cells from 3 separate experiments each at 18 hrs and 1,2,3,5 DIV; * 
refers to the percentage of axons expressing both immunolabels in which 
MAP2 is only identified proximally). At 18 hrs and lDIV primary neurites, 
including the presumptive axon express MAP2 exclusively. (The results are 
pooled in one column). By 2DIV there is an increase in NF-H expression but 
only in neurites immunolabeled by MAP2. After 3 days in culture, 
dissociation of immunolabels into respective axon and dendrite 
compartments emerges with an increase in the number of processes that 
express NF-H only. Immunohistochemical characterization of neurites is 
possible by 5DIV. Virtually all dendrites express only MAP2 . Nearly half the 
axons still express MAP2; invariably this is exhibited in the proximal axon 
only. NF-H labeling is demonstrated along the entire axon process. 
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FIGURE 3: Time course of MAP2 and NF-H distribution in cortical neurons. 
Corresponding fluorescent photomicrographs of E18 mouse cortical neurons 
grown for 1 (a and b) or 5 (c and d) days in vitro and labeled with MAP2 (a and 
c) or NF-H (b and d). At 1 DIV MAP2 staining is present in the cell body and all 
neurites, even in the longest neurite or presumptive axon (arrow). NF-H 
labeling is not observed (b ). Dissociation of immunolables is present, but not 
complete at 3 DIV. Morphological characteristics, however, allow 
identification of the processes. Immunoreactivity has a characteristic 
distribution at 5 DIV (c and d). MAP2 staining is observed in the cell body 
(large arrow), straight, short, tapering neurites typical of dendrites (small 
arrow) and the proximal portion of the axon (small arrowhead). The 
remaining axon does not contain detectable MAP2 (large arrowhead). There is 
little NF-H label (d) in the cell body (large arrow) and dendrites (small arrow), 
but intensive staining in the axon (large arrowhead). 
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Neurites with the morphologic characteristics of dendrites have a distinct 
immunologic phenotype; exclusive anti-MAP2 expression occurs in 98.9% of 
dendrites examined. Although the remaining dendrites coexpress both 
immunolabels, MAP2 staining is usually far more intense than NF-H 
expression. Beyond 5 DIV, a mat of axons dominates the culture and prevents 
accurate analysis of individual neurites along their entire length. 
In order to label entire cells and their processes, we used an additional 
antibody, M6. This antibody recognizes an antigen that is present on the 
surface of mouse neurons and their processes (Lund et al 1985, Lagenaur et al 
1992). Throughout the period examined (between 18 hours and 5 days in 
vitro), M6 immunoreactivity was present in all of the processes. Therefore, at 
5 days in vitro, a cortical neuronal process was classified as a dendrite if it was 
immunoreactive for both M6 and MAP2 and/ or lacked immunoreactivity for 
NF-H. Alternatively, at 5 days in vitro a cortical neuron process was classified 
as an axon if it was M6 and NF-H immunoreactive and/ or lacked MAP2 
immunoreactivity (Figures 4 and 5). 
DISCUSSION 
In the present experiment we examined developing mouse cortical neurons 
using immunohistochemical and morphological techniques. The results 
demonstrate that axons and dendrites elaborated by mouse cortical neurons in 
culture can be characterized by morphological and immunohistochemical 
criteria; these characteristics, however, are not present at initiation of process 
outgrowth but are acquired during development. These observations have 
several implications: 1) classification of a neurite as either an axon or a 
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FIGURE 4: Distribution of MAP2, NF-H and M6 in cortical neurons. 
Corresponding fluorescent photomicrographs of El8 mouse cortical neurons 
grown for 5 days in vitro and labeled with MAP2 (a and c), NF-H (b) and M6 
(d). MAP2 staining is present in the cell body (large arrow), straight, short, 
tapering neurites typical of dendrites (small arrow) and the proximal portion 
of the axon (small arrowhead). The remaining axon does not contain 
detectable MAP2 (large arrowhead). There is a paucity of NF-H label (b) in the 
soma (large arrow) and dendrites (small arrow), but intensive staining in the 
axon (large arrowhead). M6 labeling (d) is distributed on the cell surface of the 
soma (large arrow) and all processes and is only found in mouse neurons. 
(Scale bar= lOµm; a and b, c and d). 
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FIGURE 5: Immunohistochemical characteristics of axons. Corresponding 
fluorescent photomicrographs of axons extended by E18 mouse cortical 
neurons grown for 5 days in vitro and labeled with M6 (a), MAP2 (b and d), 
and NF-H (c). M6 expression, with patches of continuos labeling that alternate 
with punctate staining, is detected in the entire axon, including the growth 
cone (a). NF-H labeling is present as continuos staining along the entire axon 
(c). MAP2 immunoreactivity is not present in the axon or axonal growth cone 
(b and d). Occasionally MAP2 immunoreactivity may be detected in the 
proximal axon. (Scale bar= 10 µm) 
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dendrite, using only immunohistochemical criteria, is first possible after 3 to 
5 days in vitro, 2) nascent neurites are neither axons or dendrites, and 3) 
cytoskeletal constituents, alone, do not determine the identity of a developing 
neurite. 
MAP2 and NF-H expression in developing mouse cortical neurons. 
The expression of MAP2, a dendrite specific marker, is found in all neurites at 
initiation of outgrowth from mouse cortical neurons in vitro. These 
observations are consistent with immunohistochemical and morphological 
observations in other systems (Caceres et al 1986, Kosik and Finch 1987, 
Higgins et al 1988, Pennypacker et al 1991) indicating that the definite 
immunohistochemical identity of a neuronal process in vitro, is not present 
at initiation of process outgrowth but is acquired later. For example, MAP2 
immunoreactivity has similarly been observed to stain the cell body and all 
processes uniformly in primary cultures of rat hippocampal (Caceres et al 
1986, Pennypacker et al 1991) or rat cortical neurons (Kosik and Finch 1987) at 
initiation of process outgrowth. It is unlikely, therefore that the distribution 
of MAP2, alone, determines which process will become a dendrite. Uniform 
distribution of MAP2 immunoreactivity in developing neurites, however, is 
consistent with recent experimental observations which demonstrate that the 
initial establishment of neurites depends, in part, on MAP2 (Dinsmore and 
Solomon 1991, Caceres et al 1992, Brugg et al 1993). For example, expression of 
MAP2 antisense oligonucleotides in cerebellar neurons suppresses the 
expression of MAP2 and inhibits the initial outgrowth of neurites (Caceres et 
al 1992). By contrast, when antisense oligonucleotides of tau, a cytoskeletal 
protein found in the mature axon, are added to cerebellar neurons in culture, 
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elaboration of an axon like process is inhibited whereas exploratory minor 
neurites continue to extend (Caceres et al 1991). 
Neurofilament, is not detected in developing mouse cortical neurons during 
the first day in vitro. The time when neurofilament immunoreactivity can 
be detected first in developing neurons, however, is not clearly elucidated. In 
our culture system we first detected NF-H labeling after 2DIV and only in 
neurites that expressed MAP2. Coexpression of MAP2 with NF-H 
(Pennypacker et al 1991) and other axonal markers such as tau (Kosik and 
Finch 1987) or tubulin (Caceres et al 1986) has been observed in other systems. 
Most investigators have reported that NF immunoreactivity is first detected 
between 1 and 14 after culture (Shaw et al 1985, Foster et al 1987, Pennypacker 
et al 1991). There are several reasons for these discrepant results: 1) expression 
may depend on the antibody used (Shaw et al 1985, Dahl et al 1986), 2) the 
phosphorylation state of NF may determine its detection (Carden et al 1985, 
Dahl et al 1986, Foster et al 1987) and 3) the presence of glia may influence the 
expression of NF (Shaw et al 1985). Regardless of the exact timing of 
neurofilament expression, specific cytoskeletal compartmentation, detectable 
by immunohistochemical techniques, only occurs after the initiation of 
process outgrowth with progressive loss of MAP2 immunoreactivity from 
axons. NF-H expression, on the other hand is separately expressed with 
greater intensity in axons. At least 48 hours appears to be a critical time point 
in the selective separation of cytoskeletal immunolabels (Shaw et al 1985, 
Foster et al 1987, Pennypacker et al 1991). Mouse cortical neurites, in vitro, can 
be classified, by immunohistochemical criteria alone, as either an axon or a 
dendrite between 3 and 5 days after plating. 
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Electron microscopic, immunohistochemical and transport studies in the 
developing optic nerve (Pachter and Leim 1984, Dahl and Bignami 1985) and 
immunohistochemical and ultrastructural observations in dorsal root ganglia 
(Shaw et al 1985) indicate that NF-H is not required for the initial outgrowth 
of neurites or elongation of axons. Instead, NF-H expression may determine 
axon diameter (Hoffman et al 1985 and 1987, Cleveland and Hoffman 1991). 
Control of axon diameter is important as it is a critical determinant of 
conduction velocity. An increase in cross sectional area, therefore is probably 
necessary only after the process has achieved an adequate length or reached its 
target and established synaptic stabilization. The axon's diameter then 
expands and neurofilament expression becomes abundant. NF-H expression 
is probably not required to enhance process diameter in dendrites as, relative 
to axons, dendrites grow only short distances. NF-H expression, therefore, is 
very rarely seen in the developing dendrite. 
Synthesis and assembly of cytoskeletal proteins. 
After an initial uniform distribution in developing neurites, MAP2, a 
dendrite specific protein, is selectively lost from the axon. The loss of MAP2 
from developing axons could come about in one of two ways: 1) retraction of 
MAP2 containing axons and subsequent development of a MAP2 free axon, 
or 2) turnover or redistribution of MAP2 to dendrites. The progressive loss of 
MAP2 from axons, and gradient of MAP2 expression observed in developed 
axons in the experiments reported in this study are consistent with 
redistribution of MAP2, but do not completely exclude the possible retraction 
of MAP2 containing axons. 
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The cellular mechanisms that underlie compartmentation of cytoskeletal 
proteins in neurons is not known (Craig et al 1992, Solomon 1992). Protein 
synthesis is possible in dendrites (Torres and Steward 1992). Furthermore, the 
mRNA for MAP2 is present in differentiated dendrites (Kleinman et al 1990, 
1994); dendrites may thus be able to locally synthesize and assemble their 
cytoskeletal components depending on metabolic or structural demand. By 
contrast, axons are unable to synthesize proteins (Stewart 1989, Torres and 
Steward 1992); metabolic labeling and immunohistochemical experiments 
suggest that axon cytoskeletal proteins are synthesized in the cell body 
(Cleveland and Hoffman 1991, Watson et al 1993). 
Where are axonal proteins assembled? Early in vivo radiolabeling 
experiments demonstrated that axonal proteins were assembled in the cell 
body, however, subsequent experimental techniques suggest that assembly 
can also occur in the axon growth cone (Bamburg 1986, Cleveland and 
Hoffman 1991, Tanaka and Kirschner 1991, Solomon 1992). For example, 
when drugs that inhibit microtubule assembly are locally applied at the 
growth cone, axon elongation 1s stopped (Bamburg 1986). The 
immunohistochemical observations m the experiments described in this 
report suggest NF-H may be assembled distally near the axonal growth cone. 
For example, as the axon achieved its specific cytoskeletal identity, the antigen 
being eliminated, MAP2, receded in a distal to proximal direction toward the 
cell body. Furthermore, NF-H expression first became abundant distally. 
Similar immunohistochemical findings have been observed in the 
developing rat cortex and mouse hippocampus in vitro (Kosik and Finch 
1987, Pennypacker et al 1991). For example, when hippocampal neurites that 
subsequently became axons expressed both MAP2 and NF-H during 
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development, NF-H immunoreactivity was concentrated distally whereas 
MAP 2 was expressed proximally (Pennypacker et al 1991). These 
immunohistochemical results, however, may also be explained by distal post 
translational modification, such as phosphorylation, of NF-H. 
Extrinsic signals and the cytoskeleton. 
The axonal and dendritic cytoskeleton can be modulated, either directly or 
through activation of second messenger systems that regulate intracellular 
kinases or calcium, by extrinsic factors including macro- and microglial cells, 
diffusable factors, the extracellular matrix and cell adhesion molecules (Shaw 
et al 1985, Chamak et al 1987, Higgins et al 1988, Atashi et al 1992, Damsky and 
Werb 1992, Thiery and Boyer 1992, Djabali et al 1993, Letourneau et al 1994). 
Astrocytes may provide important extrinsic signals to the neuronal 
cytoskeleton. For example, when mesencephalic neurons are cultured in the 
presence of homotypic astrocytes, the number of MAP2 immunoreactive cells 
and the intensity of MAP2 expression is increased (Chamak et al 1987). 
Similarly, NF-H expression in developing hippocampal axons in vitro occurs 
more frequently where the axons are in contact with astroglial cells or in areas 
where there are large numbers of astrocytes (Shaw et al 1985). These 
observations provide provocative evidence for a role for glia in the 
determination of neurite cytoskeletal identity, and perhaps process 
differentiation, subsequent to initiation of process outgrowth. 
How does process differentiation occur? Our results are, in part, consistent 
with the model adopted by Banker and colleagues (Dotti et al 1988, Goslin et al 
1990, Deitch and Banker 1993) and others (Kosik and Finch 1987, Pennypacker 
et al 1991) and imply that neurons elaborate several immature, non-
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committed neurites which subsequently differentiate into axons and 
dendrites. This model, however, does not fully explain axonal characteristics, 
such as uniform orientation of microtubules (Baas et al 1987 and 1989, Deitch 
and Banker 1993) that are observed in all undifferentiated neurites. Neurons, 
therefore may extend several immature axons, some of which subsequently 
regress to be followed by dendrite growth, or are transformed into dendrites. 
It is possible that some experimental observations described in this report are 
an artifact of tissue culture as dissociation results in disassembly of axons and 
dendrites and therefore interferes with the localization of cytoskeletal 
elements when new processes arise (Matus 1988, Crandall et al 1989, Doering 
1992). For example, MAP2 is not observed in axons in situ (Matus 1988, 
Crandall et al 1989), and transplant studies suggest that appropriate 
interaction between neuron and target is necessary, in some circumstances, to 
maintain normal cytoskeletal composition, including MAP2 and NF 
composition (Doering 1992). It is also possible that cytoskeletal proteins may 
be present but not detectable using immunohistochemical techniques. In 
addition, since the neurons were obtained from late embryonic brain, it is 
possible that the cells were already polarized, but as new processes arose were 
stabilized according to the environment. The observations in this report, 
however, do have two important implications for the study of process 
outgrowth: 1) axons and dendrites differ early in the course of development, 
but not necessarily at initiation of outgrowth and 2) external signals can 
modulate neuron morphogenesis. 
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REGIONAL DIFFERENCES IN ASTROGLIAL DERIVED FACTORS THAT 
PROMOTE DENDRITIC OUTGROWTH FROM MOUSE CORTICAL 
NEURONS IN VITRO 
INTRODUCTION 
A number of factors have been observed to be important in regulating the 
growth of processes from neurons in CNS. The factors necessary for the 
generation of a neuron's form derive (1) from constraints intrinsic to the cell 
and (2) from molecules within the complex microenvironment of the cell. 
The most well studied examples of extrinsic factors are those derived from 
glial cells. Descriptive studies and both in vivo and in vitro manipulations 
indicate that neuron-glia interactions influence the generation and 
elaboration of neurites and provide a preferred substrate for neurite extension 
(Noble et al 1984, Fallon 1985, Tomaselli et al 1986, Neugebauer et al 1988, 
Tomaselli et al 1988, Smith et al 1990, Norris and Kalil 1991, Baird et al 1992). 
In addition to their general support of neurite growth from both central and 
peripheral neurons, there is increasing evidence that glia can regulate axon 
and dendrite growth differently. A variety of co-culture experiments 
(summarized in Table 3) have been performed by several different 
laboratories, and the results have for the most part been consistent with the 
hypotheses that homotypic astroglial cells support a greater number of more 
highly branched dendrites, whereas target derived astroglia promote axon 
growth (Prochiantz et al 1990, Rousselet et al 1990, Qian et al 1992). For 
example, Prochiantz and colleagues (Denis-Donini et al 1984, Chamak et al 
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1987, Autillo-Touati et al 1988, Rousselet et al 1988 and 1990, Prochiantz et al 
1990) have found that in the embryonic rodent CNS, both mesencephalic and 
striatal neurons elaborate a greater number of primary neurites when co-
cultured with astroglia derived from the homotypic brain region. In addition 
to the effects on dendrite morphology, Rousselet et al (1990) observed that 
mesencephalic neurons extended longer axons in medium conditioned by 
striatal (target) derived astroglia than by mesencephalon derived astroglia. 
More recently, Qian et al (1992) has extended these observations by 
demonstrating that axon growth from either hippocampal or spinal neurons 
was specifically enhanced by target derived astroglia. 
Several co-culture experiments, however, have provided results that are in 
part inconsistent with this simple model. Whereas homotypic glia can 
induce dendrite growth from rat sympathetic neurons comparable to that 
observed in situ (Tropea et al 1988), heterotypic, cerebral cortical astroglia can 
also support extensive neurite growth from these cells (Johnson et al 1989). 
Furthermore, Denis-Donini and Estenov (1988) reported that dopaminergic 
neurons of the substantia nigra exhibited more extensive neurite outgrowth 
on astroglia derived from the olfactory bulb than on homotypic or target 
derived astroglia. Also, whereas Qian et al (1992) found that axon growth was 
differentially regulated by astroglia derived from different brain regions, they 
failed to find any effects on dendrite number, similar to that described by 
Rousselet et al (1990) for mesencephalic neurons. 
Thus, it is unclear whether local or target glia are always better than 
heterotopic glia at promoting appropriate neuron morphology, or 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3: The table summarizes the available literature addressing the role of 
astroglia from different CNS regions on CNS neuron process outgrowth. 
Several points can be made. In general, homotypic astroglia appear to be the 
best stimulant of dendrite growth from neurons; however, certain astroglial 
subtypes, for example retinal and olfactory bulb may also be able to promote 
dendrite growth. Second, the astroglial effect on dendrite growth is primarily 
on process number rather than length, but in most cases length has not been 
specifically analyzed. Third, insufficient data exists to determine whether 
certain astroglia are consistently good or poor promoters of dendrite growth. 
Finally, target derived astroglia may increase axon length; however, certain 
astroglial subtypes, such as those derived from olfactory bulb may also 
stimulate axon growth. (Abbreviations: 1= data reported in the paper, 2 = an 
estimate derived from tables or figures reported in the paper, DIV = days in 
vitro, SC = spinal cord, Mes = mesencephalon, Str = striatum, OB = olfactory 
bulb, Ret = retina, Ctx = cortex, Hip= Hippocampus, Cereb = Cerebellum CM= 
conditioned medium, em = electron microscopy, IR = immunoreactive, 3H 
DA-AR = Dopamine autoradiography, # = number, L = length, + = positive 
stimulus). 
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different areas might instead be their relative ability to support axon or 
dendrite growth. Furthermore, it is not known whether glia from different 
CNS regions specifically influence cortical neurons in a selective 
neuroanatomic manner. We, therefore decided to test this hypothesis by 
examining neuron process outgrowth from cortical neurons in the presence 
of astroglia from a wide variety of CNS sources. Both axonal and dendritic 
growth from mouse cortical neurons in culture were quantified using double-
labeled immunohistochemical techniques. Neurons were plated at low 
density and isolated neurons that were not in contact with other neurons 
were analyzed, since there is evidence that increased neuron density (Chamak 
et al 1987, Bruckenstien and Higgins 1988, Mattson et al 1989), synaptic activity 
(Rubel et al 1981, Deitch & Rubel 1984, Schilling et al 1991), the presence of 
axons and the local application of neurotransmitters (Mattson et al 1988a, 
1988b, and 1989) can all influence neurite growth. The data reported here 
demonstrate that while astroglia are generally permissive for neurite growth, 
astroglia from different regions of the CNS differ in their ability to support 
dendritic, but not axonal growth from mouse cortical neurons in vitro. The 
ability to support extensive dendritic growth from cortical neurons, however, 
is not confined to either homotypic or target derived astroglia and in part, is 
due to the release of a diffusable factor. 
MATERIALS AND METHODS 
The experimental methods are described in detail in chapter 7. Briefly, cortical 
neurons were prepared from E18 mouse embryos and plated at low density 
on: 1) P4 rat astroglial monolayers prepared from various CNS regions 
including, cerebral cortex, mesencephalon, olfactory bulb, striatum, spinal 
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cord, or retina; or 2) poly-D-lysine coated coverslips in a noncontact coculture 
system in which the astroglia continuously conditioned the medium. The 
growth of axons and dendrites from cortical neurons, identified by M6, NF-H 
or MAP2 immunoreactivity, was quantified after 5 days in vitro. At least 
three experiments for each test substrate or cell monolayer were carried out. A 
total of 100 double-labeled, immunoreactive neurons were examined in each 
experimental condition as described in chapter 7. 
RESULTS 
Glial characterization. 
There is increasing evidence that astrocytes are not a homogenous population 
(Hannsen 1988, Barres 1991, O'Malley et al 1992, Black et al 1993, Holzwarth et 
al 1994). Several lines of evidence suggest that astroglia from different regions 
of the CNS differ in their ability to promote neurite outgrowth (Denis-Donini 
et al 1984, Chamak et al 1987, Autillo-Touati et al 1988, Denis-Donini and 
Estenoz 1988, Prochiantz et al 1990, Qian et al 1992). Table 3 summarizes these 
results. Two points are apparent. First, there have been relatively few studies 
that have quantitatively examined the effects of glia from different CNS 
regions on both axon and dendrite growth. Second, there is insufficient 
information to conclude whether certain glia are in general better promoters 
of dendrite growth than other glia. Taken together these studies suggest that 
homotypic astroglia are more effective at promoting dendrite growth whereas 
target derived astroglia are more effective promoting axon growth. The 
results of some experiments, however, suggest that astroglia derived from 
particular CNS regions, for example olfactory bulb, are generally more 
effective promoters of neurite growth. Therefore, in the present study, 
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astroglial cells were derived from a wide variety of different CNS regions 
including, cortex, striatum, mesencephalon, spinal cord, olfactory bulb, and 
retina from early postnatal (P4) rats. Cells were maintained for approximately 
10 days in serum containing medium and between 2 and 5 days in chemically 
defined medium. Glia, when cultured in this manner, contained few, if any 
neurons (Figure 6). MAP2 and NF-H immunoreactivity was not detected in 
the glial monolayers. To characterize the cellular composition of the 
monolayers, cultures were stained with a nuclear stain, 4', 6-diamido-2-
phenyl indole (DAPI; Sigma) and cell type specific antibodies. The number of 
immunoreactive cells were then calculated as a percentage of the total 
number of cells present. Immunohistochemical characterization 
demonstrated that the majority of the cells (83.5%-89.5%) could be classified as 
type I astrocytes based on morphology and GFAP immunoreactivity (Table 4). 
Most cells exhibited a flat, polygonal morphology (Figure 7). Some isolated 
astroglial cells were multipolar and occasional, labeled cells were stellate in 
morphology. In most of the monolayers, few cells had the 
immunohistochemical phenotype of type II astrocytes (GFAP+; A2B5+); in 
the cortical cultures, 3.7% of the cells could be classified as type II astrocytes on 
the basis of these antigens. Staining with galactocerebroside and Thy 1.1 
demonstrated few oligodendrocytes and fibroblasts, respectively, in any of the 
glial monolayers. 
The immunohistochemical and morphological characteristics of the 
monolayers were very similar for astroglia derived from most CNS regions 
examined (Table 4). Whereas retinal and olfactory bulb astroglia were 
morphologically similar to astroglia from other regions, they demonstrated 
immunohistochemical differences. The majority of cells in the retinal 
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FIGURE 6: Purified astroglial cultures were prepared from several regions of 
the rat brain as described in Materials and Methods. Representative phase 
contrast photomicrographs of developing cortical glial cultures (a-d) and 
fluorescent photomicrograph of purified astroglial monolayer labeled with 
anti-GFAP (e). After 3 days in culture (a), scattered astroglia and aggregates of 
neurons growing on top of the astroglia are visible. Flat polygonal type 1 
astrocytes proliferate in serum; it is difficult, however, to distinguish astroglia 
from fibroblasts using phase contrast microscopy after 6 days in vitro (b ). A 
few process bearing cells and small bipolar cells, that probably are type 02A 
astroglial progenitors, are spread randomly over the flat cells (b ). The 
polygonal flat cells form a confluent monolayer after 10 days in culture; 
individual cells, however, lack polarity (c). Most neurons have died by now; 
process bearing cells, microglia and occasional neurons are clustered above 
the confluent astroglia (c). Loosely adherent cells found growing on top of 
astroglia are removed by overnight shaking and gentle trypsin treatment (d). 
The vast majority of remaining attached cells exhibit a fairly uniform 
cobblestone appearance and represent type 1 astrocytes as demonstrated by 
GFAP immunoreactivity (e). (Scale bar = lOµm). 
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FIGURE 7: Astroglial monolayers were prepared from different CNS regions as 
described in Materials and Methods. Representative fluorescent 
photomicrographs of astroglial monolayers derived from cortex (a and b) and 
mesencephalon (c and d), labeled with anti-GFAP (a and c) and DAPI (b and d). 
The majority of cells demonstrated a flat polyglonal morphology and could be 
classified as type 1 astrocytes. (Scale bar = 10 µm) 

101 
TABLE 4: CELLULAR COMPOSITION OF ASTROGLIAL MONOLAYERS 
Cell type Antigenic marker FIB SC MFS STR OB REf CIX 
Type I astrocyte GFAP+/ A2B5- 83.5 83.5 86.4 33.7 89.5 
Type II astrocyte GFAP+/ A2B5+ 0.5 2 1 3.7 
02A progenitor GFAP-/ A2B5+ 
Oligodendrocyte GFAP-/GAL-C+ 1.5 1.5 1 2.3 
Fibroblast Thy 1.1 + 92.6 4.2 1.7 0.25 2.2 
Neuron MAP2+/NF+ 
Muller Glia VM+/CRABLP+ 86.5 
Ensheathing glia GFAP+/NGFR+ 14 
Immature glia VM+ 18 53 82 88 83.5 
Progenitor RAT 401+ 
Mouse contaminant M2+/M6+ 
Table 4: Astroglial cells were derived from early postnatal (P4) rat CNS 
regions as described in Materials and Methods and characterized with cell 
specific antibodies. Data are expressed as the percentage of total cells identified 
by a nuclear stain (DAPI) that are immunoreactive for a specific antibody (-
indicates not detected). Five random fields from five coverslips of each 
monolayer were examined from 3 independent cultures. The total number of 
cells counted for each CNS region ranged from 750-1000. 
Immunohistochemical characterization indicates: 1) the complete absence of 
neurons and 2) the majority of cells are either GF AP or Vimentin positive 
and therefore represent astroglia at various maturational stages. (Fib = 
fibroblasts from meninges, SC = spinal cord, Mes = mesencephalon, Str = 
striatum, OB= olfactory bulb, Ret = retina, Ctx = cortex) 
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astroglia cultures expressed vimentin and cellular retinaldehyde binding 
protein (CRALBP). The latter antibody is expressed specifically by Millier glia 
in the sensory retina (de Leeuw et al 1990). In the olfactory bulb, the following 
distinct cell populations could be distinguished; 1) flat cells with a typical 
astrocyte morphology, that were immunoreactive for vimentin, and 2) 
elongated cells, with fairly long processes that extended across the surface of 
other cells. Although these latter cells resembled the 02A progenitors (Raff 
1989), immunoreactivity for A2B5 was not detected. By contrast, these cells 
expressed GFAP and the low affinity NGF receptor, as detected by the 
monoclonal antibody 192, and may represent olfactory ensheathing glia 
(Doucette 1990, Vickland et al 1991). The majority of cells in the cortex and 
striatum as well as many cells in the mesencephalon, expressed both GFAP 
and vimentin. By contrast, very few spinal cord astroglia expressed both 
antigens, while most olfactory bulb and retinal astroglia displayed vimentin 
immunoreactivity only. No immunoreactivity was observed for Nestin (RAT 
401) in any of the cell populations examined. Vimentin cross reactivity was 
not observed with Thy 1-1 or neurons that expressed NF-Hor MAP2. 
Dendritic growth is selectively influenced by the anatomic source of the 
astroglial monolayer. 
We analyzed the potential influence of astroglia from different CNS regions 
on cortical neuron dendrite growth. In order to identify the full extent of the 
processes from cortical neurons, embryonic (E18) mouse cortical neurons 
were cocultured onto rat astroglial monolayers and the antibody M6 was used 
to selectively label the mouse neurons (Lund et al 1985, Lagenaur et al 1992). 
The M6 antigen was distributed on all processes of the neurons with patches 
of continuous labeling alternating with punctate staining. As we were 
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principally interested in the effect of astroglia on dendrite growth, we plated 
neurons at low density (lx104 cells/ml) and only analyzed isolated neurons; 
i.e. those not in contact with other neurons, that were double 
immunoreactive for M6 and MAP2 or NF-H. Neurite outgrowth was 
analyzed after 5 days in vitro to allow for the selective localization of MAP2 
and NF-H to dendrites and axons, respectively. 
Figure 8 illustrates the main differences observed in the morphologic aspects 
of cortical neurons grown for 5 days in vitro on different glial monolayers. On 
monolayers generated from cortex, retina and olfactory bulb; most neurons 
were round, multipolar and extended one long process and several shorter 
processes. By contrast, neurons grown on striatal, mesencephalic or spinal 
cord astroglia exhibited a unipolar or bipolar morphology. The neuronal 
processes were characterized using antibodies directed against NF-H and 
MAP2 to identify axon and dendrites respectively. The results of this analysis 
are illustrated in figure 9 and table 5. On cortical or retinal glial monolayers, 
the cortical neurons had an average of three or more primary dendrites. By 
contrast, almost all neurons (86.4% -100%) grown on striatal, mesencephalic or 
spinal cord astroglia extended only one or occasionally two MAP2 
immunoreactive processes (Table 5). Between 56.2% and 81.7% of primary 
dendrites were greater than lOµm in length. With the exception of striatal 
astroglia, the length of individual primary dendrites did not significantly 
differ on the different astroglial monolayers (Figure 9). When neurons were 
grown on astroglia from the striatum, only 12% of primary dendrites achieved 
lengths greater than 20µm. By contrast, 25.5% - 42.9% of primary dendrites 
examined on other monolayers had lengths greater than 20µm. Dendrites 
tapered and grew directly from the cell body in a relatively straight direction. 
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FIGURE 8: Cortical neurons growing on different glial monolayers in vitro 
exhibit striking dendritic differences dependent on the CNS region from 
which the cells are derived. Representative fluorescent photomicrographs of E 
18 mouse cortical neurons labeled with anti-M6 after 5 days in vitro (a-f). 
Whereas axonal growth was similar on all monolayers tested, on glial 
monolayers derived from spinal cord, striatum or mesencephalon (a, c, e), 
neurons do not demonstrate an extensive dendritic arbor and usually exhibit a 
uni- or bipolar morphology. By contrast, on glial monolayers generated from 
the retina, olfactory bulb or cortex (b, d, f), most neurons are multipolar and 
extend an axon and several dendrites. Neurons grown on polylysine coated 
coverslips in continuously conditioned astroglial medium, exhibit similar 
morphologic differences depending on the CNS source of the astroglia. Lower 
power micrographs of E18 mouse cortical neurons grown on astroglial 
monolayers derived from mesencephalon (e) and cerebral cortex (f) 
demonstrate that although the axons are of similar length (arrowheads), the 
neuron growing on the cortical astrocytes has four dendrites extending from 
the cell soma, whereas the neuron growing on mesencephalic astrocytes has 




TABLE 5: THE NUMBER OF PRIMARY DENDRITES ELABORATED BY 
CORTICAL NEURONS DEPENDS ON THE ORIGIN OF THE ASTROGLIA. 
MONOLAYER 0 
FIB cc 14.3 
FIB mp 23.8 
SC cc 0 
SC mp 3.7 
MES cc 0 
MES mp 13.3 
STRcc 0 
STRmp 0 
OB cc 0 





































3 4 >4 
0 0 0 
0 4.8 0 
13.6 0 0 
3.8 0 0 
6.6 0 0 
6.6 0 0 
0 0 0 
0 0 0 
31.8 13.6 9.1 
12.5 12.5 0 
45.8 33.3 12.5 
23.5 41.2 11.8 
8.7 60.8 26.1 
33.3 22.2 16.7 
Table 5: Mouse cortical neurons were cocultured with astroglia from different 
CNS regions as described in Materials and Methods. After 5 DIV the number 
of primary MAP2 immunoreactive processes elaborated from 100 random, 
isolated cortical neurons on each monolayer were examined. The results 
represent the percentages of neurons with a specified number of MAP2 
positive neurites. Although the most primary dendrites were observed on 
cortical astroglia, the number of primary dendrites were also observed to 
significantly increase on retinal and olfactory bulb astroglia. (0 to >4 represent 
the number of MAP2 positive neurites elaborated by neurons; mp = 
noncontact coculture, cc = direct coculture, Fib = fibroblasts from meninges, 
SC = spinal cord, Mes = mesencephalon, Str = striatum, OB = olfactory bulb, 
Ret = retina, Ctx = cortex) 
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FIGURE 9: Cortical neuron morphogenesis can be selectively influenced by 
astroglial cells in culture. Histograms illustrating axon length (a), primary 
dendrite number (b), primary dendrite length (c) and total dendrite output (d) 
from mouse cortical neurons cocultured with rat glia derived from different 
CNS regions as described in Materials and Methods. Neurite elaboration was 
examined in 100 randomly selected neurons growing on each glial monolayer 
using quantitative analysis and double-labeling immunohistochemical 
techniques. Values represent the mean + SEM. Fib included as control for 
Students t -test but not for ANOV A. Whereas axon length was similar on all 
monolayers tested (ANOV A p> 0.05), total output of primary dendrites was 
threefold greater on astroglia derived from cortex, retina or olfactory bulb than 
for astroglia from other CNS regions (ANOVA p< 0.001; a= p>0.05 vs fib, mes, 
sc; b = p<0.0001 vs fib, sc, mes, str; c = p> 0.1 vs ob, ret). An increase in the 
number of primary dendrites (ANOVA p<0.001; a = p>0.1 vs fib, mes, sc; b = 
p<0.0001 vs fib, sc, mes, str; c = p< 0.01 vs ob, ret) and to a lesser extent, 
elongation of individual dendrites (a = p>0.05 vs fib, sc, mes, ctx and p< 0.01 
vs ob, ret; b= p>0.05 vs fib, sc, ret) observed from cortical neurons was 
dependent on the source of astroglial cells. (Fib = fibroblasts from meninges, 
SC = spinal cord, Mes = mesencephalon, Str = striatum, OB = olfactory bulb, 
Ret = retina, Ctx = cortex) 
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Branch points were seen from only a few primary dendrites particularly those 
growing on cortical or retinal monolayers or when contact had been made 
with other neurons. Too few branch points were demonstated to quantify 
this observation. 
In order to characterize the influence of astroglia on primary dendrite output 
further, the total extent of the primary dendritic arbor was quantified. The 
results indicated that 21.7% of the cortical neurons cocultured with cortical 
astrocytes had primary dendritic arbors with lengths greater than lOOµm. 
Extensive primary dendrite elaboration was also observed from cortical 
neurons that were cocultured with olfactory bulb or retinal astroglia; 12% and 
16.7% of neurons achieved arbors greater than lOOµm respectively. By 
contrast, total primary dendritic elaboration only exceeded SOµm on 8%, 0% 
and 13.6% of mesencephalic, striatal or spinal cord astroglial monolayers, 
respectively (Figure 9). Mean total primary dendritic outgrowth was greatest 
on astroglia derived from cortex, olfactory bulb or retina and was nearly 
threefold greater than that observed on astroglia from striatum, 
mesencephalon or spinal cord (ANOV A p<0.001; Figure 9). These 
observations indicate that astroglia demonstrate regional differences, 
although not exclusively region or target specific, in their ability to support 
cortical neuron dendrogenesis. This effect is principally on dendrite number 
and total dendrite output rather, than on elongation of individual dendrites. 
Axon length does not differ on astroglial cells from diverse CNS regions. 
Antibodies directed against NF-H stained only one neurite emerging from the 
cell body. The process with NF-H immunoreactivity was usually the longest 
process in both multipolar and bipolar cells. In unipolar cells, the cell body 
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expressed MAP2 whereas the process was usually immunoreactive only for 
NF-H. Occasionally, neurites were observed to be immunoreactive for both 
MAP2 (proximally) and NF-H (along the entire length of the process). These 
neurites were classified as axons. Since the mouse neurons were plated at 
low density, the entire length of individual axons could be followed and 
quantified. Axons tended to follow a meandering course from the cell body 
and virtually all axons had a growth cone at their tips. Axonal length of 
cortical neurons did not differ significantly when plated on the various glial 
monolayers; 86.8% -100% of axons examined were greater than 130 µm and 
38% -61.5% were greater than 170 µm in length. There was a tendency for 
greater axon lengths from cells cultured on cortical astroglia; however the 
difference was not statistically significant, (ANOVA p>0.05; Figure 9). The 
shortest axons were observed on Muller glia; less than 10% achieved lengths 
greater then 200 µm whereas on other astroglia, between 18.2% and 35.2% of 
axons were greater than 200 µm in length. 
These immunohistochemical data indicate that astroglial cells derived from 
cortex, retina and olfactory bulb allowed initiation and growth of axons and 
dendrites from mouse cortical neurons in vitro, while astroglial cells derived 
from striatum, mesencephalon and spinal cord supported axon growth, but 
only limited dendrite elaboration. 
Diffusible factors released by astroglia may account for part of the regional 
differences observed in dendrite growth. 
Do the observed differences in the capabilities of astroglia to support dendrite 
growth reflect specific cell-surface interactions, or differences in soluble factors 
released by astroglia? In the next series of experiments, we compared the 
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number and length of neurites from cortical neurons grown on glial 
monolayers with those grown in a noncontact coculture system in which the 
astroglia continuously conditioned the medium. Embryonic mouse cortical 
neurons were plated at low density (lxl04 cells/ml) directly onto polylysine 
coverslips in a chemically defined medium. Astroglial cells derived from 
different CNS regions were grown on a millipore filter above and separate 
from the polylysine coverslips. 
After 5 days in vitro, neurons exhibited regional morphological differences 
similar to the differences that were described in the previous section. The 
majority of neurons grown in the presence of cortical, retinal or olfactory bulb 
astroglia were multipolar whereas neurons grown under spinal cord, 
mesencephalon or striatal glial monolayers were typically unipolar or bipolar. 
Significant differences in the number of primary dendrites from cortical 
neurons were observed depending on the CNS source of the astroglia, 
(ANOVA p<0.001; Table 5 and Figure 10). In medium conditioned by cortical 
or retinal astroglia, 72.2% and 76.5% respectively, of neurons examined had 3 
or more dendrites. By contrast 0%, 6.6% and 3.8% of neurons grown in 
medium conditioned by striatal, mesencephalon or spinal cord astroglia 
respectively, elaborated three or more dendrites. Olfactory bulb astroglial 
conditioned medium had an intermediate effect, 25% of neurons 
demonstrated three or more dendrites. Interestingly, the length of individual 
primary dendrites from cortical neurons did not differ significantly between 
the different glial monolayers; however an average 15%-25% reduction was 
observed when dendrite length in conditioned medium was compared to 
dendrite length in direct coculture. Although total primary dendritic 
elaboration was less profuse in continuously conditioned medium than in 
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direct coculture, regional heterogeneity was still observed. The greatest 
amount of primary dendritic growth was observed in medium continuously 
conditioned by astroglia derived from cortex, retina and to a lesser extent 
olfactory bulb (ANOV A p<0.001; Figure 10). Taken together these 
observations suggest that astroglial cells may release factors into the culture 
medium, which are both generally permissive for neurite growth but can also 
specifically initiate and maintain primary dendrite growth. 
Analysis of neuron survival and morphology. 
A critical point in the interpretation of our results is possible selective 
survival or selection of a subpopulation of neurons, rather than astroglial 
stimulated neurite outgrowth. To determine whether this is a relevant factor, 
we assessed neuron survival at 1, 3 and 5 days in vitro using both 
morphological and immunohistochemical techniques. The number of viable 
neurons were expressed as a percentage of the number of viable cells that 
were initially plated. Six random microscopic fields on five coverslips were 
examined in three separate cultures of each cellular subtype. In order to avoid 
ambiguity, the neuronal cell types were confirmed by immunostaining with 
the antibody to MAP2. Immediately after plating at least 500 cells were 
counted for each monolayer; at each subsequent time point greater than 200 
cells were examined. Viable cells had smooth, round to oval somata and 
neurites that appeared uniform in diameter and smooth in appearance. Non-
viable cells had rough, swollen and vacuolated somata and irregular, 
fragmented or beaded neurites. Although there was some variation in 
neuron survival at 5 days in vitro among the monolayers prepared from 
different CNS regions; from 41 % in stria tum and retina to 48% for olfactory 
bulb and spinal cord (ANOVA p<0.001; Figure 11); this variation, however, 
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FIGURE 10: Cortical neuron dendrite growth is, in part regulated by a 
diffusible factor released by astroglia. Mouse cortical neurons were grown in a 
noncontact coculture system in which the medium was continuously 
conditioned by glial monolayers derived from various CNS regions. After 5 
DIV axon length (a), primary dendrite number (b), dendrite length (c) and total 
primary dendrite output (d) was quantified from 100 randomly selected 
neurons for each astroglial subtype. Results represent the mean + SEM. Fib 
included as control for Students t-test but not for ANOVA. Noncontact (mp) 
and direct coculture (cc) are compared. In continuously conditioned medium 
(mp), regional heterogeneity in astroglial mediated axon growth was not 
observed with the exception of olfactory bulb astroglia (a = p<0.0001 vs fib; 
p<0.05 vs sc, mes, str, ret, ctx; b = p>0.05 vs sc, mes, str, ctx). By contrast, 
dendrite output depended on the region from which the astroglia were 
derived. Although primary dendrite elaboration was less prolific in 
continuously conditioned medium (mp) than direct coculture (cc), greater 
total primary dendrite output (ANOV A p<0.001, a = p<0.05 vs fib; p<0.01 vs 
ob; p> 0.5 vs mes, str; b = p<0.05 vs ret, ctx; c= p>0.05 vs ctx) and in particular 
an increase in the number of primary dendrites (ANOVA p<0.001; a= p>0.5 vs 
fib, sc, mes; p<0.01 vs ob; b = p<0.01 vs ret, ctx) was still observed in the 
presence of cortical or retinal astroglia and to a lesser extent olfactory bulb 
astroglia. The length of individual dendrites (c), unlike direct coculture, did 
not demonstrate regional differences (ANOVA p>0.1; a = p<0.001 vs fib; p > 
0.05 vs mes, str, ob, ret, ctx; b = p>0.05 vs mes, ret). (Fib = fibroblasts from 
meninges, SC = spinal cord, Mes = mesencephalon, Str = striatum, OB = 
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FIGURE 11: Neuron survival and cell body diameter. A) Cortical neuron 
survival varies among different glial monolayers but does not correlate with 
dendrite outgrowth. Neurons were plated at lx104 cells/ml in the presence of 
astroglia derived from various regions of the CNS and neuron viability 
determined with morphologic and immunohistochemical techniques at 1, 3 
and 5 DIV. Values for neuronal survival are expressed as the percentage of 
the original number of viable neurons at 3 hours in culture and represent the 
mean + SEM. Six random microscopic fields on 5 coverslips were examined 
in three separate cultures of each astroglial subtype. Fibroblasts and polylysine 
represent controls. Although astroglia had a clear effect on survival and 
variance was observed among the various astroglial subpopulations 
(ANOVA p< 0.001), the extent of dendritic elaboration was independent of 
this effect. B) Astroglia derived from different CNS regions do not select 
subpopulations of cortical neurons. Histograms illustrating mouse cortical 
neuron cell body diameter. Embryonic neurons were cocultured with 
astroglia for 5 days and examined after labeling with M6 or MAP2. Although 
there was a tendency for neurons with more dendrites to appear larger, 
quantitative analysis did not demonstrate a difference in neuron cell body 
diameter on the different glial monolayers tested (between group ANOVA 
p>0.1). Values represent the mean + SEM (n=lOO neurons for each glial 
subtype). (Fib = fibroblasts from meninges, SC = spinal cord, Mes = 
mesencephalon, Str = striatum, OB = olfactory bulb, Ret = retina, Ctx = cortex) 
A B 
Mono layer 1 DIV 3DIV 5DIV ctx 
Fibroblast 68.6±3.3 52.9±5.6 38.8±2.5 
Spinal Cord 81.6±2.8 66.5±3.1 48.1±2.7 rat 
Mesencephalon 81.1±4.7 64±3.6 43.8±3.2 
cii 
ob >-"' Striatum 80.4±4.1 63.2±5.3 41.5±3.3 0 E mes 0 
Olfactory bulb 80.8±2.7 59.6±3.2 48.4±4.3 E 
Retina 82.4±4. 7 63.3±3.7 41.7±4.3 str 
Cortex 83.6±3.8 60.8±3.1 44.9±2.5 SC 
0 2 4 6 8 
cell body diameter µm 
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did not correlate with the observed differences in process growth. The results 
of these experiments correlated closely with estimates of neuron viability in 
living cultures in which survival was determined by examining the same 
marked microscopic fields of approximately lmm2 at successive timepoints 
during coculture experiments. 
To determine whether astroglia from different CNS reg10ns selectively 
promoted survival of particular neuronal subpopulations, such as 
interneurons or projection neurons, we compared the size and morphology 
of the cell body of neurons plated on the different glial monolayers. Although 
there was a range in neuronal diameter on each monolayer, mean cell body 
diameter was virtually identical on all monolayers (Figure 11). Similarly, no 
distinct difference in neuron cell body shape was observed. In addition, 
neurons on all the various monolayers demonstrated axons of similar length 
(see above). Taken together these results indicate that the effect on process 
outgrowth on the various glial monolayers was specific rather than mediated 
through selective survival of a distinct neuronal subpopulation or a selective 
influence on neuronal survival. 
DISCUSSION 
The data reported in these experiments are consistent with and extend 
previous observations that astroglia can selectively modulate the 
morphologic development of neurons in culture. First, dendrite number, 
total primary dendrite output and to a lesser degree, length of individual 
dendrites from mouse cortical neurons in vitro were greater when cortical 
neurons were plated on astroglia from cortex, retina and olfactory bulb than 
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when plated on astroglia derived from mesencephalon, striatum or spinal 
cord. Although homotypic astroglia are not the exclusive source for 
promotion of cortical neuron dendrite outgrowth, they are among the most 
effective glia for stimulating dendrite elaboration. Second, axonal growth was 
similar on all the glial monolayers that were tested. Striatal, mesencephalic, 
spinal cord and even cortical astroglia may be regarded as target astroglia for 
cortical neurons. Cortical neurons, however, do not project to either the 
retina or olfactory bulb; thus target astroglia alone do not appear to selectively 
promote axonal growth from cortical neurons in vitro. Third, neurons grown 
in medium conditioned by astroglia, exhibited regional morphological 
differences depending on the CNS source of the astroglia. We propose, 
therefore, that for mouse cortical neurons in vitro: 1) axonal and dendritic 
growth are separately regulated, 2) astroglia from different CNS regions differ 
in their ability to support the outgrowth of primary dendrites, though not in 
an exclusively homotypic manner, and 3) certain astroglia release a factor or 
factors that can specifically modulate primary dendrite outgrowth. 
Astroglia influence the number of primary dendrites. 
In what way do astroglia modulate neurite growth from cortical neurons? 
The results suggest the interesting possibility that astroglia can specifically 
regulate or maintain the number of primary dendrites that are elaborated by 
neurons. Although in vitro studies have demonstrated that neurons may 
have an intrinsic ability to initiate dendrites and axons (Bartlett and Banker 
1984a and 1984b), other studies have provided evidence that dendritic growth 
of a neuron can be influenced by interactions with other cells. In vitro studies 
of both the autonomic nervous system and CNS indicate that differences in 
glial modulation of neurite outgrowth, are primarily manifested in the 
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number of neurites elaborated and, to a lesser extent, in the degree of 
branching or elongation (Denis-Donini et al 1984, Chamak et al 1987, Autillo-
Touati et al 1988, Rousselet et al 1988, Tropea et al 1988, Johnson et al 1989, 
Rousselet et al 1990, Qian et al 1992). The final form that dendrites develop, 
including their secondary and tertiary branches may also be supported by 
astroglia but, in part, may be further influenced by neuronal activity (Wise et 
al 1979, Hammer et al 1981, Mattson et al 1988a, Petit et al 1988, Schilling et al 
1991, Sanes et al 1992a). 
This selective promotion of dendrite number has been argued as a basis for 
homotypic influences of astroglia on neurons. For example, Chamak et al 
(1987) observed an increase in the number of MAP2 immunoreactive 
neurites from mesencephalic neurons in the presence of homotypic astroglia 
than when cocultured with striatal astroglia. The change in the mean number 
of neurites per neuron, however, although significant, was small; 
approximately 1.5 dendrites per neuron on striatal astroglia versus 2 on 
mesencephalic astroglia. It is possible, therefore, that the differences observed 
by Chamak et al (1987) may, in part, be explained by the relative abilities of 
striatal or mesencephalic astroglia to support dendrite growth, rather than a 
specific homotypic influence. In addition, other studies have failed to find an 
exclusively homotypic pattern of astroglial-mediated neurite outgrowth. For 
example, Qian et al (1992) reported that the length and number of primary 
dendrites from spinal cord neurons were similar, when cocultured with 
either spinal cord or cerebellar astroglia. Our results confirm that there are 
substantial regional differences in the ability of astroglia to promote dendritic 
outgrowth, but that these differences do not follow exclusively homotypic 
lines. 
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Could the maturational state of astroglial cells in the vanous monolayers 
account for our observations? Experiments both in vitro and in vivo, 
indicate that mature astrocytes have a reduced capacity to support neurite, 
but not specifically dendrite, growth when compared with immature 
astrocytes (Smith et al 1986 and 1990). The relative degree of astrocyte 
maturation is likely to vary in different regions of the CNS at any particular 
developmental time (Edwards et al 1990, Landry et al 1990). However, it is 
unlikely that this is the sole explanation for the differences we have observed 
in the ability of astroglia to promote dendritic growth. Vimentin expression, 
typically expressed by immature astrocytes (Dahl 1981, Prochiantz et al 1982, 
Bovolenta et al 1984, Dupovey et al 1985, Frederickson and McKay 1988, 
Cameron and Rakic 1991), did not correlate with the ability of the astroglia to 
support dendrite growth. Although robust dendritic growth was observed on 
glial monolayers that contained a relatively high percentage of Vimentin 
immunoreactive cells, such as cortical astroglia, neurons plated on 
monolayers with a similar percentage of vimentin immunoreactive cells, 
such as striatal astroglia, had a limited dendritic arbor. A similar conclusion 
was reached by Chamak et al (1987) who did not find substantial differences in 
the number of MAP2 immunoreactive processes from embryE>nic 
mesencephalic neurons when cocultured with embryonic (E15 or El8) or 
postnatal astroglia (P4). 
Astroglial origin does not determine axon length. 
We have found that astroglia from all regions of the CNS that we tested 
support axon growth to a similar extent. This finding is, in part, consistent 
with previous investigations in vitro that indicate that axon growth appears 
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to continue even in conditions that do not support dendrite growth (Autillo-
Touati et al 1988, Bruckenstein and Higgins 1988, Rousselet et al 1988 and 
1990). In addition, other studies have found that astroglia are generally a 
favorable substrate for neurite outgrowth (Noble et al 1984, Fallon 1985). 
There is some evidence that target derived astroglia may promote axonal 
growth. For example, Qian et al (1992) observed enhanced axonal growth 
when spinal cord neurons were cultured in the presence of, but not in direct 
contact with, cerebellar astroglia compared to astroglia from other CNS 
sources. Similarly, they observed enhanced axonal growth from hippocampal 
neurons cultured with cortical astroglia when compared to hippocampal 
astroglia. They concluded that target derived astroglia specifically promote 
axon growth and that axons are more sensitive than dendrites to factors 
released by astroglia. Some support for this contention is provided by 
Prochiantz and colleagues (Rousselet et al 1990). Although these investigators 
observed a more noticeable effect of homotypic astroglia on dendrite number, 
they also found that axon length was different depending on whether 
mesencephalic neurons were cultured with medium conditioned by striatal 
astroglia (mean length 173.2+5.7µ) or mesencephalic astroglia (mean length 
116.8+3.7µ). This result is consistent with the proposal by Qian et al (1992) 
since the striatum is a target of certain neurons in the mesencephalon. In an 
earlier study, however, the same investigators (Rousselet et al 1988) observed 
that total neurite length from mesencephalic neurons was greatest in 
homotypic and not target derived (striatal) astroglial conditioned medium. 
The observation by Denis-Donini and Estenoz (1988), further complicates a 
simple interpretation. The primary mesencephalic neurons that project to the 
striatum are the dopaminergic neurons of the substantia nigra. These 
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investigators specifically examined this population of cells and observed that 
dopaminergic mesencephalic neurons had shorter neurites when cultured on 
striatal (target) astroglia than homotypic astroglia. The longest neurite 
outgrowth occurred on olfactory bulb astroglia, a non target, non-homotypic 
source of astroglia. Axons, however, were not specifically identified. 
In this study, the retina and olfactory bulb can not be regarded as targets for 
cortical neurons, yet axon length was the same on these monolayers when 
compared to target derived astroglia such as striatum, mesencephalon or 
even spinal cord. Thus, for cortical neurons at least, astroglial heterogeneity 
and in particular target derived astroglia do not appear to selectively 
influence axon length in vitro. The apparent discrepancy between our results 
and those of Qian et al (1992) and Rousselet et al (1990) may, in part, be 
explained by our selection criteria. We only analyzed neurons that were not 
in synaptic contact with other neurons and may therefore have excluded 
axons from long projection neurons that are more likely to be in contact with 
other neurons. In addition, the small neuron cell bodies that we observed 
indicates that our sample may have included primarily non projection 
neurons. It is therefore possible that the astroglial factors that stimulate axon 
growth may be different for projection and non-projection neurons. This 
possibility has not been addressed by any study to date and needs further 
investigation. 
Astroglial heterogeneity 
Although no obvious morphologic differences were observed between glial 
monolayers derived from different CNS regions, there is increasing evidence 
that more subtle biochemical differences exist between the different astroglia. 
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Astrocytes from different anatomic regions have been found to express 
characteristic ion channel phenotypes, adhesive properties and 
neurotransmitter receptors (Hannson 1988, Barres 1991). Mesencephalic or 
striatal astroglia in vitro synthesize and express distinct glycoproteins on their 
surface (Barbin et al 1988). In addition, specific post- translational 
modifications or alternate mRNA splicing resulting in multiple isoforms of 
the same molecule may also play a role in generating functional 
heterogeneity among astrocytes. Support for this hypothesis has been 
demonstrated by LaFont et al (1992) who observed that embryonic neuron 
polarity can be mediated by dermatan sulfate protoeglycan, but not other 
proteoglycans, and that this function was dependent on the specific sugar 
moiety expressed rather than the protein epitope. 
A variety of studies indicate that neurotrophic factors support neurite growth 
from central neurons (Walicke et al 1986, Hatten et al 1988, Mattson et al 1989, 
Kawaja and Gage, 1991). Our results indicate that in part, dendrite growth is 
modulated by a diffusable factor. Could the functional diversity of astroglia, 
therefore, be secondary to specific localization of these substances? 
Immunohistochemical reactivity or mRNA expression of several growth 
factors including bFGF (Ferrara et al 1988, Finklestein et al 1988, Gonzalez et al 
1990, G6mez-Pinilli et al 1992, Logan et al 1992, Woodward et al 1992), NGF 
(Furukawa et al 1986, Lu et al 1991, Saad et al 1991, Yoshida and Gage 1991, 
Zafra et al 1992), BDNF (Zafra et al 1992), EGF (Gomez-Pinilla et al 1988, Nieto-
Sampedro et al 1988), IGF (Rotwein et al 1988, Garcia-Estrada et al 1992, 
Chernusek 1993), PDGF (Mapstone 1991, Yeh et al 1991, Pringle et al 1992) and 
cytokines such as TGF (Fallon et al 1990, Wesselingh et al 1990, Saad et al 
1991) and IL-1 (Wesselingh et al 1990) have been detected in astroglial cells 
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both in vitro and in vivo. None of these studies, however, determined 
whether there are regional differences in synthesis, expression or release of 
growth factors from astroglial cells. Recently, Lazar and Blum (1992) using a 
solution hybridization ribonuclease protection assay, demonstated that the 
expression of EGF mRNA exhibited regional variation in the brain. It is thus 
conceivable that astrocytes in specific regions of the brain express or 
synthesize different concentrations or isoforms of growth factors. 
Are there any similarities between cortex, olfactory bulb and retina that 
might explain their selective ability to promote dendrite growth? All are 
derived from the prosencephalon and are composed primarily of gray matter. 
Nevertheless, we observed little dendrite growth on striatal astrocytes, which 
are also derived from the prosencephalon and composed of gray matter. 
Thus, a common embryological site of origin or the relative amount of gray 
or white matter are unlikely explanations for the differences. One possible 
explanation is the interesting similarity in the basic architecture and circuitry 
of the three regions. The cortex, olfactory bulb and retina are all, to some 
extent, laminar structures composed of vertical pathways with numerous 
horizontal pathways that integrate the vertical signals. Thus it is conceivable 
that astroglia and/ or neurons of these regions share common structures, 
surface molecules or receptors that permit astroglial mediated dendrite 
growth that is not entirely region specific. 
Mechanism of astroglial mediated dendrite growth. 
Axon and dendrite growth appear to be dissociable events and at least in part, 
separately regulated. Regardless of the reason for astroglial heterogeneity in 
promoting dendrite outgrowth, an important issue is whether dendrite 
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elaboration is solely dependent on molecules associated with the cell surface 
or regulated by soluble factors. Our findings suggest that, at least in part, 
astroglial-mediated dendrite growth, independent of axon growth, is 
promoted by a diffusable factor. This is the first direct evidence that astroglia 
may release a factor or factors that can selectively modulate dendritic 
morphology in the CNS; whether this is a novel factor or a known factor with 
a novel function is currently not known. Consistent with this is the recent 
finding by De Konnick et al (1993) that nerve growth factor (NGF) induces an 
increase in dendrite outgrowth, but has little effect on axon growth from 
neonatal rat sensory neurons. 
There is considerable evidence that astroglial cells secrete diffusable neurite 
promoting factors, (Hatten et al 1988, Rousselet et al 1988, 1990, Qian et al 
1992). For example, medium conditioned on homotypic astroglia can 
enhance polarity of embryonic mouse mesencephalic neurons in primary 
culture (Rousselet et al 1988 and 1990). Similarly, Seil et al (1992), have 
observed that medium conditioned by cerebellar astrocytes promotes the 
development of Purkinje cell dendritic spines. The precise molecular nature 
of the factor or factors responsible is not known although protein degradation 
studies indicate that they are proteins or require protein cofactors. While 
previously identified soluble peptide growth factors have been observed to 
promote neurite outgrowth from CNS neurons, none of these studies have 
reported selective effects on the growth of either axons or dendrites (Hatten et 
al 1988, Rousselet et al 1988, Lein and Higgins 1989, Mattson et al 1989). 
The simplest explanation of the data is that astroglia release a diffusible 
factor(s) that can specifically mediate dendrite growth independent of axon 
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growth. This factor could be labile or easily degraded in medium, explaining 
the less prolific dendrite growth observed in astroglia conditioned medium. 
Alternatively, close cell contact might provide a higher concentration of the 
factor(s). Other plausible explanations include the possibility that factors 
released by astroglia interact with molecules associated with the extracellular 
matrix or alternatively that soluble factors regulate or directly promote cell 
adhesion of growth cones in a process specific manner (Seilhamer et al 1987, 
Burgess and Maciag 1989, Rossino et al 1990, Flanagan et al 1991, Yayon et al 
1991, Damsky and Werb 1992, Doherty et al 1992, Doherty and Walsh 1992, 
Thiery and Boyer 1992). 
An important role for astroglia in modulation of dendrite growth does not 
exclude other mechanisms but rather emphasizes the complex integrative 
nature of the CNS. Further experiments will be necessary to elucidate the 
mechanism of astroglia mediated dendrite growth. From the present 
experiments it is apparent that astroglia mediate dendrite growth not only in 
a region specific manner, but that certain astroglia may regulate specific 
process outgrowth from cortical neurons independent of their anatomic 
origin. In part, diffusible factors may regulate astroglial mediated dendrite 
growth in collaboration with molecules associated with the cell surface or 
matrix. 
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ASTROGLIA DEMONSTRATE REGIONAL DIFFERENCES IN THEIR 
ABILITY TO MAINTAIN PRIMARY DENDRITIC OUTGROWTH FROM 
MOUSE CORTICAL NEURONS IN VITRO 
INTRODUCTION 
Astroglia are critical for the regulation of differentiation and process 
outgrowth from CNS neurons (chapter 9). Neuron differentiation is 
accompanied by the development of two morphologically distinct processes: 
the axon and the dendritic arbor. There is evidence that astroglial regulation 
of development of axons and dendrites is differently controlled. For example, 
several studies have demonstrated that CNS neurons exhibit a more 
extensive primary dendritic arbor when cultured on astroglia derived from 
the same anatomic region or specialized glia such as olfactory bulb or retinal 
astroglia (Denis-Donini et al 1984, Chamak et al 1987, Autillo-Touati et al 
1988, Rousselet et al 1988, Prochiantz et al 1990, Rousselet et al 1990, chapter 9). 
Do astroglial cells regulate the initiation or maintenance of dendrites from 
neurons? Several experiments suggest that glia may regulate the initiation of 
dendrite growth. For example, glial cells have been observed to induce 
dendrite initiation in sympathetic neurons (Higgins et al 1988). Sensory 
neurons, which do not possess dendrites in situ, elaborate a dendritic arbor in 
vitro when nonneuronal cells are removed and NGF is added (De Konnick et 
al 1993). Mesencephalic neurons demonstrate greater neuritic output (Denis-
Donini et al 1984) and MAP2 expression (Chamak et al 1987) on homotypic 
astroglia after 2 days in culture; however, no difference is observed after 
longer culture periods. Similarly, Rousselet et al (1988 and 1990) found that 
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mesencephalic neurons extended more primary dendrites in medium 
conditioned by mesencephalic astroglia than in medium conditioned by 
striatal astroglia after only one day in culture. 
Astroglial control of dendrite initiation separate from axon elaboration 
implies that axons and dendrites differ at the onset of process outgrowth. 
There is considerable evidence, however, that neurites are not differentiated 
at the initiation of outgrowth: 1) when neurites first emerge during 
development in vitro, axons and dendrites can not be morphologically 
distinguished (Dotti et al 1988); 2) if an axon is transected close to its soma 
soon after differentiation, a presumptive dendrite may become the axon 
instead (Goslin and Banker 1990, Goslin et al 1990), and 3) selective 
compartmentation of cytoskeletal elements (Caceres et al 1986, Kosik and 
Finch 1987, Pennypacker et al 1991) or mRNA (Kleinman et al 1994) is not 
observed during the initial elaboration of neurites . 
These data, taken together, present a paradox. If axons and dendrites do not 
differ in their initiation, how is it that glial cells can differ in their ability to 
promote the growth of these two processes at their initiation. We have 
previously found that astroglia demonstrate regional differences in their 
ability to support the number of primary dendrites elaborated by mouse 
cortical neurons after five days in culture (chapter 9). In this study we asked 
whether astroglia differ in their ability to initiate or to maintain primary 
dendrite growth? To address this question we used quantitative 
morphological and double-labeled, immunohistochemical techniques to 
examine neurite formation in primary cultures of embryonic mouse cortical 
neurons and determine: 1) the earliest time point at which regional 
130 
differences in astroglial mediated dendrite growth can be observed and 2) 
whether astroglia are necessary for the initiation or maintenance of the 
primary dendritic arbor. The data demonstrate that for embryonic mouse 
cortical neurons in vitro all the glial monolayers support the initiation of an 
equal number of neurites, but that astroglia derived from cortex, olfactory 
bulb and retina maintain a higher number of primary dendrites, whereas 
astroglia derived from spinal cord, mesencephalon and striatum initially 
support longer axons and do not maintain the primary dendritic arbor. 
MATERIALS AND METHODS 
Cortical neurons were prepared from E 18 mouse brains and cocultured on P4 
rat astroglial monolayers derived from: cerebral cortex, striatum, 
mesencephalon, spinal cord, olfactory bulb and retina and on fibroblast 
monolayers derived from the meninges as described in chapter 7. In some 
experiments cortical neurons were plated on poly-D-lysine coated coverslips 
and grown in cortical or mesencephalic astroglial conditioned medium. 
Neurite outgrowth was examined at 18 hours, 1, 3, and 5 days in vitro. 
Neurites were characterized using double-labeled immunohistochemical 
techniques as described in chapter 8, and outgrowth quantified as described in 
chapter 7. 
RESULTS 
Changes in dendrite number during neuron development. 
Previous studies have demonstrated that astroglia from different regions of 
the CNS differ in their ability to regulate the number of primary dendrites 
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that are elaborated by neurons in culture (Prochiantz et al 1990, Rousselet et al 
1990, chapter 9). It is not clear, however, whether astroglia differ in their 
ability to initiate or maintain primary dendrite growth. Therefore, the 
morphologic and immunohistochemical differentiation of cortical neurons 
grown on various glial monolayers including those derived from cortex, 
retina, olfactory bulb, mesencephalon, striatum and spinal cord were 
investigated at 18 hours, 1, 3 and 5 days in vitro. The results are summarized 
in figure 12 and illustrated in figure 13. 
Eighteen hours after plating, the majority of cortical neurons, identified by M6 
or MAP2 immunoreactivity, on all glial monolayers and on fibroblasts had 
elaborated multiple neurites. These processes had definite features of neurites 
and emerged at uniform intervals around the circumference of the cell body, 
giving the cell a symmetric appearance. A few processes were transitional in 
appearance between lamellipodia and neurites. Typically, these processes were 
expanded and flattened proximally and exhibited more neuritic characteristics 
distally. Lamellipodia and transitional neurites were not included in our 
quantification. Neurons without processes represented less than 1 % of the 
total population. In addition to a presumptive axon, almost all cortical 
neurons (90-100%) grown on each glial monolayer had four or more 
presumptive dendrites. Similar growth characteristics were observed on 
fibroblasts; 83% of neurons elaborated a presumptive axon and 4 or more 
presumptive dendrites. The presumptive dendrites were typically short, the 
majority were less than 10 µmin length. The shortest dendrites were observed 
on fibroblasts ( p<0.05). The length of presumptive dendrites on the various 
glial monolayers varied slightly; 20%-25% of presumptive dendrites were 
greater than lOµm when neurons were grown on astroglia from 
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FIGURE 12: Astroglia demonstrate regional differences in their ability to 
maintain the primary dendritic arbor elaborated by cortical neurons in culture. 
Histograms illustrating axon length (a), primary dendrite number (b), primary 
dendrite length (c) and total dendrite output (d) from mouse cortical neurons 
cocultured with rat astroglia derived from different CNS regions as described 
in Material and Methods. Neurite elaboration was quantitatively examined in 
100 randomly selected neurons growing on each glial monolayer at each time 
point using morphologic and double-labeling immunohistochemical 
techniques. Values represent the mean± SEM. Fibroblasts included as control 
for Students t-test but not for ANOV A. Whereas the number of dendrites 
elaborated by neurons was similar on all monolayers tested at 18 hrs in vitro 
(ANOV A p> 0.05; a = p=0.055 vs str), astroglia derived from cortex, and retina 
or olfactory bulb were better able to maintain the total primary dendritic arbor 
than astroglia from other CNS regions ( a = p>0.05 vs ctx, p<0.05 vs str, p<0.01 
vs ob; b = p>0.5 vs str, p<0.01 vs ctx; c = p> 0.5 vs mes, p<0.05 vs ob; d = p>0.05 
vs sc, p<0.001 vs ob). These regional differences were observed at 24 hrs in 
culture and became more pronounced with time. In particular, the 
maintenance of the number of primary dendrites elaborated by neurons (a = 
p=0.055 vs str; b = p>0.05 vs str, p<0.01 vs ctx; c = p> 0.5 vs mes, p<0.05 ob; d = 
p>0.5 vs sc, p<0.01 vs ob) and to a lesser extent, elongation of individual 
dendrites (a = p>0.05 vs ctx, p<0.05 vs str; b = p>0.05 vs ctx, p<0.05 vs ob, c = 
p>0.05 vs str, ret) observed from cortical neurons was dependent on the source 
of astroglial cells. During early process elaboration, greater axon elongation 
was observed on astroglia derived from spinal cord, mesencephalon and 
striatum (a= p<0.01 vs ctx, c = p<0.001 vs ret). By 3 and 5 DIV, however, axon 
length was comparable on the various glial monolayers (b = p<0.001 vs mes, 
p>0.05 vs ob, ctx and d = p>0.05 vs ret, ctx). (Fib = fibroblasts from meninges, SC 
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= spinal cord, Mes = mesencephalon, Str = striatum, OB = olfactory bulb, Ret = 
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FIGURE 13: Cortical neurons growing on different glial monolayers in vitro 
exhibit dendritic differences depending on the CNS region from which the 
astroglia are derived. Representative fluorescent photomicrographs of E 18 
mouse cortical neurons grown on cortical (a, c, e, and g) or mesencephalic 
astroglia (b, d, f and h) and labeled with anti-MAP2 after 18hrs (a and b) and 1 
day in vitro (c and d), or labeled with anti-M6 after 3 (e and f) and 5 (g and h) 
days in vitro. Mesencephalic astroglia are illustrated to represent astroglia that 
do not maintain the primary dendritic arbor, whereas cortical astroglia are 
illustrated as an example of astroglia that maintain dendrite number. The 
majority of neurons had elaborated multiple neurites on both monolayers at 
18 hours in culture. At 1 DIV neurons typically extend a long process and 
several shorter neurites. The number of processes, however, was different; 
more primary dendrites were usually observed on cortical astroglia. The 
morphologic difference became more pronounced after 3 days in vitro. 
Whereas axon growth was similar on monolayers tested at 5DIV; on glial 
monolayers derived from spinal cord, mesencephalon or striatum (h), 
neurons do not demonstrate an extensive dendritic arbor and usually exhibit 
a uni- or bipolar morphology. By contrast, on glial monolayers generated 
from the retina, olfactory bulb or cortex (g), most neurons are multipolar and 
extend an axon and several dendrites. (Scale bar = 10 µm) 
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striatum, olfactorybulb and retina. By contrast only 6%-11.9% of these 
processes were longer than lOµm on spinal cord, mesencephalic or cortical 
astroglia. 
Six hours later most neurons had one process that was significantly longer 
than the others. Typically the long process was 15-40µm longer than the next 
longest neurite. The total number of presumptive dendrites elaborated by the 
neurons on each monolayer, however, had decreased. The decline in the total 
number of presumptive dendrites was dependent on the type of astroglial 
cells on which the neurons were plated. The smallest reduction, 1.3 dendrites 
per cell, was observed on cortical glial monolayers. A decrease in dendrite 
number of similar magnitude was observed from neurons grown on olfactory 
bulb or retinal astroglia. A larger reduction, between 2 and 3.5 dendrites per 
cell, was demonstrated from neurons grown on astroglia derived from the 
remaining regions (p<0.05). The length of individual primary dendrites, 
however, was similar on the different glial monolayers. 
The number of primary dendrites from neurons cultured on the different 
glial monolayers continued to diverge with longer periods of cell culture. By 3 
DIV the number of primary dendrites elaborated by neurons remained 
constant on retinal and cortical glial monolayers, whereas the number of 
primary dendrites from neurons grown on monolayers generated from spinal 
cord, mesencephalon and striatum continued to decline. A small, but not 
significant, decrease in primary dendrite number was identified on olfactory 
bulb astroglia. While the majority of cortical neurons cultured on olfactory 
bulb, retinal or cortical astroglia were multipolar (between 59.1 % and 89.6% 
had four or more dendrites), most of the neurons cultured on astroglia 
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derived from spinal cord, mesencephalon or striatum had only one or two 
primary dendrites. With the exception of spinal cord astroglia, the length of 
individual primary dendrites did not differ significantly on the different glial 
monolayers. When neurons were grown on astroglia from the spinal cord, 
48.4% of primary dendrites achieved lengths greater than 15µm. By contrast, 
between 28.2% and 37% of primary dendrites examined on other monolayers 
had lengths greater than 15µm. 
The morphologic differences observed in neurons at 3 days in culture were 
more pronounced at 5 DIV. The majority of neurons, 54.5% to 91.6%, grown 
on olfactory bulb, retina and cortical astroglia elaborated three or more 
primary dendrites. By contrast, only 3.6% to 13.6% of neurons observed on 
spinal cord, striatal or mesencephalic monolayers extended three or more 
dendrites. Between 18 hours and 5 DIV neurons lost between 70 and 84% of 
their primary dendrites when cultured on monolayers derived form spinal 
cord, mesencephalon or striatum. In this same period, neurons grown on 
cortical astroglia lost only 20% of their dendrites (p<0.001). An intermediate 
decrease, between 35% and 41 %, in dendrite number was observed from 
neurons grown on retinal or olfactory bulb astroglia. With the exception of 
striatal astroglia, the length of individual primary dendrites again did not 
significantly differ on the different glial monolayers. 
The same effects are observed when the total extent of the primary dendritic 
arbor is quantified. Cortical neurons cultured on glial monolayers derived 
from cortex, olfactory bulb and retina increased their primary dendritic arbor 
nearly threefold between 18 hours and 5 days in culture. By contrast, the 
primary dendritic arbor of neurons grown on glial monolayers from spinal 
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cord, striatum and mesencephalon decreased by almost half during the same 
time period (Figure 12). 
These observations indicate that astroglia demonstrate regional differences, in 
their ability to maintain, but not initiate, cortical neuron primary dendrite 
growth. Homotypic astroglia, appear best able to maintain a primary dendritic 
arbor once it is elaborated. This effect is principally on dendrite number and 
total primary dendrite output rather than on elongation of individual 
primary dendrites. 
Axon growth. 
After 5 DIV axon length of cortical neurons did not differ significantly when 
plated on the various glial monolayers; 53.3%-86.6% of axons examined were 
greater than 150µm in length. By contrast, all axons on fibroblast monolayers 
were less than lOOµm in length. There was a tendency for greater axon 
lengths from cells cultured on cortical astroglia; however the difference was 
not statistically significant, (p>0.05; Figure 12). Since the mouse neurons were 
plated at low density, the entire length of individual axons could be followed 
and quantified. 
During early process outgrowth the extent of axonal elongation differed on 
the various glial monolayers. With the exception of striatal astroglia, axon 
length was similar on the various monolayers at 18 hours in vitro. In the 6 
hour period between 18 hours and 24 hours in vitro, however, a three to 
fourfold increase in mean axon length was observed from cortical neurons 
grown on spinal cord, mesencephalic and striatal astroglia whereas axon 
length from cortical neurons only increased two to threefold on the 
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remaining cell monolayers, including fibroblasts. Thus at 1 DIV average axon 
length was between 38.4µm and 49 .6µm on spinal cord, mesencephalic and 
striatal astroglia, whereas average length of axons was between 24.Sµm and 
29.4µm on fibroblasts or cortical, retinal or olfactory bulb astroglia (Fig 12). 
The early difference in astroglial support of axon growth is also reflected in 
the difference in length between the longest and second longest neurite 
elaborated from each neuron on monolayers derived from different CNS 
regions (Table 6). As observed above, at 18 hours, there were no significant 
differences between the longest and second longest neurites in most cortical 
neurons regardless of the source of the glial monolayers. Furthermore this 
difference, with the exception of striatal astroglia, was similar on the various 
monolayers. In the next six hours, however, the mean difference in lengths 
between the two longest neurites was twofold greater from neurons grown on 
spinal cord, mesencephalon and striatum derived astroglia than those 
observed on cortex, olfactory bulb or retinal astroglia (Table 6, p<0.05). These 
data demonstrate that astroglia derived from spinal cord, mesencephalon and 
striatum support greater initial axon elongation than observed from neurons 
grown on olfactory bulb, retinal or cortical astroglia. This support of axonal 
elongation corresponds to the period of time when the total number of 
processes begins to decline in these cells. At subsequent time periods (3 and 5 
DIV), however, astroglial support of axon growth fails to demonstrate any 
correlation with a particular group of astroglia. 
Astroglia are necessary to maintain the primary dendritic arbor. 
To verify that astroglia maintain rather than initiate primary dendrite growth 
from cortical neurons in vitro we performed the following experiment. In a 
141 
TABLE 6: THE TIME COURSE OF AXON ELONGATION DIFFERS ON 
VARIO US ASTROGLIAL MONOLAYERS. 
Monolayer'Il 18 Hours 1 DIV 3 DIV 5 DIV 
Fibroblast§ 1.65±0.16 15.74±0.81 46.94±2.8* 30.69+ 1.93* 
Spinal cord 2.28±0.21 27.68+ 1.35* 107.63±4.44 155.76±2.8 
Mesencephalon 3.1±0.25 27.5±1.74 * 64.86±3.01 * 168.62±3.01 
Stria tum 4.55±0.03* 39.76±1.83* 106 .88±3 .83 158.44±3.61 
Olfactory bulb 1.27±0.05 17.87±1.41 89.39±5.09 t 158.64±3.27 
Retina 1.11±0.08 17.74±0.76 99.39±5.94 140.32±2.04 * 
Cortex 1.83±0.12 17.59±0.94 116.18±5.3 165.33±3.16 
Table 6: Difference between longest and second longest process, in µm, 
elaborated by mouse cortical neurons on various cell monolayers. During 
early process outgrowth the extent of axon elongation differed on the various 
glial monolayers. Glial monolayers derived from spinal cord, mesencephalon 
or striatum supported longer axons at lDIV than neurons grown on astroglia 
derived from olfactory bulb, retina or cortex. The different abilities of astroglia 
to support axon growth was confined to this early phase of culture only, as 
axon length and the difference in length between the longest and second 
longest process did not demonstrate a correlation with a particular group of 
astroglia at subsequent time periods. Values represent the mean + SEM; 
n=lOO neurons for each astroglial subtype at each time point. ('Il CNS region 
from which the glial monolayer is derived; § fibroblasts, derived from the 
meninges, represent controls; * = p<0.05; t = p=0.051 compared with cortex at 
the same time in culture). 
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previous study (see chapter 9) we found that soluble factors are, at least partly, 
responsible for the different capacities of astroglia to support dendrite 
number. Therefore in the present study, we plated El8 mouse cortical 
neurons at low density (lxlo4 cells/ml) directly onto polylysine coverslips for 
24 hours in conditioned medium from either mesencephalic astroglia or 
cortical astroglia, and after 24 hours in vitro exchanged the media so that 
cortical neurons initially exposed to cortical astroglia were now grown in 
medium conditioned by mesencephalic astroglia (CM) whereas cortical 
neurons first exposed to mesencephalic astroglia were now exposed to cortical 
astroglia (MC). Neurite outgrowth was analyzed after 5 days in vitro. The 
results of this analysis are illustrated in table 7. 
The results are consistent with the conclusion that astroglial cells differ in 
their ability to support, but not initiate dendrite growth. In medium 
conditioned by cortical astroglia for the first 24 hours in vitro and 
mesencephalic astroglia thereafter, only 18.1 % of neurons examined had 3 or 
more dendrites, whereas 49% of neurons grown in medium conditioned by 
mesencephalic astroglia for the first 24 hours in vitro, and cortical astroglia 
thereafter had three or more dendrites (p<0.01; Table 7). The length of 
individual primary dendrites from cortical neurons did not differ 
significantly between the different glial monolayers (p=0.078). These 
observations indicate that astroglial cells release factors into the culture 
medium which can specifically maintain the number of primary dendrites 
elaborated by cortical neurons. By contrast, these factors released by astroglia 








































































































































































































































































































































































































































































































































































































































































































































































































































































Previous work has demonstrated that astroglial cells derived from different 
regions of the CNS are heterogeneous in their abilities to support dendrite 
growth from mouse cortical neurons in vitro (Denis-Donini et al 1984, 
Chamak et al 1987, Autillo-Touati et al 1988, Rousselet et al 1988, Prochiantz 
et al 1990, Rousselet et al 1990, chapter 9). The results from the experiments 
described in this chapter demonstrate that this difference is due to differential 
maintenance of primary dendrite number, rather than differences in the 
ability of various astroglia to induce the initiation of dendritic processes. The 
cortical neurons initially elaborate the same number of neurites when 
cultured on glial monolayers, regardless of the region from which the cells 
were derived. Surprisingly, even fibroblast monolayers initially supported the 
same number of neurites from cortical neurons. Within 24 hours, however, 
the astroglial cells began to demonstrate differences in their ability to 
maintain dendritic growth, and these differences became progressively more 
pronounced with continued culture. 
The results of this study further suggest that the number of primary dendrites 
maintained by cortical neurons in vitro may be associated with the cell's 
initial axon growth. The decline in neurite number from cortical neurons 
grown on spinal cord, mesencephalic or striatal glial monolayers is first 
discernible at the same time that the axonal process can be distinguished from 
the other neurites. In addition to this temporal correlation, we have found 
that those astroglial cells that initially support longer axons are the same as 
those that subsequently sustain the fewest dendrites. These results suggest 
that astroglial support of axon growth may occur at the expense of dendrite 
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growth; however, this effect appears only to be confined to the early phase of 
axonal elongation since axonal growth is subsequently comparable regardless 
of the source of the glial monolayer. Interestingly, the effect appears to be 
exerted primarily on dendritic number, rather than on dendritic length. 
These findings are consistent with previous reports that have observed an 
inverse relationship between the extent of axon and dendrite growth in 
developing neurons in culture (Kosik and Finch 1987, Chamak and 
Prochiantz 1989, Caceres et al 1991, Lochter and Schachner 1993). For example, 
Chamak and Prochiantz (1989) observed that accelerated axon growth form 
mesencephalic neurons cultured with either substrate bound fibronectin or 
soluble laminin was associated with an almost complete absence of dendritic 
growth. 
As noted in the Introduction of this chapter, previous studies have provided 
evidence both for glial mediated initiation of dendritic growth, and also 
heterogeneity in the ability of glial cells to promote different numbers of 
dendrites from neurons, depending on the region of the CNS from which the 
neurons were derived. The results of this study suggest that the two 
phenomena may not be directly related. All of the glial monolayers supported 
neurite initiation to the same degree, consistent with previous observations 
that glia can mediate dendrite initiation. For example, when glia are added to 
sympathetic neurons in culture, the neurons promptly initiate a dendritic 
arbor (Higgins et al 1988). We have found that the differences between 
astroglia in their support of dendrites is detectable only after 24 hours, when 
neurons cultured on certain glial monolayers begin to lose their primary 
dendrites. Since all other studies that have reported glial heterogeneity in this 
property have assayed the cells after 24 hours or longer in vitro, our results 
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would suggest that these previous studies were also assessing differing 
abilities in the maintenance of dendrite number, rather than initiation of 
dendrites (Denis-Donini et al 1984, Chamak et al 1987, Autillo-Touati et al 
1988, Rousselet et al 1988, Tropea et al 1988, Johnson et al 1989, chapter 9). 
Further support for the possibility that astroglia demonstrate regional 
difference in their ability to maintain dendrite number comes from the 
results of the conditioned medium experiments described in this chapter. 
When neurons were cultured in medium conditioned by mesencephalic 
astroglia, a source of astroglia that maintains dendrite number poorly, for the 
first 24 hours and for the subsequent 4 days in medium conditioned by 
cortical astroglia, the number of dendrites observed was similar to that of 
neurons grown on mesencephalic astroglia alone for 24 hours. This result 
indicates that cortical astroglia were unable to initiate further dendrite 
outgrowth. 
Taken together our results suggest that dendritic development involves an 
initial stage of proliferation followed by retraction; branches that are initially 
present may disappear altogether. The degree of retraction is determined by 
the local cellular environment. Ramon y Cajal was the first to observe that 
the young neuron undergoes a period of tremendous proliferation and 
profusion of dendritic processes many of which are eliminated in later life. 
This phenomenon has been verified by many investigators in various parts 
of the nervous system both in vivo and in vitro (Weiss and Pysh 1978, Smith 
1981, Rogowoski and Feng 1982, Purves et al 1986, Role and Fischbach 1987, 
Dotti et al 1988, Purves et al 1988, Ramoa et al 1988, Sanes et al 1992a and 
1992b). 
147 
Many factors in the local microenvironment have been demonstrated to be 
important regulators of dendritic remodeling (Van der Loos 1965, Rubel et al 
1981, Young and Poo 1983, Deitch and Rubel 1984, Denis-Donini et al 1984, 
Chamak et al 1987, Autillo-Touati et al 1988, Rousselet et al 1988, Mattson et al 
1988a, Chamak and Prochiantz 1989, Lipton and Kater 1989, Mattson et al 1989, 
Prochiantz et al 1990, Rousselet et al 1990, Schilling et al 1991, Sanes et al 1992a 
and 1992b). Our results indicate that astroglial cells may be important in 
controlling the size of the primary dendritic arborization. Qualitative and 
quantitative in situ Golgi analysis of the rodent cortex (Wise et al 1979, Petit et 
al 1988) or brainstem (Hammer et al 1981) demonstrate that an immature 
dendritic arbor composed almost entirely of primary dendrites is formed early 
in development and is present before the arrival of afferents and 
establishment of synapses. Subsequent dendritic development occurs post 
natally after the arrival of axons and is observed principally in the distal 
dendritic tree, i.e. non terminal secondary or tertiary branches. Furthermore, 
the number and length of primary dendrites remains constant once 
branching has occurred (Petit et al 1988). Developmental studies in other parts 
of the nervous system similarly demonstrate that the primary dendritic arbor 
is present early in development prior to the arrival of afferents and largely 
independent of the presence of preganglionic innervation (Voyvodic 1987, 
Snider et al 1992, Sutton et al 1992). The basic form of the neuron, its primary 
neuritic arbor is therefore established before neuronal input. Our results 
suggest that the local astroglial environment maintains the primary neuritic 
arbor; prior to the arrival of afferents this may be critical for establishing 
appropriate and specific connections in the CNS. Once appropriate synapses 
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are established, neuronal activity may selectively refine dendritic morphology 
by promoting or removing secondary and tertiary dendrites. 
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REACTIVE AND MATURE ASTROGLIA SUPPORT PRIMARY DENDRITIC 
BUT NOT AXONAL OUTGROWTH FROM MOUSE CORTICAL NEURONS 
IN VITRO. 
INTRODUCTION 
A striking characteristic of astrocytes is their vigorous response to a variety of 
CNS insults such as trauma or ischemia. The response to injury, known as 
reactive astrogliosis is distinguished by hyperplasia, hypertrophy, extension of 
processes and an increase in glial fibrillary acidic protein (GFAP) expression in 
astrocytes (Dahl and Bignami 1976, Berry et al 1983, Mathewson and Berry 
1985, Topp et al 1989, Balasingam et al 1994). The characteristics of reactive 
astrocytes found in vivo are likewise demonstrated by injured astroglia in 
culture (Rudge and Silver 1990, McKeon et al 1991, Shepard et al 1991, Yu et al 
1993, McMillan et al 1994). These dramatic changes are thought to have a 
variety of functional consequences which may be both beneficial and 
detrimental to the injured CNS. 
Several lines of evidence suggest that reactive astrocytes do not support 
neurite growth and may even be impediments to axon regrowth (Reier et al 
1983, Liuzzi and Lazek 1987). First, ultrastructural analysis of regrowing axons 
demonstrates growth arrest in the immediate vicinity of reactive astrocytes 
(Reier et al 1983, Liuzzi and Lazek 1987, Reier et al 1992). Second, reactive 
astrocytes in vivo can express surface molecules that limit neurite extension 
in vitro (McKeon et al 1991, Laywell et al 1992). Third, explants of injured rat 
cortex (Rudge and Silver 1990) and astrocyte cell lines that express cell surface 
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characteristics of reactive astroglia in vivo (Groves et al 1993), are less 
effective than neonatal astrocytes at promoting neurite outgrowth in vitro. 
Following injury, the mature mammalian CNS demonstrates vigorous 
reactive astrogliosis and rarely supports axon regrowth. By contrast, the 
immature CNS demonstrates mild reactive astrogliosis and can support axon 
regrowth (Berry et al 1983, Barrett et al 1984, Moore et al 1987, Trimmer and 
Wunderlich 1990, Balasingam et al 1994). Observations in vivo and in vitro 
demonstrate that as the normal astrocyte matures the ability to support 
neurite growth decreases (Smith et al 1986 and 1990); reduced reactive 
astroglial support of neurite growth may, therefore, represent a functional 
difference between mature and immature astroglia. 
Dendrite growth and remodeling, in contrast to axon growth, have been 
observed to continue in the adult nervous system (Purves et al 1986, Coleman 
and Flood 1986) and following injury dendritic proliferation and hypertrophy 
is thought to play a role in recovery of neuronal function (Coleman and 
Flood 1986, Jones and Schallert 1994). There is compelling evidence that axon 
and dendrite growth is differently regulated by normal astrocytes (Denis-
Donini et al 1984, Chamak et al 1987, Rousselet et al 1988 and 1990, chapter 9); 
these data raise the possibility that the differences observed in axon and 
dendrite growth after injury, or in the mature CNS may, in part, be due to 
differences in the ability of reactive or mature astroglia to support the growth 
of these distinct types of processes. To test this hypothesis we quantified 
neurite growth from embryonic mouse cortical neurons cultured on normal, 
mature, or reactive glial monolayers using quantitative morphological and 
double-labeling immunohistochemical techniques. The data demonstrate 
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that for embryonic mouse cortical neurons in vitro mature and both neonatal 
or mature reactive astroglia exhibit a reduced ability to support axon growth. 
By contrast, mature and reactive astroglia are able to support the primary 
dendritic arbor. 
MATERIALS AND METHODS 
Dissociated E18 mouse cortical neurons were cultured at low density on: 1) 
normal astroglial monolayers derived from neonatal (P4) rat cerebral cortex 
and mesencephalon, 2) mature astroglial monolayers (Smith et al 1990) 
derived from late postnatal (P12) rat cerebral cortex and mesencephalon, and 
3) monolayers of reactive astroglia derived from P4 and P12 lesioned rat 
cortex. Details are provided in chapter 7. After 5 days in vitro, axon and 
dendrite growth from isolated cortical neurons was quantified using double-
labeled immunohistochemical techniques as described in chapter 7. Three 
experiments were performed for each condition. Approximately 100 neurons 
were examined on each glial monolayer. 
RESULTS 
Characterization of cellular monolayers. 
Astroglial maturation and injury alter their ability to support neurite growth 
in vitro (Smith et al 1990, Rudge and Silver 1990, McKean et al 1991). 
Astroglia derived from different CNS regions also differ in their ability to 
support neurite growth in vitro (Denis-Donini et al 1984, Chamak et al 1987, 
Rousselet et al 1988 and 1990, chapter 9). In the present study, therefore, 
mesencephalic and cortical astroglia were derived from P4 (immature) or P12 
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(mature) rats and reactive cortical astroglial cells were derived from P4 and 
P12 rats 3 days following penetrating cortical injury. Representative cultures 
were labeled with a nuclear stain and cell type specific antibodies; the 
immunohistochemical and morphological characteristics of the various 
monolayers are illustrated in Table 8. 
The major cell type occupying all glial cultures were astroglia or reactive 
astroglia. A slight increase in the percentage of fibroblasts was observed in 
cultures obtained from older or injured animals (Table 8). The majority of 
cells in immature (P4) and mature (P12) cultures derived from 
mesencephalon and cortex demonstrated morphologic and immunologic 
characteristics of type 1 astrocytes in vitro (Table 8). Qualitatively, P12 
astroglia demonstrated stronger GFAP immunolabeling. In general, the 
immature cultures appeared more heterogeneous. 
The majority of cells obtained from lesioned cortex were reactive astroglia 
(Table 8) and extended swollen, elongated cytoplasmic processes that 
expressed GFAP. Hypertrophy and lobulation of the nuclei were observed in 
some cells. Reactive astroglia were larger, extended more processes and 
qualitatively were more strongly labeled with GF AP than normal astroglia. 
Vimentin coexpression with GFAP and rare small GFAP negative cells were 
occasionally observed. Reactive astroglia derived from older lesioned animals 
demonstrated greater GFAP immunoreactivity, elaborated more processes 
and formed a more haphazard monolayer when compared with cells 
obtained from lesioned P4 cortex. 
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TABLE 8: IMMUNOHISTOCHEMICAL CHARACTERISTICS OF CELLULAR 
MONOLAYERS 
Cell type Antigenic marker MEN P4MES P12MES P4CTX P12CTX RXP4 
Type I astrocyte GF AP+ I A2B5- 83.5 85 89.5 88.6 
Reactive astrocyte GFAP+/ A2B5- 87.7 
Type II astrocyte GFAP+/A2B5+ 2 3.7 1.2 
02A progenitor GF AP-/ A2B5+ 
Oligodendrocyte GFAP-/GAL-C+ 1.5 2.3 2 
Fibroblast Thy 1.1 + 92.6 4.2 6.5 2.2 7.1 5.7 
Neuron MAP2+/NF+ 
Immature glia VM+ 53 10 83.5 42 10 
Microglia OX42+ 1.2 1.9 1.1 2.3 
Mouse contaminant M2+/M6+ 
Table 8: Astroglia were derived from P4 and P12 rat cortex or mesencephalon 
and reactive astroglia from P4 and P12 lesioned rat cortex as described in 
Materials and Methods and characterized with cell specific antibodies. Data 
are expressed as the percentage of total cells identified by a nuclear stain 
(DAPI) that are immunoreactive for a specific antibody (- indicates not 
detected). Five random fields from 5 coverslips of each monolayer were 
examined from 3 independent cultures. Immunohistochemical 
characterization demonstrates: 1) the complete absence of neurons and 2) the 
majority of cells are GF AP positive and therefore represent astroglia or 
reactive astroglia. Reactive astroglia were larger, extended longer and more 
processes and demonstrated more prominent nuclei than normal astroglia 







Dendrite growth is supported by immature and mature astroglia. 
Astroglial age did not influence the extent of dendrite growth (Figure 14 and 
15). The majority of neurons, 91.6% and 94.4%, grown on P4 or P12 purified 
cortical glial monolayers, respectively, elaborated three or more primary 
dendrites. The length of individual primary dendrites did not differ 
significantly, although there was a tendency for longer primary dendrites to 
be observed on P12 cortical astroglia. Total primary dendritic elaboration 
exceeded 50µm from 82.5% and 60% of neurons grown on monolayers 
derived from P4 and P12 cortex respectively. 
Cortical neurons grown on monolayers derived from the mesencephalon did 
not demonstrate an extensive dendritic arbor; astroglial age, however, did not 
influence the extent of the arbor (Figure 14 and 15). Only 6.6% of neurons 
observed on P4 and no neurons grown on P12 mesencephalic astroglia 
extended three or more MAP2 immunoreactive processes. Mean total 
primary dendritic outgrowth was approximately threefold greater on astroglia 
derived from P4 or P12 cortex than that observed on astroglia derived from P4 
(p<0.001) or P12 (p<0.001) mesencephalon. Immature and mature 
mesencephalic astroglia, however, achieved similar total primary dendritic 
arbors; 8% and 0% of neurons examined on P4 mesencephalic and on P12 
mesencephalic glial monolayers respectively extended a total primary 
dendritic arbors greater than 50µm (Figure 15). 
Mature astroglia exhibit a reduced capacity to support axon growth. 
Mature astroglia derived from P12 cortex or mesencephalon demonstrated a 
reduced capacity to support axon elongation (Figure 14 and 15); axon length, 
however, was not influenced by the anatomic source of the glial monolayer. 
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FIGURE 14: Mature astroglia are able to support dendrite growth, but not axon 
growth from cortical neurons in vitro. Representative fluorescent 
photomicrographs of El8 mouse cortical neurons grown on astroglial 
monolayers derived form P4 cortex (a), Pl2 cortex (b), P4 mesencephalon (c), 
and P12 mesencephalon (d), and labeled with anti-M6 after 5 days in vitro. 
Whereas similar dendrite output is observed from cortical neurons (arrows) 
grown on monolayers derived from P4 (a) or P12 (b) cerebral cortex, axon 
length (arrowhead) is reduced on P12 astroglia (d). On monolayers derived 
from mesencephalon (c and d), neurons do not demonstrate an extensive 
dendritic arbor (arrows); astroglial age, however, does not influence the extent 
of the arbor. By contrast, P12 mesencephalic astroglia ( d) demonstrate a 
reduced ability to support axon growth (arrowhead). (Scale bar= 10 µm) 
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FIGURE 15: Dendrite growth reflects the region of the CNS from which the 
astroglia are derived and not the age of the animal. By contrast, mature 
astroglia demonstrate a reduced ability to support axon growth from mouse 
cortical neurons in vitro. Histograms illustrating axon length (a), primary 
dendrite number (b), primary dendrite length (c) and total dendrite output (d) 
from mouse cortical neurons cocultured with rat astroglia derived from P4 
and P12 cortex and mesencephalon as described in Materials and Methods. 
Neurite elaboration was examined in 100 randomly selected neurons growing 
on each glial monolayer using quantitative analysis and double-labeling 
immunohistochemical techniques. Values represent the mean + SEM. Axon 
length was decreased on both cortical and mesencephalic P12 glial monolayers 
(a = p<0.001 vs P4 mes; b = p<0.001 vs P4 ctx and p<0.05 vs P12 mes). Total 
output of primary dendrites was threefold greater on astroglia derived from P4 
or P12 cortex than for astroglia from P4 or P12 mesencephalon (a= p<0.001 vs 
P4 ctx; b = p<0.001 vs P12 ctx). Astroglia derived from the same anatomic 
region did not demonstrate an age related difference in supporting total 
dendrite output (b = p>O.l vs P4 mes and c = p>O.l vs P4 ctx). An increase in 
the number of primary dendrites (a= p<0.001 vs P4 ctx; b = p>O.l vs P4 ctx) and 
to a lesser extent, elongation of individual dendrites (a = p>O.l vs P12 ctx and 
P4 mes) observed from cortical neurons was dependent on the source, but not 
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Since the mouse neurons were plated at low density, the entire length of 
individual axons could be followed and quantified. Axon length was 
decreased when the neurons were grown on mature (P12) cortical astroglia 
(p<0.001); 39.2% of neurons extended axons greater than 150µm in length, 
whereas 93.8% of axons examined were greater than 150µm in length when 
cortical neurons were plated on P4 cortical monolayers. Similar results were 
observed on mesencephalic glial monolayers; 14.2% of axons examined were 
greater than 150µm in length when grown on P12 mesencephalon whereas 
86.2% of cortical neurons extended axons greater than lSOµm in length when 
grown on astroglia derived from P4 mesencephalon (p<0.001). 
These immunohistochemical observations demonstrate that astroglia exhibit 
regional anatomic, but not age related differences in their ability to support 
primary dendrite growth from mouse cortical neurons in vitro. By contrast, 
whereas axon growth was similar on monolayers derived from different CNS 
regions, mature astroglia demonstrated a reduced ability to support axon 
growth. 
Reactive cortical astroglia demonstrate a reduced ability to support axon 
growth but not dendrite number. 
A significant morphologic difference was observed when neurite output from 
cortical neurons grown on reactive astroglia was compared with neurite 
growth on normal astroglia derived from animals of the same age (Figure 16). 
Cortical neuron axon length was reduced when plated on P4 reactive astroglia 
(p<0.001); 71.5% of axons were less than 150µm in length whereas on non 
reactive astroglia, 93.8% of axons achieved lengths greater than 150µm. In 
contrast to axon growth, primary dendrite number, primary dendrite length 
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and total primary dendritic output from neurons grown on astroglia derived 
from P4 lesioned or normal cortex were similar (Figure 16 and 17). 
To determine whether a more vigorous reactive astrogliotic response was 
associated with a greater attenuation of neurite elaboration, axon and 
dendrite growth from cortical neurons were quantified on astroglia derived 
from lesioned P12 rat cortex (Figure 17). On P12 reactive astroglia there was a 
significant decrease in axon growth, all axons were less than 150µm in length. 
The relative reduction of axon length on P4 reactive or P12 reactive astroglia 
compared to normal astrocytes of the same age, however, was not different 
(p>0.05). The length of individual primary dendrites elaborated by neurons 
on P4 or P12 reactive astroglia was not significantly different (p>0.05); 
however, the mean reduction in length compared with normal astroglia of 
the same age was greater on P12 reactive astroglia (p<0.001). The number of 
primary dendrites and total dendrite output observed on P12 reactive 
astroglia was similar to that observed from neurons grown on normal P4 and 
P12 astroglia. 
Reactive astroglia may release diffusible factors that support neurite growth. 
Previous investigations have demonstrated that normal astroglial cells secrete 
diffusible neurite promoting factors (Hatten et al 1988, Rousselet et al 1988 and 
1990, Qian et al 1992, chapter 9). To determine whether mature, reactive 
astroglia also release diffusible neurite promoting factors, we compared the 
number and length of neurites from cortical neurons grown on glial 
monolayers with those grown in a noncontact coculture system in which the 
astroglia continuously conditioned the culture medium. 
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FIGURE 16: Reactive astroglia are able to support dendrite growth from 
cortical neurons in vitro. Representative fluorescent photomicrographs of: 1) 
cell monolayers derived from P4 cortex (a) and P4 cortex 3 days following a 
penetrating injury (c) labeled with anti-GFAP (a and c) and 2) E18 mouse 
cortical neurons labeled with anti-M6 after 5 days in vitro (b, d). The majority 
of cells from non-lesioned animals demonstrated a flat polyglonal 
morphology and could be classified as astrocytes. By contrast, cells derived 
from lesioned cortex demonstrated multiple processes and could be classified 
as reactive astrocytes. On glial monolayers generated from the nonlesioned 
and lesioned P4 cortex, most neurons are multipolar and extend an axon and 
several dendrites (b, d). Whereas dendrite output is similar on normal and 
reactive astroglia, axon length (arrowhead) is reduced on reactive astroglia (d). 
Neurons grown on normal or reactive astroglia derived from P12 animals 




FIGURE 17: Reactive astroglia derived from lesioned cortex support dendrite 
growth, but demonstrate a reduced ability to promote axon growth from 
mouse cortical neurons in vitro. Histograms illustrating axon length (a), 
primary dendrite number (b), primary dendrite length (c) and total dendrite 
output (d) from mouse cortical neurons cocultured with rat astroglia derived 
from P4 and P12 non-lesioned and lesioned cortex as described in Materials 
and Methods. Neurite elaboration was examined in 100 randomly selected 
neurons growing on each glial monolayer using quantitative analysis and 
double-labeling immunohistochemical techniques. Values represent the 
mean + SEM. Axon length was decreased on both P4 and P12 reactive cortical 
glial monolayers (a = p<0.001 vs P4 normal; b = p<0.01 vs P12 normal and 
p<0.05 vs P4 reactive). Total output of primary dendrites was similar on 
astroglia derived from lesioned or nonlesioned cortex (a = p>0.1 vs P4 normal; 
b = p>O.l vs P4 reactive and P12 normal). The number of primary dendrites (a 
= p>0.5 vs P4 normal and Pl2 reactive; b = p>0.5 vs P12 normal) and to a lesser 
extent, elongation of individual dendrites (a = p>0.1 vs P4 normal; b= p<0.05 
vs P12 reactive and p>O.l vs P4 reactive) observed from cortical neurons was 
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After 5 days in vitro, neurons grown directly on P12 reactive astroglia, or in 
the presence of medium conditioned by P12 reactive astroglia exhibited 
similar morphological appearances. Primary dendritic outgrowth was slightly 
less in continuously conditioned medium than direct coculture; however, the 
small reduction in dendrite growth, between 20 and 30%, was similar to that 
observed when normal P4 astroglial coculture or noncontact coculture was 
compared (Figure 18). These observations suggest that reactive astroglial cells 
may release factors into the culture medium, which support neurite and 
dendrite growth from cortical neurons. 
Fibroblast influence on astroglial supported axon and dendrite growth. 
A greater number of fibroblasts, which are known to be poor substrates for 
neurite growth (Noble et al 1984, Fallon 1985), were observed in monolayers 
that demonstrated poor support of neurite growth. To determine whether the 
presence of fibroblasts might explain the observed differences in the ability of 
mature or reactive astroglia to support process outgrowth, fibroblasts derived 
from P4 rat meninges, and normal P4 cortical astroglia were mixed in defined 
ratios in monolayer cultures. Cortical neuron axon and dendrite growth on 
these monolayers was quantified at 5 days in vitro. 
Neuron morphology on mixed cultures was similar to the morpholgy 
observed on pure P4 astroglial cultures, until fibroblasts constituted greater 
than 40% of the monolayer. Once this occurred a decrease in total neurite 
length and primary dendrite number was observed (Figure 19). On P4 
astroglial monolayers greater than 90% of neurons elaborated 3 or more 
dendrites and extended axons greater than 150µm in length. By contrast, on 
monolayers composed of 60% fibroblasts, 28.6% of neurons extended 3 or 
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FIGURE 18: Cortical neuron dendrite growth is, in part, regulated by a 
diffusable factor released by astroglia or reactive astroglia. Mouse cortical 
neurons were grown in a noncontact coculture system in which the medium 
was continuously conditioned by glial monolayers derived from non-lesioned 
P4 or lesioned P12 cortex. After 5 DIV axon length (a), primary dendrite 
number (b), dendrite length (c) and total primary dendrite output (d) was 
quantified from 100 randomly selected neurons for each astroglial subtype. 
Results represent the mean + SEM. Noncontact and direct coculture of normal 
P4 astroglia, reactive P12 astroglia and P4 meninges are compared. Axon 
growth was similar in either contact or noncontact coculture systems of each 
monolayer tested, but varied depending on the cellular source of the 
monolayer (a = p>0.5 vs P12 contact; p<0.01 vs men non contact; p<0.001 vs P4 
ctx non contact). Primary dendrite elaboration was slightly less prolific in 
continuously conditioned normal or reactive astroglial medium than direct 
coculture. However, greater total primary dendrite output (a = p<0.001 vs men 
non contact; p>O.l vs P12 RX contact and P4 ctx non contact); an increase in the 
number of primary dendrites (a = p<0.001 vs men non contact; p>0.05 vs P12 
RX contact and P4 ctx non contact) and an increase in the length of primary 
dendrites (a = p<0.01 vs men non contact; p > 0.1 vs P12 RX contact and P4 Ctx 
non contact) was still observed in the presence of medium continuously 
conditioned by P12 reactive astroglia when compared with noncontact 
meningeal coculture (Ctx = cortex, RX = reactive astroglia from injured cortex, 
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more dendrites and 14.7% of axons were greater than 150µm in length. 
Cortical neurons grown on pure meningeal monolayers usually exhibited a 
unipolar or bipolar morpholgy. Individual processes were very short and 
tended to fasiculate; all axons were less than lOOµm in length and only 24% of 
primary dendrites were greater than 15µm in length. 
The relative proportion of fibroblasts to astroglia observed in reactive or 
mature astroglial monolayers was less the number of fibroblasts observed to 
decrease neurite growth on P4 astroglia. Therefore, the reduced axon length 
observed when cortical neurons are grown on P4 and P12 reactive astroglia 
and the reduction in primary dendrite length observed on P12 reactive 
astroglia, probably represent an inability of the reactive astroglia to support 
process growth, rather than attenuation of neurite growth by fibroblasts. 
Neuron survival. 
A critical point in the interpretation of our results is possible selective 
survival of neurons, rather than astroglial supported neurite outgrowth; 
therefore, we determined neuron survival at 5 days in vitro. Although 
neuron survival at 5 days in vitro varied among the monolayers prepared 
from various CNS sources; from 33% on mature mesencephalic astroglia to 
52% on mature cortical astroglia (p<0.001; Figure 20); this variation did not 
clearly correlate with the ability of normal or reactive astroglia to support 
either axon or dendrite growth. 
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FIGURE 19: The reduction in neurite growth observed on reactive or mature 
glial monolayers represents a reduced ability of mature or reactive astroglia to 
support process growth rather than fibroblast mediated attenuation of neurite 
growth. Line graphs illustrating axon length (a), primary dendrite number (b), 
primary dendrite length (c) and total dendrite output (d) from mouse cortical 
neurons cocultured with P4 rat meningeal fibroblasts and cortical astroglia 
mixed in defined ratios. Neurite elaboration was examined in 50 randomly 
selected neurons growing on each monolayer using quantitative analysis and 
double-labeling immunohistochemical techniques. Values represent the 
mean + SEM. A decrease in axon length, primary dendrite number and total 
dendrite output was observed when the percentage of fibroblasts in the 
monolayer exceeded 40% of the cells present. The length of individual 
primary dendrites decreased when monolayers contained greater than 60% 
fibroblasts. This proportion of fibroblasts necessary to attenuate neurite 
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FIGURE 20: Cortical neuron survival varies among different glial monolayers 
but does not clearly correlate with the ability of the astroglia to support 
process outgrowth. Neurons were plated at lx1Q4 cells/ml in the presence of 
various CNS astroglia as described in Materials and Methods and neuron 
viability determined using morphologic and immunohistochemical 
techniques at 5 DIV. Values for neuron survival are expressed as the 
percentage of the original number of viable neurons at 3 hours in culture 
and represent the mean + SEM. Five random microscopic fields on 5 
coverslips were examined in three separate cultures of each astroglial subtype. 
Although variance was observed among the various astroglial 
subpopulations (ANOVA p<0.001), the extent of dendritic or axon elaboration 
did not appear to correlate with this effect. (Mes = mesencephalon, Ctx = 





















FIGURE 21: Dendrite growth is similar when embryonic cortical neurons are 
cultured on neonatal, mature or reactive cortical astroglia. By contrast, axon 
growth is significantly reduced when cortical neurons are cultured on mature 
or reactive astroglia. Histograms illustrating axon length (a), primary dendrite 
number and primary dendrite length (b) from mouse cortical neurons 
cocultured with rat astroglia derived from P4 and P12 non-lesioned or 
lesioned cortex. Values represent the percentage of mean growth observed on 
normal P4 cortical astroglia. Neurite elaboration was examined in 100 
randomly selected neurons growing on each glial monolayer after 5 DIV 
using quantitative analysis and double-labeling immunohistochemical 
techniques. (RX = reactive astroglia obtained from lesioned cortex; a = p<0.001 
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The data reported here (summarized in figure 21) are consistent with, and 
extend previous observations that mature and reactive astroglia have a 
reduced ability to support neurite growth in vitro. Our results suggest that 
mature and reactive astroglia are able to support dendrite growth, whereas 
their ability to support axon growth is reduced. A mechanism that allows 
separate regulation of axon and dendrite growth may have important 
implications in CNS regeneration, re-establishment of synaptic contacts and 
functional recovery after injury to the mature mammalian brain. 
Mature astroglia support dendrite growth but demonstrate a reduced ability to 
support axon growth. 
The results in this study suggest that primary dendrite, but not axon growth is 
supported by mature astroglia. This observation is consistent with previous 
investigations, both in vitro and in vivo, indicating that mature astrocytes, 
derived from rats older than postnatal day 8, have a reduced capacity to 
support neurite growth when compared with immature astrocytes (Smith et 
al 1986 and 1990). The difference, however, is almost entirely explained by the 
reduction in length of the longest process, i.e. the axon, on mature astroglia. It 
is possible that astrocyte differentiation, but not necessarily chronological age 
may determine its relative ability to support axon or dendrite growth (Hatten 
et al 1991). For example, in the developing mammalian brain, radial glia, 
rather than differentiated astrocytes, act as guide posts for axon growth (Rakic 
1988, Norris and Kalil 1991). Expression of MAP2, a dendrite specific marker, 
is not found during the time radial glia are observed in the brain (Crandall et 
al 1986); suggesting perhaps that radial glia do not support dendrite growth. 
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Dendritic architecture may never reach a mature or stable state in the adult 
mammalian nervous system (Purves et al 1986, Coleman and Flood 1986, 
Petit et al 1988). Furthermore, there is evidence that dendritic morpholgy can 
remodel and grow in response to the environment and release of 
neurotransmitters (Coleman and Flood 1986, Mattson et al 1988 and 1989, 
Popov et al 1992). For example, dendritic proliferation is observed in regions 
of the brain that demonstrate age related neuronal loss both in animal 
models of aging and the human brain (Coleman and Flood 1986). Previous 
observations in vitro have demonstrated that astroglia can selectively 
modulate the development of primary dendrites (Denis-Donini et al 1984, 
Chamak et al 1987, Rousselet et al 1988 and 1990, chapter 9); therefore it is 
perhaps not surprising that mature astrocytes may also provide support of 
dendrite elaboration. Subsequent refinement of the dendritic tree, however, 
may depend on neuronal activity or other factors in the environment. 
Reactive astroglia in the immature and mature mammalian brain. 
Astrocytes respond to a variety of insults to the CNS by rapid and vigorous 
reactive astrogliosis. Reactive astrogliosis is observed in acute conditions such 
as trauma or stroke, around neoplasms and also in neurodegenerative 
conditions such as Alzheimer's disease (Hatten et al 1991, Eddlestone and 
Mucke 1993). Studies of injury in the young mammalian brain demonstrate 
that reactive astrogliosis can occur and is present within 2-4 days of injury 
(Berry et al 1983, Barrett et al 1984, Moore et al 1987, Trimmer and 
Wunderlich 1990, Balasingam et al 1994). Injuries sustained during the 
embryonic or neonatal period, however, produce less astrogliosis relative to 
similar injuries in the adult (Dahl and Bignami 1976, Berry et al 1983, Barrett 
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et al 1984, Smith et al 1986, Rudge et al 1989, Rudge and Silver 1990, 
Balasingam et al 1994). Our results suggest that one of the functional 
consequences of reactive astroglia, reduced support of axon growth, is a 
feature of reactive astroglia in general and not necessarily the severity of the 
reaction. 
Reactive astroglia support primary dendrite number but not axon growth. 
The relationship of the neuroglial scar, in particular the reactive astrocyte and 
the failure of CNS regeneration is often linked (Berry et al 1983, Fishman et al 
1983, Reier et al 1983, Liuzzi and Lasek 1987); however, several recent 
experimental observations indicate that reactive astrocytes may, in some 
circumstances, support process outgrowth (Gage et al 1988, Anders and 
Johnson 1990, David et al 1990 Hatten et al 1991, Kawaja and Gage 1991). Our 
results suggest the interesting possibility that reactive astroglia are able to 
maintain dendrite growth, principally primary dendrite number. By contrast, 
axon elongation is reduced on both neonatal and mature reactive astroglia. 
These observations are consistent with previous in vitro investigations 
indicating that total neurite growth is reduced on reactive astroglia, 
particularly if the astroglia are matured in culture (Rudge and Silver 1990, 
McKeon et al 1991). The difference in growth, however, is almost entirely 
accounted for by the reduction in support for the longest neurite, suggesting 
that dendrite growth appears to be equally supported on reactive astroglia of 
different ages. A role for reactive astroglia in regeneration is consistent with 
tissue culture studies that consistently demonstrate that astroglia are an 
excellent substrate for process outgrowth and appear to regulate axon and 
dendrite growth separately (Denis-Donini et al 1984, Chamak et al 1987, 
Rousselet et al 1988 and 1990, chapter 9). 
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How do reactive astrocytes support dendrite growth? The production of 
astrocyte soluble peptide growth factors such as insulin like growth factor 1 
(Garcia Estrada et al 1992), nerve growth factor (Bakhit et al 1991), epidermal 
growth factor (Nieto-Sampedro et al 1988) and fibroblast growth factor 
(Finklestein et al 1988, Gomez-Pinilla et al 1992, Logan et al 1992) is increased 
after cortical lesions (Nieto-Sampedro et al 1982, Manthorpe et al 1983). The 
biologic significance of astrocyte released growth factors in the cascade of 
cellular events that occur after injury is uncertain; however, soluble peptide 
growth factors may mediate neuron protection (Vilbulsreth et al 1987, 
Mattson and Rychlik 1990, Cheng and Mattson 1991, Yamada et al 1991, Frim 
et al 1993, Maeise et al 1993), neurite outgrowth (Hatten et al 1988, Walicke et 
al 1988, De Konnick et al 1993) or attenuate the deleterious effects of excitatory 
amino acids on dendrite growth (Mattson et al 1989). This latter action may be 
particularly significant since excitatory amino acids are considered integral to 
the pathophysiology of neuronal injury and death in a variety of neurologic 
disorders (Lipton and Rosenberg 1994). There is considerable evidence that 
normal astroglial cells secrete diffusable neurite promoting factors, (Hatten et 
al 1988, Rousselet et al 1988 and 1990, chapter 9) which, in part, mediate 
dendrite growth independently from axon growth. Locally produced astroglial 
growth factors may be better able of support dendrite growth, whereas poor 
axonal growth may result from a lack of target derived neurotrophic factors 
from distant neuronal cell bodies. 
What accounts for limited growth of axons observed on reactive astroglia? 
Reactive astroglia have been postulated to create a mechanical barrier to 
process growth (Reier et al 1983). Analysis of the glial scar cellular 
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environment in vivo, however, demonstrates many additional factors that 
may contribute to decreased axon growth. For example, the glial scar, in 
addition to astrocytes is composed of a complex mixture of microglia, 
oligodendrocytes, neutrophils, macrophages and fibroblasts (Berry et al 1983, 
Matthewson and Berry 1985, Giulian et al 1989, Moreno-Flores et al 1993); 
each or these cell types may contribute to reduced axon growth (Fallon 1985, 
Schwab and Caroni 1988, Rudge and Silver 1990, Savio and Schwab 1990, 
Schnell and Schwab 1990, McKean et al 1991, Johnson-Green et al 1992, 
Giulian et al 1993, Thanos et al 1993). Too few of these cell types were present 
in our culture system for this to be a significant factor. We cannot, however, 
exclude that relatively small numbers of cells, such as microglia or 
oligodendrocytes, were able to release sufficient quantities of inhibitory 
substances to attenuate reactive astroglial support of process growth. 
Oligodendrocytes and myelin products can attenuate axon growth. For 
example, when sections of rat CNS are used as substrata for peripheral 
neuron growth, neurite elongation is possible on gray but not white matter 
(Savio and Schwab 1989, Crutcher 1989). In addition, when antibodies raised 
to proteins eluted from white matter (Caroni and Schwab 1988) are applied to 
transected nerves in vivo spinal cord regeneration can occur (Schnell and 
Schwab 1990). Similarly if oligodendrocytes are first eliminated by radiation, 
corticospinal axon growth is observed in the transected spinal cord (Savio and 
Schwab 1990). 
It is unlikely, however, that the few oligodendrocytes identified in the 
various glial monolayers contributed to the experimental observations. First, 
the reactive astroglia were obtained from gray matter which does not contain 
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the inhibitory molecules associated with oligodendrocytes (Caroni and 
Schwab 1988). Second, oligodendrocytes constituted less than 2.5% of the cells 
identified in the monolayers. In mixed cultures an oligodendrocyte to 
astrocyte ratio of least 6:1 does not modify the pattern of neurite growth 
supported by astroglia (Ard et al 1991). Purified cortical astroglia, or their 
conditioned medium, have also been observed to inhibit myelination and 
decrease oligodendrocyte proliferation and survival in vitro (Rosen et al 
1989). Finally, several experiments demonstrate that axonal regeneration is 
limited even in wounds where myelin or oligodendrocytes are not a major 
component (Carlstedt et al 1985), such as the nonmyelinated retina 
(McConnell and Berry 1982). In addition, Schwab and colleagues have 
acknowledged that even in the presence of myelin protein antibodies, the 
majority of axons fail to regenerate in transected nerves (Schnell et al 1993). 
Oligodendrocytes and myelin products may therefore only be relevant in 
injuries where they are present in large quantities such as when white matter 
is involved. 
Microglia are among the first cells to respond to CNS injury (Kitamura et al 
1978) and are postulated to stimulate astrogliosis (Giulian and Baker 1985, 
Giulian and Lachman 1985, Giulian et al 1988) or the release of other growth 
factors by astrocytes (Vige et al 1991). Reactive astrocytes, however, can also be 
observed in the absence of microglia or before microglial accumulation 
(Steward et al 1990, Mucke et al 1991). For example, cessation of neuronal 
activity (Canady and Rubel 1992) or alterations in the extracellular milieu, 
including the accumulation of glutamate (Petito et al 1991), can initiate 
reactive astrogliosis. 
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Can microglia contribute to the limited axonal growth observed on reactive 
astroglia? Several lines of evidence suggest it is unlikely that the microglia 
observed in our experiments had either a direct or indirect influence on axon 
growth. First, for microglia to modify astrocyte function, a greater density of 
microglia than were found in our experiments is required (Johnson-Green et 
al 1992). Few microglia were observed because: 1) simple penetrating injuries 
to the CNS appear to be accompanied by a limited microglial response (Rio-
Hortega 1932, Berry et al 1983, Balasingam et al 1994), and 2) the culture 
techniques used to produce the reactive glial monolayers are similar to those 
used by other investigators that reliably yield cultures from normal or injured 
brain that are up to 99% pure for astrocytes with few if any microglia 
detectable by techniques such as morphology, ultrastructural analysis and 
immunohistochemistry (Morrisson and DeVellis 1981, Kimelberg 1983, Raff 
et al 1988, Hansson 1988, Ingraham and McCarthy 1989, Rudge et al 1989, Kliot 
et al 1990, Wesselingh et al 1990, O'Malley et al 1992, Schwartz and Marini 
1992, Schwartz and Wilson 1992, Wang et al 1994). Second, microglia may not 
be active unless activated by mediators of inflammatory reactions (Giulian 
and Baker 1985, Heiter et al 1988 and 1990, Johnson-Green et al 1992, Giulian 
et al 1993) In addition, the release of microglial cytokines in vitro, which can 
affect the astrocytic reaction, is also only observed after stimulation by 
mediators of inflammatory reactions (Johnson-Green et al 1992, Giulian et al 
1993). Since these substances were not present in our culture system, it is 
unlikely that the few microglia identified were active or released cytokines. 
Finally, microglia appear to contribute to neurotoxicity both in vitro and in 
vivo (Thanos 1991, Giulian and Robertson 1990, Giulian 1993, Thanos et al 
1993). For example, cell culture studies indicate that microglia release a 
variety of cytotoxic agents, including free radicals that contribute to neuronal 
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death (Giulian and Baker 1986, Giulian et al 1993). Neuronal death often 
stimulates axonal sprouting (Steward 1989). In addition, neuron survival on 
monolayers derived from injured brain was not adversely affected suggesting 
that reactive astroglia rather than microglia were the dominant cell type in 
the glial monolayers. 
The most likely explanation for reduced axon growth observed on reactive 
astroglia is secondary to intrinsic cellular changes such as the expression of 
nonpermissive isoforms of growth promoting molecules and the expression 
of growth inhibiting molecules by the reactive astroglia. Increased expression 
of putative inhibitory molecules, which alone or in combination may inhibit 
elongation of neurites, have been observed in the injured brain. For example, 
increased immunoreactivity for tenascin and chondroitin sulfate 
proteoglycan (CS-PG) have been observed at sites of glial injury or in explants 
of cortical wounds derived from older animals (McKeon et al 1991, Laywell et 
al 1992). In the normal developing CNS both tenascin and CS-PG play an 
important role in restricting processes to the appropriate position (Snow et al 
1990a and 1990b, Steindler 1993). In the setting of injury, however, 
overexpression of inhibitory molecules may prevent regrowth of axons 
(McKeon et al 1991). This may have important functional consequences since 
inappropriate axonal connections may often be deleterious to CNS function. 
Continued astroglial support of primary dendrite growth, however, may 
enhance synaptic connections and provide a framework on which neuronal 
activity can refine neural structure. Astroglial mediated coordination of axon 
and dendrite growth in the mature or injured CNS may therefore represent a 
critical factor in the establishment of appropriate neuronal connections, 
adaptation to the environment and restoration of function. 
183 
THE MOLECULAR BASIS OF DENDRITE GROWTH: A PRELIMINARY 
ANALYSIS OF ASTROGLIAL CONDITIONED MEDIA AND REVIEW OF 
POTENTIAL MECHANISMS OF ASTROGLIAL MEDIATED DENDRITE 
GROWTH 
INTRODUCTION 
The establishment, development and maintenance of CNS neuron 
morpholgy and function, including the elaboration of axons and dendrites, 
depends, in part, on neuron-glial interactions. Neuron-glial interactions are 
mediated by a tremendous diversity of factors including soluble trophic 
molecules, molecules linked to cell membranes such as cell adhesion 
molecules, components of the extracellular matrix, physical parameters such 
as adhesion, and second messenger systems (Dodd and Jessel 1988, Barde et al 
1989, Lipton 1989, Sanes 1989, Crossin et al 1990, Bixby and Harris 1991, 
Reichardt and Tomaselli 1991, Thiery and Boyer 1992, Letourneau et al 1994). 
Each class of molecules or factors has been observed to influence major steps 
in neuron development including survival, migration, differentiation, axon 
growth and guidance, and synapse formation. 
Astroglia can modulate dendrite elaboration; the precise molecular nature of 
the factor or factors responsible for astroglial mediated dendrite growth, 
however, is not known. Diffusible protein factors released by astroglia 
(Rousselet et al 1988 and 1990, Seil et al 1992), and soluble components of the 
extracellular matrix associated with the surface of astrocytes (Rousselet et al 
1988 and 1990, LaFont et al 1992) have both been implicated in the 
morphogenetic process of cerebellar or mesencephalic neurons in culture. In 
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other tissue culture studies, previously characterized peptide growth factors 
or purified extracellular matrix molecules that are known to be expressed by 
astrocytes have also been observed to support dendrite growth from 
sympathetic, sensory or mesencephalic neurons (Chamak and Prochiantz 
1989, Lein and Higgins 1989, Lafont et al 1992, De Konnick et al 1993), or 
attenuate glutamate mediated dendrite regression in hippocampal neurons 
(Mattson et al 1989). 
Our earlier experimental observations demonstrated that cortical neuron 
dendrite growth is supported by astroglia that continuously condition the 
culture medium (chapter 9). In this preliminary study we asked what 
diffusible factor or factors released by astroglia may be responsible for 
mediating dendrite growth. To address this question we used protein 
biochemical techniques and a tissue culture bioassay to determine the 
following: 1) does astroglial conditioned medium demonstrate regional 
heterogeneity supporting dendrite growth and release of corresponding 
diffusible factors, 2) what are the biochemical characteristics of dendrite 
supporting medium, and 3) which previously characterized soluble peptide 
growth factors can support dendrite growth? The preliminary biochemical 
findings provide necessary background for the identification and purification 
of molecules that can promote dendrite growth in the CNS. 
MATERIALS AND METHODS 
The experimental methods are described in detail in chapter 7. Briefly, cortical 
neurons prepared from El8 mouse embryos were plated at low density on 
poly-D-lysine coated coverslips in: 1) astroglial conditioned medium obtained 
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from purified confluent mesencephalic or cortical glial monolayers, 2) 
conditioned medium that had been subjected to protein denaturation, 
molecular weight fractionation or heparin affinity chromatography, and 3) 
chemically defined medium to which soluble peptide growth factors were 
added. The growth of neurites from cortical neurons, identified by M6, NF-H 
or MAP2 immunoreactivity, was quantified after 5 days in vitro. Three 
experiments for each condition were carried out. A total of 30 double-labeled 
immunoreactive neurons were examined in each experimental condition. In 
a_ddition, 355 methionine radiolabeled protein samples were extracted from 
astroglial monolayers derived from various CNS regions and astroglial 
conditioned medium and subjected to SDS-PAGE electrophoresis. 
RESULTS 
Neurite outgrowth in astroglial conditioned medium. 
We have previously observed that neurons grown m an astroglial non-
contact coculture system elaborate dendrites depending on the CNS region 
from which the astroglia are derived (chapter 9). To confirm that astroglia 
release diffusible factors that regulate dendrite growth, we plated E18 cortical 
neurons at low density on polylysine coated coverslips in the presence of 
medium conditioned by cortical or mesencephalic astroglial monolayers. 
After 5 DIV axon and dendrite growth was quantified using morphologic and 
double-labeling immunohistochemical techniques. Table 9 summarizes the 
extent of axon and dendrite elaboration observed in coculture, non-contact 
coculture, or conditioned medium (CM). Figure 22 illustrates the main 
morphological differences observed between cortical neurons cultured in 

























































































































































































































































































































































































































































































































































































































































































































































































































































Dendrite growth was influenced by the CNS region from which the astroglial 
CM was derived (Table 9). In medium conditioned by cortical astroglia, the 
majority of cells, 72.9%, elaborated 3 or more primary dendrites. By contrast, 
the majority of neurons grown in medium conditioned by mesencephalic 
astroglia were unipolar or bipolar; only 21 % of neurons elaborated 3 or more 
primary dendrites (p<0.001). Neurons grown in medium conditioned by 
cortical astroglia extended longer primary dendrites (p<0.01) and elaborated a 
more extensive total primary dendrite arbor (p<0.001) than neurons grown in 
mesencephalic astroglial CM. 
Axon length did not differ significantly in medium conditioned from various 
CNS regions; 69.3% of axons examined in cortical astroglial CM were greater 
than 150µm in length, whereas 63% of neurons extended axons greater than 
150µm in mesencephalic astroglial CM (Table 9). 
Protein factors mediate neurite growth. 
To determine the molecular nature of the factors present in cortical astroglial 
CM that support dendrite growth, protein in the medium was denatured by 
boiling or trypsin treatment. To ensure optimal neuron survival, treated 
medium was supplemented with 20% of chemically defined medium. 
Embryonic (E18) cortical neurons were plated at low density on polylysine 
coated coverslips. Both heat inactivation and trypsin treatment reduced the 
cortical astroglial CM induced neurite elaboration and decreased the number 
of primary dendrites elaborated by neurons (Figure 22 and 23). In addition, 
neurons grown in treated medium elaborated shorter axons than neurons 
grown in CM. These results suggest that the factors present in the cortical 
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FIGURE 22: Cortical neurons growing in astroglial conditioned medium (CM) 
in vitro exhibit dendritic differences depending on the treatment of the 
medium. Representative fluorescent videophotomicrographs of El8 mouse 
cortical neurons grown in mesencephalic CM (a) cortical CM (b ), trypsin 
treated cortical astroglia CM (c), heparin bound cortical CM fraction (d), 
cortical CM fraction containing molecules greater than lOOkDa (e) and cortical 
CM fraction containing molecules between 10 and lOOkDa (f), and labeled 
with anti-M6 after SDIV. The majority of neurons extended multiple neurites 
in cortical CM, its heparin bound fraction and the fraction containing 
molecules between 10 and lOOkDa. By contrast, in medium conditioned by 
mesencephalic astroglia, cortical CM denatured by trypsin or greater than 
lOOkDa, the majority of neurons were uni or bipolar. (Scale bar= 10 µm) 
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FIGURE 23: The treatment of cortical astroglial conditioned medium (CM) 
influences the extent of the primary dendritic arbor elaborated by cortical 
neurons in culture. Histograms illustrating axon length (a), primary dendrite 
number (b), primary dendrite length (c), and total dendrite output (d) from 
mouse cortical neurons cocultured in cortical astroglial CM treated as 
described in Materials and Methods. Neurite elaboration was quantitatively 
examined in 30 randomly selected neurons growing in each conditioned 
medium using morphologic and double-labeling immunohistochemical 
techniques. Values represent the mean + SEM. (CCM = cortical astroglial 
conditioned media, HI = heat inactivated CCM, TRYP = trypsin treated CCM, 
S-100 = 10 to lOOkDa CCM fraction, P-100 = CCM fraction greater than lOOkDa, 
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medium that mediate both axon and dendrite growth are proteins, or require 
protein cofactors. 
Astroglial conditioned medium derived from various CNS sources contain 
different proteins. 
Protein gel electrophoresis was performed to determine whether astroglia 
derived from different CNS regions released different proteins into the 
culture medium. Glial monolayers and proteins released into the medium 
were labeled with 355 methionine. The electrophoretic profile of 355 
methionine labeled proteins extracted from astroglia of various CNS sources 
is illustrated in figure 24. Conditioned medium demonstrated different 
protein bands depending on the CNS region from which the astroglia were 
derived (Figure 24). By contrast, radiolabeled protein extracted from the 
various glial monolayers demonstrated markedly similar protein profiles. A 
single protein that was common to dendrite supporting medium, such as 
cortical or retinal astroglial CM, but was not visible in non-supporting 
dendrite medium, could not be identified (Figure 24). These results suggest 
that more than one protein factor present in astroglial CM may be capable of 
supporting dendrite growth. 
Factors between lOkDa and lOOkDa support dendrite growth. 
To determine the molecular weight of the factor present in medium 
conditioned by cortical astroglia that promotes process growth, CM was 
separated by ultrafiltration and dialysis into three molecular weight fractions: 
1) less than lOkDa, 2) between 10 and lOOkDa, and 3) greater than lOOkDa. 
Embryonic cortical neurons were plated at low density on polylysine and 
grown in each media fraction. 
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FIGURE 24: Conditioned medium (CM, a), but not protein extracted from the 
various glial monolayers (b ), demonstrated different protein bands depending 
on the CNS region from which the astroglia were derived. Proteins were 
labeled with 355 Methionine and samples subject to SDS-PAGE 
electrophoresis as described in Materials and Methods. A single protein that 
was common to dendrite supporting CM, such as cortex or retina, but not 
observed in dendrite non-supporting CM, such as mesencephalic CM, 
however, was not observed. (Fib = fibroblasts from meninges, SC= spinal cord, 
Mes = mesencephalon, Str = striatum, OB = olfactory bulb, Ret = retina, Ctx = 
cortex) 
A CTX MES RET 
B SC MES STR OB RET CTX 
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The extent of process outgrowth, after 5 DIV, depended on the molecular 
weight fraction of the medium (Figure 23). The majority of neurons (80%) 
grown in the cortical astroglial CM fraction between 10 and lOOkDa extended 
more than three primary dendrites. By contrast, few neurons (28.5%) grown 
in the CM fraction greater than lOOkDa extended more than three primary 
dendrites. Neuron survival was poor in the CM fraction containing 
molecules less than lOkDa; the majority of surviving neurons, however, 
were unipolar and elaborated only a short axon. Mean total primary dendritic 
arbor was greatest in the CM fraction containing molecules between 10 and 
lOOkDa and was nearly threefold greater than that observed from neurons 
cultured in CM containing molecules greater than lOOkDa. This effect was on 
both the number and length of individual primary dendrites (Figure 23). In 
contrast to dendrite growth, axon length was similar in the CM fractions 
between 10 and lOOkDa and the fraction greater than lOOkDa; axons in both 
these fractions, however, were nearly threefold longer than the axons 
elaborated by neurons grown in the fraction less than lOkDa. 
Fibroblast growth factor supports dendrite and axon growth. 
Several previously identified polypeptide growth factors, many of which are 
between 10 and lOOkDa in weight, have been observed to promote neurite 
outgrowth from CNS neurons (Morrison et al 1986, Walicke et al 1986, Hatten 
et al 1988). None of these investigations, however, have reported separate 
quantification of axon or dendrite growth. Are these growth factors able to 
support dendrite growth? In the next series of experiments we compared the 
number and length of neurites elaborated by E18 cortical neurons after 5 days 
in culture in the presence of various growth factors. Neurons were plated at 
low density (lxl04 cells/ml) on polylysine coverslips and maintained in 
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chemically defined medium. Growth factors were added one hour after 
plating the neurons, the culture medium was changed every two days and 
fresh growth factors were added at each feeding. Cultures were treated with 
cytosine arabinoside (AraC; lOµM) to eliminate the growth of non-neuronal 
cells. Heparin (lµg/ml) was added to FGF fed cultures to maximize the effect 
of the growth factor. 
Four groups of growth factors were tested: 1) astrocyte expressed growth 
factors that promote CNS neurite, but not specifically axon or dendrite, 
growth (aFGF and bFGF; Morrison et al 1986, Ferrara et al 1988, Hatten et al 
1988, Woodward et al 1992), 2) astrocyte expressed growth factors that promote 
neurite growth in the peripheral and sympathetic nervous system (NGF, 
TGF; Saad et al 1991, Chalazonitis et al 1992, Lazar and Blum 1992, de Konnick 
et al 1993), 3) growth factors of possible astrocyte origin that promote CNS 
neurite, but not specifically axon or dendrite, growth (EGF; Fallon et al 1984, 
Morrison 1987), and 4) growth factors of possible astrocyte origin that do not 
promote neurite growth (PDGF; Morrison et al 1987, Richardson et al 1988, 
Yeh et al 1991, Pringle et al 1992). The results of this analysis are illustrated in 
Figure 25. 
After 5DIV embryonic cerebral neurons maintained in the presence of aFGF 
and bFGF exhibited similar morphologies to neurons grown on cortical 
astroglial monolayers or in cortical astroglial CM. The majority of neurons 
grown in the presence of aFGF and bFGF were multipolar and typically 
extended a long axon and three or more primary dendrites. By contrast, 
neurons grown in the presence of TGF, EGF, NGF or PDGF were usually uni-
or bipolar and extended a relatively short axon. Interestingly, the length of 
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FIGURE 25: Fibroblast growth factor supports axon and dendrite growth from 
cortical neurons in culture. Histograms illustrating axon length (a), primary 
dendrite number (b), primary dendrite length (c) and total dendrite output (d) 
from mouse cortical neurons cultured in the presence of: PDGF (lOng/ml), 
NGF (200ng/ml), EGF (lOng/ml), TGF (lOng/ml), aFGF (lng/ml) and bFGF 
(lng/ml). All cultures were treated with cytosine arabinoside (AraC; lOµM) 
and heparin (lµg/ml) was added to FGF fed cultures. After 5DIV neurite 
elaboration was quantitatively examined in 30 randomly selected neurons 
growing in the presence of each growth factor using immunohistochemical 
and morphologic techniques. Values represent the mean + SEM. (PDGF = 
platelet derived growth factor, NGF = nerve growth factor, EGF = epidermal 
growth factor, TGF = transforming growth factor, aFGF = acidic fibroblast 
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individual primary dendrites from cortical neurons grown in the presence of 
TGF, EGF, NGF or PDGF were similar or longer than those elaborated by 
neurons grown in the presence of aFGF and bFGF. 
Fibroblast growth factor is probably present in cortical astroglial conditioned 
medium. 
Expression of FGF protein and mRNA is observed in astrocytes in vivo and 
in vitro (Ferrara et al 1988, Emoto et al 1989, Woodward et al 1992). To 
determine whether biologically active FGF is present in medium conditioned 
by cortical astroglia, CM was eluted on a heparin binding column. FGF is 
distinguished by strong binding to heparin (Shing et al 1984). The bound 
fragment was therefore reconstituted in chemically defined medium and fed 
to embryonic cortical neurons plated at low density on polylysine coverslips. 
Extensive dendrite and axon growth comparable to that observed in cortical 
astroglial CM, or in the presence of FGF, was observed in the heparin bound 
fraction of cortical astroglial CM (Figure 22 and 23). The majority of neurons 
(71.4%) elaborated four or more primary dendrites. Axons greater than 150µm 
in length were observed from 64.2% of neurons examined. Insufficient 
protein concentration was present in the non-bound elutant to determine 
whether the non heparin binding fraction of cortical astroglial CM was 
biologically active. 
DISCUSSION 
The results of the preliminary biochemical analysis reported in this study 
indicate that astroglia may mediate dendrite growth from cortical neurons in 
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culture by a soluble, heparin binding protein with a molecular weight 
between 10 and lOOkDa. Fibroblast growth factor (FGF), a heparin binding 
peptide growth factor was observed to support similar dendrite growth. Axon 
growth, however, was also supported by FGF, which does not fully explain 
the regional differences that astroglial demonstrate in promoting dendrite, 
but not axon growth. In addition, protein extraction and gel electrophoresis 
studies suggest more than one soluble, astroglial released factor may be 
capable of mediating dendrite growth. 
Astroglial conditioned medium and dendrite growth. 
Previous studies have provided evidence that astroglial conditioned medium 
can mediate dendrite growth from mesencephalic (Rousselet et al 1988 and 
1990) or cerebellar neurons (Seil et al 1992) in vitro. The extent to which 
dendrite growth is supported, however, is not clear. For example, astroglial 
conditioned media has been observed to promote Purkinje cell dendritic 
spine growth in some studies (Seil et al 1992), whereas other investigations 
suggest that astroglia provide some, but not all the necessary signals for 
complete dendritic maturation of Purkinje cells (Baptista et al 1994). 
It is not known how diffusible factors released by astroglia mediate dendrite 
growth. Prochiantz and colleagues have postulated that astrocyte derived 
factors capable of regulating dendrite growth primarily modulate adhesion of 
the neuron to the substrate (Prochiantz et al 1990, Rousselet et al 1990, Lafont 
et al 1992). Promotion of adhesion by diffusible factors, however, appears to 
depend on the presence of extracellular matrix (ECM) components. For 
example, FGF promotes the adherence of embryonic chick neural tube cells to 
ECM components but not to polycationic substances such as polylysine 
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(Kinoshita et al 1993). When astrocytes are cultured without serum, as in our 
coculture experiments, ECM components are frequently absent (Ard et al 
1991). In addition, when we examined the role of astroglial diffusible factors, 
neurons were cultured on polylysine yet the influence of astroglial 
conditioned medium on process outgrowth was still observed. It is thus 
feasible that diffusible factors stimulate dendrite growth directly through an 
as yet unidentified second messenger signaling pathway and in turn greater 
dendrite growth contributes to increased cell adhesion. 
Our results and those of others (Rousselet et al 1988 and 1990) are, in part, 
consistent with the hypothesis that a diffusible factor or factors released by 
astroglia are responsible for the regional heterogeneity observed in astroglial 
mediated dendrite growth. Other co-culture experiments, however, do not 
support this model. For example, Qian et al (1992) observed that axon, and not 
dendrite growth from spinal cord and hippocampal neurons was 
differentially supported by medium conditioned by astrocytes derived from 
different CNS regions; in these experiments a noncontact coculture system, 
rather than conditioned medium was used. 
The biochemical characteristics of astroglial conditioned medium associated 
with dendrite growth have not been extensively investigated. Protein 
degradation studies, however, suggest that a protein or protein cofactor 
present in astroglial conditioned medium can mediate dendrite growth 
(Rousselet et al 1988, Seil 1992). Although the precise molecular weight of this 
factor is not known, ultrafiltration and fractionation of astroglial conditioned 
medium indicate it has a molecular weight greater than lOkDa (Matthiessen 
et al 1989, Seil 1992). 
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Extracellular matrix molecules are found in astroglial conditioned medium 
that supports dendrite growth. For example, medium conditioned by 
mesencephalic astrocytes supports dendritic arborization from mesencephalic 
neurons in vitro; laminin, fibronectin and proteoglycans can be found in 
immunoblots of the medium (Rousselet et al 1988 and 1990). Quantitative 
immunoprecipitation experiments, however, demonstrate that medium 
conditioned by striatal astrocytes, which does not support dendrite growth 
from mesencephalic neurons, contains similar quantities of these matrix 
molecules. When separated into soluble and insoluble fractions by 
ultracentrifugation, the dendrite promoting properties of mesencephalic 
astrocyte conditioned medium are retained in the soluble fraction even 
though the same extracellular matrix components are found in both fractions 
(Rousselet et al 1990). The differential morphogenetic effects and regional 
heterogeneity that astroglial conditioned medium demonstrates may thus be 
attributable to different isoforms of the same molecule. 
Our preliminary biochemical analysis of cortical astroglial conditioned 
medium that supports dendrite growth, suggests that a heparin binding factor 
may be required for dendrite growth. The electrophoretic profile of other 
astroglial conditioned medium known to support dendrite elaboration, 
however, suggests that more than one factor may promote dendrite growth. 
Two factors known to promote neurite growth in vitro, fibroblast growth 
factor (Morrison et al 1986, Walicke et al 1986, Hatten et al 1988, Mattson et al 
1989) and fibronectin (Carbonetto et al 1983) are distinguished by heparin 
binding (Shing et al 1984, Price and Hynes 1985, Burgess and Maciag 1989, 
Thierry and Boyer 1992). The role of these molecules and other potential 
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molecular mechanisms of astroglial mediated dendrite growth including: cell 
adhesion molecules, other peptide growth factors, and components of the 
extracellular matrix is reviewed in the remainder of the chapter. 
Peptide growth factors and dendrite growth. 
Polypeptide growth factors mediate a variety of cell-cell interactions and are 
capable of promoting neuron proliferation, migration, differentiation, 
survival, and neurite growth in the CNS (Walicke et al 1986, Barde 1989, 
Reynolds and Weiss 1992, Svendsen et al 1994). The prototypical growth factor 
is nerve growth factor which was initially demonstrated to be required for 
neuronal survival in the peripheral and sympathetic nervous systems (Levi-
Montaclini 1987). In addition, NGF can induce dendritic arborization from 
sympathetic neurons in vivo (Snider 1988) or vertebrate sensory neurons in 
vitro (De Konnick et al 1993). 
In the CNS nerve growth factor has a more limited role (Hefti et al 1984, 
Kromer et al 1987, Barde 1989, Cattaneo and McKay 1990, Svendsen et al 1994) 
and has not been observed to promote neurite growth form CNS neurons 
(Banker 1980, Morrison et al 1987, Mattson and Rychlik 1990). Indirect 
evidence, however, suggests that homologous members of the neurotrophin 
family, brain derived growth factor (BDNF) and neurotrophin 3 (NT-3, Barde 
1989), may be capable of mediating dendrite growth in the cerebellum. For 
example, in primary cultures of Purkinje cells, granule cells regulate neuron 
differentiation and maturation of dendrites (Baptista et al 1994). These same 
cells express the neurotrophins NT-3 and BDNF (Lindholm et al 1993). 
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Can astroglia release neurotrophins or other peptide growth factors that can 
mediate dendrite growth? As discussed in chapter 9 immunohistochemical 
and in situ hybridization studies have demonstrated that astroglia can express 
a variety of growth factors or their mRNA in vitro and in vivo. Some of 
these factors such as TGF (Chalazonitis et al 1992), IGF-1 (Ang et al 1993), EGF 
(Morrison et al 1987) and FGF (Morrison et al 1986, Walicke et al 1986, Hatten 
et al 1988) have been observed to promote neurite growth from peripheral, 
spinal cord or central neurons; a specific promotion of dendrite growth from 
cortical neurons, however, has not been reported. 
Fibroblast growth factor. 
Several peptide growth factors were tested in this study; only acidic and basic 
fibroblast growth factor were observed to promote primary dendrite extension 
similar to that observed when cortical neurons were grown in medium 
conditioned by cortical astroglia. Both aFGF and bFGF are found in relatively 
high levels in the CNS (Burgess and Maciag 1989); immunohistochemical 
and biochemical studies demonstrate that FGF and its mRNA is primarily 
localized in astrocytes (Ferrara et 1988, Emoto et al 1989, Gomez -Pinilla et al 
1992, Woodward et al 1992). Whether FGF is found in medium conditioned 
by astrocytes, however, is not clear (Hatten 1988, Woodward et al 1992). Our 
preliminary results suggest biologically active FGF may be present in 
astroglial conditioned medium. FGF has a molecular weight of 18kDa and is 
distinguished by strong heparin binding (Shing et al 1984, Burgess and Maciag 
1989); these biochemical characteristics are consistent with the dendrite 
promoting properties demonstrated by biochemical analysis of medium 
conditioned by cortical astroglia. 
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A variety of potent in vitro effects for FGF have been identified in the 
developing and adult central nervous system (Cheng and Mattson 1991, 
Pittack et al 1991, Yoshida and Gage 1991, Engele and Bohn 1992, Chernusek 
1993, Maiese et al 1993, Meiners et al 1993, Vescovi et al 1993). In particular, 
tissue culture experiments demonstrate that the addition of FGF to culture 
medium improves survival and increases the number of process bearing 
neurons derived from several different CNS regions including cerebellum 
(Hatten et al 1988), cerebral cortex (Morrison et al 1986), and hippocampus 
(Walicke et al 1986, Mattson et al 1989). 
Can FGF promote dendrite growth? A specific effect on dendrite growth was 
not reported in the studies described above (Morrison et al 1986, Walicke et al 
1986, Hatten et al 1988). We observed that the addition of FGF to the culture 
medium supported primary dendrite growth from cortical neurons. The 
effect, however, was not specific for dendrites since axon growth was also 
promoted. These findings are, in part, consistent with previous studies in 
which the effects of astroglial conditioned medium and FGF on 
mesencephalic neurons have been compared; whereas FGF supported 
dendrite growth, the extent of FGF mediated arborization was not as great as 
that observed in conditioned medium (Rousselet et al 1988). Studies in other 
systems, such as the sympathetic nervous system, did not find that FGF 
promoted dendrite elaboration (Lein and Higgins 1989); collectively these 
observations suggest that the specific effect of FGF on dendrite growth is far 
from established. 
It is possible that FGF, alone, provides a non-specific promotion of neurite 
growth through its neurotrophic effect (Walicke et al 1986, Mattson et al 
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1989). For example, when added to hippocampal neurons in vitro FGF 
decreases glutamate neurotoxicity, primarily by reducing the expression of 
NMDA receptor proteins (Mattson et al 1993). This decreased vulnerability to 
neurotoxicity is associated with FGF attenuation of glutamate mediated 
dendrite regression (Mattson et al 1989). Specific effects of FGF, such as 
selective modulation of neurite outgrowth (Walicke et al 1986, Uniscker et al 
1987) may only result from interactions with the cell surface and the 
extracellular matrix (Gospodarowicz 1991, Rusolahti and Yamaguchi 1991, 
Yayon et al 1991, Letourneau et al 1994). 
The extracellular matrix, proteoglycans and dendrite growth. 
The extracellular matrix includes many diverse secreted molecules that are 
immobilized outside cells (Rutka et al 1988, Sanes 1989, Reichardt and 
Tomaselli 1991, Letourneau et al 1994). Several extracellular matrix 
components such as tenascin (Kruse et al 1985, Steindler et al 1989, Crossin et 
al 1990), laminin (Liesi et al 1983, Price and Hynes 1985, Ard and Bunge 1988 
Matthiessen et al 1989), fibronectin (Price and Hynes 1985, Liesi et al 1986, 
Matthiessen et al 1989), and proteoglycans (Ard and Bunge 1988, Johnson-
Green et al 1992, Lafont et al 1992) are expressed by astrocytes during CNS 
development. 
Immunohistochemical and in situ hybridization studies in vivo demonstrate 
that ECM components have acquired specialized functions and are generally 
expressed in the CNS during neuron migration, axon growth or 
compartmentation of the CNS (Dodd and Jessel 1988, Sanes 1989, Snow et al 
1990a and 1990b Steindler 1993, Letourneau et al 1994). Several in vitro 
experiments, however, suggest that some soluble ECM components, when 
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added to the culture medium, may also mediate neuron morphogenesis and 
dendrite growth (Chamak and Prochiantz 1989, Lein and Higgins 1989, Lafont 
et al 1992). By contrast, neurons grown on tenascin, laminin, or fibronectin 
culture substrates do not form mature dendritic arbors, instead axon 
elongation is favored (Lochter et al 1993, Baptista et al 1994). For example, 
when embryonic mesencephalic neurons are grown on a fibronectin substrate 
the majority of cells are unipolar and extend only an axon, whereas when 
soluble fibronectin is added to the culture medium the majority of neurons 
are multipolar (Chamak and Prochiantz 1989). 
Indirect evidence suggests soluble fibronectin may be responsible for dendrite 
growth from other neuronal populations. For example, soluble, but not 
bound, basement membrane extract derived from EHS sarcoma (BME) 
promotes dendrite growth from cultured sympathetic neurons (Lein and 
Higgins 1989). BME is similar to the high molecular weight fraction of serum 
that also promotes dendrite growth from cultured sympathetic neurons 
(Bruckenstein and Higgins 1988). Fibronectin and thrombospondin are 
common to both BME and serum. Can fibronectin promote cortical neuron 
dendrite growth? Astroglia in culture synthesize and secrete fibronectin into 
the culture medium that binds to heparin (Price and Hynes 1985, Thierry and 
Boyer 1992) consistent with our observation that a heparin binding protein 
found in astroglial conditioned medium supports dendrite growth. 
Fibronectin, however, is found enriched in high molecular weight subunits. 
By contrast, we did not observe dendrite growth in the astroglial conditioned 
fraction greater than lOOkDa, suggesting that fibronectin may not be 
responsible for cortical neuron dendrite growth. 
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Another important component of the extracellular matrix, proteoglycans may 
be involved in dendrogenesis. Proteoglycans are molecules composed of a 
protein core that carry long chains of various sulfated sugars or 
glycosaminoglycans (GAGs); dermatan, heparan and chondroitin sulfate are 
most commonly found in the brain (Herndon and Landon 1990, Letourneau 
et al 1994). Astrocytes express proteoglycans on their surface and excrete them 
into the extracellular environment (Johnson-Green et al 1992, LaFont et al 
1992). Whereas proteoglycans have generally been observed to direct axon 
growth and not promote neurite growth (Carbonetto et al 1983, Snow et al 
1990a and 1990b, Brittis et al 1992), specific glycosaminoglycans appear to 
influence neuron polarity. For example, when added as soluble molecules 
GAGs, such as heparan and chondroitin sulfate favor axon elongation and 
fasciculation, whereas dermatan sulfate supports both dendrite and axon 
growth from hippocampal neurons in culture (LaFont et al 1992). Substrate 
bound GAGs, however, do not promote neurite growth (Carbonetto et al 1983, 
Snow et al 1990a and 1990b, LaFont et al 1992). 
Proteoglycans and other components of the extracellular matrix bind many 
soluble substances including growth factors (Gospodarowicz 1991, Rusolahti 
and Yamaguchi 1991, Thierry and Boyer 1992). For example, the mode of 
action of FGF is intimately linked to the extracellular matrix (Gospodarowicz 
et al 1986, Yayon et al 1991). There are several interactions between the ECM 
and soluble factors that may be of potential benefit to dendrite growth: 1) the 
local trophic effect of the soluble factor may be augmented by protecting it 
from degradation and providing a matrix bound reservoir (Yayon et al 1991), 
2) protein kinases or other second messenger systems that can alter 
cytoskeletal composition can be activated (Bixby 1989, Yayon et al 1991), 3) a 
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direct link between the soluble factor and cytoskeleton can be provided 
(Pollerberg et al 1986, Rapraeger et al 1986), and 4) internalization and 
intracellular targeting of growth factors to cytoplasmic or nuclear signal 
transducing receptors can occur (Rusolahti and Yamaguchi 1991, Damsky and 
Werb 1992, Thierry and Boyer 1992, Woodward et al 1992). Collectively, these 
interactions may be fundamental to translating a soluble factor released by 
astroglia into a regionally specific, instructive signal for dendrite growth. 
Cell adhesion and dendrite growth. 
Cell adhesion has been implicated in cell-cell sorting, cell migration, axon 
growth, and the formation of neuronal connections during development of 
the nervous system (Dodd and Jessel 1988, Grumet 1991, Doherty and Walsh 
1992); does adhesion influence dendrite growth? Several experimental 
observations suggest that dendrite growth in vitro may require high adhesion 
conditions, whereas axons grow in low adhesion conditions (Prochiantz et al 
1990, Rousselet 1990, LaFont et al 1993, Lochter et al 1993). First, the 
correlation of a small cell body diameter and absence of dendrites in vitro has 
been observed in sympathetic (Bruckenstein and Higgins 1988) and central 
neurons (Autillo-Touati et al 1988, Rousselet et al 1990), whereas cells that 
bear dendrites exhibit a larger cell body surface (Rousselet et al 1990, Lochter et 
al 1993). Second, neurons grown under conditions permissive for dendrite 
growth are less likely to detach from the culture substrate after shaking than 
neurons that do not elaborate dendrites (Lieth et al 1990, Rousselet et al 1990). 
Finally, cytoskeletal perturbation experiments demonstrate that decreasing 
the compression force exerted by microtubules to overcome low adhesion 
conditions affects axon growth to a greater extent than dendrite growth 
(Abosch and Lagenauer 1993, LaFont et al 1993). 
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The relationship between adhesion and dendrite growth may not be 
straightforward. First, the model proposed by Prochiantz and colleagues 
suggests that axon growth is initiated in low adhesion conditions whereas 
dendrite growth is initiated in high adhesion conditions (Prochiantz et al 
1990). The implication of this model, that a neurite is differentiated as soon as 
it is initiated, is not consistent with: 1) observations of developing neurites in 
culture made by Banker and colleagues (Caceres et al 1986, Dotti et al 1988, 
Goslin et al 1990, Kleinman et al 1994), or observations described in chapter 8 
which demonstrate that neurites are not differentiated at initiation of 
outgrowth, and 2) observations described in chapter 10 that demonstrate that 
astroglia are primarily responsible for the maintenance of the dendritic arbor 
rather than the initiation of process outgrowth. Second, the association 
between cell adhesion and cell spreading is not clear. For example, 
measurements of the adhesive forces developing between cells, or between 
cells and substrate demonstrate dissociation between the initial binding and 
subsequent cell spreading of fibroblasts (Lotz et al 1989). We did not observe 
an association between cell body diameter and dendrite growth (see figure 
llb). Adhesion, however, was not quantified. These results, although not 
conclusive, suggest that there may not be a simple relationship between 
dendrite growth, cell spreading and adhesion. Finally, it s not clear from the 
experiments described by Prochiantz and colleagues (Rousselet et al 1990, 
LaFont et al 1992) and other investigators (Leith et al 1990, Lochter et al 1993) 
what comes first: does an extensive dendritic arbor result from increased 
adhesion or is increased adhesion a consequence of greater dendritic growth? 
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Other experiments suggest that a simple functional correlate between the 
degree of adhesion and neurite growth may not exist (Buettner and Pittman 
1991, Kapfhammer and Schwab 1992, Lemmon et al 1992, Smith 1994). For 
example, antibodies to N-cadherin or integrin Bl inhibit neurite elongation 
from retinal neurons growing on astroglial monolayers, but quantitative 
attachment assays do not demonstrate an association between this inhibition 
and decreased neuronal adhesion to the astroglial monolayers (Neugebauer 
et al 1988). Instead adhesive signals from the environment may lead to 
changes in cytoplasmic second messengers such as calcium, inositol 
phosphates, or protein kinases that in turn can regulate cytoskeletal 
organization and provide an instructive signal for process growth (Bixby 
1989, Reichardt and Tomaselli 1991, Atashi et al 1992, Damsky and Werb 1992, 
Thierry and Boyer 1992, Lee 1993). 
A large variety of different molecules, collectively known as cell adhesion 
molecules (CAM's) mediate adhesion. The cell adhesion molecules include 
three families of integral membrane proteins: 1) the immunoglobulin 
superfamily, 2) the cadherin family, and 3) integrins (Edelman 1987, Takeichi 
1988, Crossin et al 1990, Grumet 1991, Doherty and Walsh 1992). Neurite 
outgrowth on astroglial surfaces has been demonstrated to be dependent on 
several adhesion molecules (Neugebauer et al 1988, Tomaselli et al 1988); 
whether these molecules can specifically mediate dendrite growth is not 
known. 
Growth factors can regulate cell adhesion and in turn CAM's can modify the 
cellular response to growth factors (Saad et al 1991, Thierry and Boyer 1992, 
Kinoshita et al 1993). The interaction between growth factors and CAM's can 
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occur m both a paracrine and autocrine fashion and may, in part, be 
responsible for translating the release of diffusible factors into locally relevant 
cues for dendrite growth. In addition, several aspects of CAM structure, such 
as multiple exon genes, multiple structural domains that exhibit different 
biological functions, and a high degree of glycosylation (Grumet 1991, 
Reichardt and Tomaselli 1991, Frei et al 1992, Kapfhammer and Schwab 1992, 
Appel et al 1993) may give rise to regional or developmental specific isoforms 
through alternative RNA splicing or post-translational processing (Pollerberg 
et al 1987, Doherty et al 1990, Acheson et al 1991, Doherty and Walsh 1992, 
Mayford et al 1992, Zhang et al 1992). The functional significance of these 
structural attributes are not known; it is plausible, however, that they may 
contribute to the regional heterogeneity observed in astroglial mediated 
dendrite growth. 
Molecular diversity and synergism. 
How do regional differences in astroglial mediated dendrite growth occur at a 
molecular level? The structure of various molecules and their receptors that 
may be involved in dendrite growth encodes a tremendous potential 
functional diversity (Reichardt and Tomaselli 1991, Damsky and Werb 1992, 
Doherty and Walsh 1992, Frei et al 1992, Hynes et al 1992, Appel et al 1993, 
Tomaselli et al 1993, Letourneau et al 1994). Multiple genes, alternative 
splicing and distribution of the various receptors further increase the 
functional diversity of these molecules (Acheson et al 1991, Reichardt and 
Tomaselli 1991, Hunter et al 1991, Zhang et al 1992). Astrocytes in different 
regions, therefore, may release: 1) unique molecules for that region, 2) 
different concentrations of the same molecule, 3) molecules at different times, 
or 4) different isoforms of the same molecule. 
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Rather than molecular structural heterogeneity, regional heterogeneity in 
astroglial mediated dendrite growth may also result from cellular 
characteristics of individual neurons or astroglia complementing the action 
of one or two astroglial diffusable factors. First, soluble factors such as peptide 
growth factors can influence ECM production or regulate receptor expression 
and adhesion strength (Rossino et al 1990, Thierry and Boyer 1992, Kinoshita 
et al 1993, Meiners et al 1993). In turn cell-cell and cell-substrate adhesion 
molecules modify the cellular response to growth factors (Saad et al 1991, 
Thierry and Boyer 1992, Kinoshita et al 1993). Second, growth factors and 
cytokines regulate the expression of other growth factors (Huff and Schreier 
1990, Yoshida and Gage 1991, Zafra et al 1992, Chernusek 1993), or are 
biologically active only when combined with other soluble peptide factors 
(Cattaneo and McKay 1990, Vescovi et al 1993). Third, neurotransmitters and 
neural activity appear to work in concert with some growth factors to 
determine neuron development, (Mattson et al 1989, Cohen-Cory et al 1991). 
Finally, the different external signals from growth factors, extracellular 
matrix, neurotransmitters, and cell adhesion molecules can converge on the 
same cellular pathways and cooperate to induce a biological response 
(Damsky and Werb 1992, Thierry and Boyer 1992, Letourneau et al 1994, 
Williams et al 1994). The signal transduction mechanisms that connect 
intercellular interactions with intracellular control of process growth, 
however, are just beginning to be understood. 
The molecular mechanisms that mediate dendrite growth are far from fully 
elucidated but appear complex and diverse. Furthermore, it is becoming 
increasingly apparent that molecular mechanisms such as peptide growth 
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factors, components of the extracellular matrix and cell adhesion molecules 
are part of a complex interactive process that mediates neuron differentiation, 
maturation and function (Cattaneo and McKay 1990, Saad et al 1991, Damsky 
and Werb 1992, Doherty and Walsh 1992, Thierry and Boyer 1992, Kinoshita et 
al 1993, Meiners et al 1993, Letourneau et al 1994). Part of the challenge of 
developmental neurobiology is to unravel the molecular mechanisms of 
dendrite growth. The preliminary results described in this report are far from 
the answer, but provide needed initial information. 
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CONCLUDING REMARKS 
The vast majority of neurons in the central nervous system extend two types 
of processes, axons and dendrites. The precise mechanisms that regulate 
growth of dendrites remain largely unknown, however, an understanding of 
dendrite growth is important for several reasons: 1) dendrite structure 
underlies many aspects of normal CNS function (Stewart 1989, Midtgaard 
1994) and adaptation to the environment, 2) dendrite growth appears to 
compensate for neuronal loss in the aging CNS (Coleman and Flood 1986) 
and correlate with functional recovery after injury (Jones and Schallert 1994), 
and 3) dendritic abnormalities are observed in many acute neurologic insults 
(Mattson et al 1988a, Kitigawa et al 1989, Taft et al 1992, Shigeno et al 1993) and 
chronic neurodegenerative conditions (Buell and Coleman 1979, McKee et al 
1989, Jacobsen 1991). 
Numerous factors, that influence or may influence growth and maturation of 
the dendritic arbor of central nervous system neurons have been identified 
(summarized in Table 10). The results of the experiments reported in this 
study are consistent with and extend previous observations that astroglia can 
influence the shape of the dendritic arbor elaborated by CNS neurons (Denis-
Donini et al 1984, Chamak et al 1987, Autillo-Touati et al 1988, Rousselet et al 
1988, Prochiantz et al 1990, Rousselet et al 1990). The novel and important 
findings of this study are: 
1) Astroglia can influence dendrite growth from cerebral cortical neurons. 
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2) The astroglial influence on dendrite growth is principally on primary 
dendrite number rather than on the length of dendrites. 
3) Astroglia demonstrate regional differences in their ability to maintain, but 
not initiate, cortical neuron primary dendrite growth. 
4) Homotypic astroglia appear best able to maintain the primary dendritic 
arbor once it is elaborated; the ability to support primary dendrite growth, 
however, is not confined to homotypic astroglia only. 
5) Axon and dendrite growth are separately regulated by astroglia, however, 
the number of primary dendrites maintained by cortical neurons in vitro may 
be related to the cell's axon growth. 
6) Mature astroglia are able to support primary dendrite, but not axon growth. 
7) Reactive astroglia are able to support primary dendrite but not axon 
growth. 
8) Astroglia release a diffusable factor or factors that can specifically influence 
the growth of primary dendrites, either alone or in combination with other 
factors. 
9) Diffusible heparin binding proteins that have a molecular weight between 
10 and lOOkDa may play a role in astroglial mediated dendrite growth. 
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TABLE 10: FACTORS AFFECTING THE DEVELOPMENT OF THE 
DENDRITIC ARBOR OF NEURONS IN THE CENTRAL NERVOUS SYSTEM 
FACTOR REFERENCE 
Intrinsic Van der Loos 1965, Bartlett and 
Banker 1984a, Banker and Waxman 
1988, Neale et al 1993 
Cytoskeleton Matus et al 1986, Matus 1988 
Neuron density Chamak et al 1987 
Afferent innervation Rakic and Sidman 1971, Cowan et al 
1980, Rubel et al 1981, Perry and 
Linden 1982, Deitch and Rubel 1984, 
Mattson et al 1988, Leventhal et al 
1989 
Synapse formation Vaughan 1989, Schilling et al 1991 
Neurotransmitters Mattson et al 1988a, 1989b 
Neuronal activity Weiss and Pysh 1978, Smith 1981, 
Rogowoski and Feng 1982, 
Greenough et al 1985, Ramoa et al 
1988, Sanes et al 1992a and 1992b, 
Jones and Schallert 1994 
Sensory deprivation or enrichment Valverde 1968, Globus et al 1973 
Local astroglial environment Denis-Donini et al 1984, Chamak et al 
1987, Autillo-Touati et al 1988 
Astroglial diffusible factors Rousselet et al 1988 and 1990, Seil et 
al 1992 
Peptide growth factors Mattson et al 1989 
Extracellular matrix components Chamak and Prochiantz 1989 






Prochiantz et al 1990, Rousselet et al 
1990, LaFont et al 1993 
Goldstein et al 1990, McEwan 1991 
Hauser et al 1989 
Rees and Harding 1988 
Table 10: The table summarizes select published data describing factors that 
influence or are postulated to influence the morphology of the dendritic arbor 
elaborated by neurons in the central nervous system. 
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Do these tissue culture observations correlate with in situ or in vzvo 
findings? Transplant and lineage studies of the developing cortex (Renfranz 
et al 1991, Schlagger and O'Leary 1991, McConnel 1992), and a variety of 
studies using Golgi, autoradiographic, ultrastructural, biochemical and 
immunohistochemical techniques in situ indicate that cortical neuron 
dendrite growth occurs once neurons have reached their final position in the 
developing mammalian cortex (Ramon y Cajal 1954, Shoumakis and Hinds 
1978, Crandall et al 1986, Miller 1988). Furthermore, qualitative and 
quantitative in situ studies in many areas of the developing CNS, including 
the cerebral cortex, demonstrate that primary dendritic projections, although 
immature are established before the arrival of afferents and formation of 
synapses (Wise et al 1979, Hammer et al 1981, Petit et al 1988, Snider et al 
1992, Sutton and Brunso-Bechtold 1993). Subsequent dendritic development, 
maturation, and refinement is influenced by afferents and synaptic activity 
(Weiss and Pysh 1978, Smith 1981, Rogowoski and Feng 1982, Greenough et al 
1985, Ramoa et al 1988, Leventhal et al 1989, Black et al 1990, Kolb and Gibb 
1991, Sanes et al 1990, 1992a, and 1992b, Jones and Schallert 1994). Thus, in 
vivo, it is likely that the local astroglial environment can influence 
maintenance of the primary dendritic arbor. 
We propose therefore that: 1) neurons have an intrinsic ability to initiate 
growth of multiple undifferentiated dendrites, 2) the basic structure of the 
neuron, the primary dendritic arbor, is largely determined by activity 
independent mechanisms and maintained by the local astroglial 
environment, and 3) establishment of the fully differentiated dendritic arbor 
and its subsequent refinement into a highly tuned and functional circuit with 
other neurons depends on neuronal activity and environmental influences. 
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These postulates are consistent with a recent study which demonstrated that a 
combination of purified cerebellar astroglia and granule cells mediated full 
differentiation of Purkinje cell dendrites in culture (Baptista et al 1994). 
What is the biological significance of the results reported in this study? A 
mechanism allowing separate but coordinated regulation of axonal and 
dendritic growth may represent a critical factor in the establishment of 
neuronal circuitry. For example, the repression of dendrite growth may 
reduce the time for the axon to reach its specific target, particularly when the 
target is a source of further neurotrophic factors. Alternatively, the basic form 
of a neuron, its primary neuritic arbor, prior to the arrival of afferents may be 
critical for establishing appropriate and specific connections in the CNS. In 
the mature CNS the maintenance of the primary dendritic arbor and 
coordinated dendrite and axon growth may represent a means to adapt to the 
ever changing environment, whereas in the injured CNS these mechanisms 
may prove crucial in reforming appropriate neuronal connections and 
restoring function. The preliminary biochemical findings in this study 
suggest that it may eventually be feasible to develop an endogenous means of 
recreating these events. 
Astroglia are but one of many environmental signals which, in conjunction 
with intrinsic factors, influence the final form and function of neurons in the 
central nervous system (Table 10). It is unlikely that astroglia act in isolation 
or promote dendrite growth in a simple fashion. Instead intrinsic and 
extrinsic signals interact and act in cumulative and diverse ways to regulate 
dendrite development and differentiation. The challenge of developmental 
neurobiology is to determine how the immense number of signals are 
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coordinated and information interpreted to generate the enormous variety of 
dendritic arbors and their complex interrelationships in the CNS. An 
understanding of these developmental processes has implications in such 
pathologic conditions as head and spinal cord injury, stroke, subarachnoid 
hemorrhage and degenerative conditions such as Parkinson's and 
Alzheimer's Disease. While these results may not be immediately 
transferable to the clinical treatment of neurologic disorders, they are 
essential if we are ever to devise systematic treatment to actively promote 
recovery and regeneration of the injured or diseased brain. 
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